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ABI ankle brachial pressure index
AGE advanced glycation endproduct
AMI acute myocardial infarction
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DD duplex Doppler
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64. ABSTRACT
Introduction: Critical leg ischaemia is a manifestation of the atherosclerotic disease and reflects the
state of the whole vascular tree. If no prodromal symptoms have been present, critical leg ischaemia may
be difficult to distinguish from other complaints with similar symptoms. This study will show that up to
one third of patients may experience critical leg ischaemia as the first manifestation of vascular disease.
This should be taken into consideration both in the clinical assessment and epidemiological estimations.
Aim of the study: The aim of this study was to assess the clinical course of peripheral arterial disease
leading to critical leg ischaemia, to assess the accuracy of basic pressure measurements in critically
ischaemic patients and to evaluate the role of pressure measurement in predicting major amputation risk.
Furthermore the outcome of critically ischaemic patients in a selected patient population as well as on
population basis was to be studied. The influence on regional differences and referral model on
amputation risk was assessed. 
Methods:
The study was divided into five parts:
1. The variability of pressure measurements in CLI-patients was assessed when measured by
inexperienced (22 legs) and experienced (33 legs) personnel.
2. In 110 critically ischaemic patients treated conservatively, the predictive value of ankle and toe
pressure measurements and ankle brachial indices in terms of major amputation risk was assessed.
3. The duration of the symptoms preceding and indicating critical leg ischaemia was recorded in 100
patients referred to the vascular surgical clinic.
4. The outcome in 105 conservatively treated critical leg ischaemia-patients was investigated
retrospectively using hospital records and death certificates.
5. The revascularisations of CLI-patients as well as age and sex-standardised amputation incidences in
the Uusimaa hospital district during 7 years were assessed on registry basis.
Results:
1. Interobserver agreement between experienced measurers proved to be good while measurements
performed by inexperienced measurers showed considerable variation. 
2. Ankle and toe pressure measurements or ankle brachial indices performed by experienced measurers
on critically ischaemic patients not suitable for reconstruction, showed no clear cut-off levels for
subsequent major amputation risk and predictive value proved to be poor.
3. A considerable proportion (37%) of the patients with critical leg ischaemia presenting to the vascular
surgical clinic had not experienced symptoms of claudication prior to developing critical leg
ischaemia
4. In a population of conservatively treated critically patients the cumulative leg preservation was 54%
at one year. Cumulative survival was 46%, and 28% of the patients were alive with a preserved leg.
5. The amputation incidences showed considerable variation throughout the study years. No clear
differences could be found between populations treated in different health care models. In fact, the
implementation of these models was discovered to be poor, as a large proportion of critically
ischaemic patients were never subjected to vascular surgical evaluation before major amputation.    
7Conclusions: 
To identify CLI-patients, objective assessment methods such as ankle systolic pressure measurements
are needed. In our study untrained measurers achieved widely varying pressure values in critically
ischaemic patients while the measurements performed by skilled vascular technicians were all within
acceptable variability. Therefore experienced nurses or technicians should perform ABI measurements
in order to achieve reproducible results. 
Still, pressure measurements alone are not enough to determine the major amputation risk of critically
ischaemic patients, as confirmed in this study. Although low pressures are associated with higher
amputation risk, no cut-off values could be determined. Therefore ABI-measurements can only be used
as supplementary information to clinical judgement when assessing leg viability.  
Overall, critical leg ischaemia has a very poor prognosis. If surgical, or endovascular, improvement of
the blood supply to the leg is not provided in due course; half of the legs will be amputated within a
year. A high mortality is an additional issue in critically ischaemic patients, due to the involvement of
the whole vascular tree. More than two thirds may lose either their life or their leg within one year after
diagnosis. Critical leg ischaemia should be regarded as a predictor of an adverse outcome to the patient
or the limb. 
One of the main goals of vascular surgery is to prevent major amputations in order to enable the patients
to keep their independence and mobility for their remaining lifetime. In order to avoid unnecessary
amputations, it is important to direct sufficient vascular treatment on time to those patients potentially
benefiting from reconstructive measures. Each municipality has to decide how to provide their
population with the necessary treatment. Different treatment models have been designed in order to cut
down costs and to provide services in the most efficient way. The proper implementation of these
models is a prerequisite to achieving better results in the treatment of critical leg ischaemia, as well as
evaluating each model’s success.
85. INTRODUCTION 
Atherothrombotic disease comprises both the atherosclerotic process of the arterial wall and the
thrombotic process within the artery. Although it is mainly caused by atherosclerosis, alterations of the
blood flow as well as coagulation disorders affect the development and progression of the disease. It is a
common disease in the industrialised world and, by affecting a major proportion of the population, is the
most significant health problem in the western world (Vogt 1992). Diseases developing on the basis of
general atherosclerosis are among the leading death causes (Statistical Yearbook of Finland 2000). 
The changing age structure in western civilisations, due to higher life expectancy and lower birth rates,
causes atherothrombotic disease to be a growing burden on the narrowing resources of our health care
and social systems. The conditions arising from arterial occlusive disease affect the functional status in
several fields of life both for the individual and for society. Atherothrombotic disease causes
considerable morbidity and mortality (Statistical Yearbook of Finland 2000). It thus has an impact on
national economies especially as the population structure changes in industrialised nations. Early
diagnosis of one of the manifestations of atherothrombotic disease in the coronary arteries, carotid
arteries or arteries feeding the lower limbs, makes early intervention possible, facilitating treatment as
well as prevention of other manifestations (Favilli 1998). 
The prevalence of symptomatic arterial occlusive disease in the lower extremities has been shown to be
between 1,2 - 6,6% (Bainton 1994, Stoffers 1996) from the 5th decade of life onwards, while the
proportion of asymptomatic arterial occlusive disease is estimated to be two thirds of the total amount of
PAD (da Silva 1990). Critical leg ischaemia is the most severe form of arteriosclerosis in the leg, with
arterial circulation impaired to an extent that it endangers the viability of the leg (Second European
Consensus Document 1992, TASC 2000). It warrants treatment to avoid major amputation, which in
most of the cases results in loss of functional ability frequently leading to hospitalisation. 
Therefore the treatment of critical leg ischaemia (CLI) is one of the most important tasks for vascular
surgery. Although only 5% of symptomatic arterial occlusive disease in the lower limb is estimated to
become critically ischaemic (TASC 2000), the workload caused by CLI in vascular surgical units is
disproportionately high. CLI accounts for a major part (35%) of vascular surgical activity in Finland
(Luther 2000). 
96. REVIEW OF THE LITERATURE
6.1  Occlusive arterial disease - a systemic disease
Atherothrombotic arterial disease is a systemic disease affecting, in principle, all of the arterial tree with
the carotid-, coronary- and lower limb vessels being areas of predilection. Its distribution differs
individually, but it can grossly be estimated that almost all patients presenting with symptoms of
claudication or critical leg ischaemia do have manifestations of the disease elsewhere, and the disease
surfacing as occlusive arterial disease of the lower limbs only reflects the state of the overall vasculature
of the patient (Newman 1993). 
The clinical manifestations of atherosclerosis in different organs have been reported to occur with
different frequency. According to the Framingham Study coronary heart disease (CHD) showed
symptoms in males 8 times as often as cerebrovascular disease and PAD twice as often. In females
cerebrovascular disease and PAD occurred equally often and the incidence of coronary heart disease was
fourfold that of PAD (Kannel 1970). More recent data by Aronow and Ahn emphasises a more even
distribution with CHD occurring approximately twice as often as the other two manifestations (Aronow
1994). Similar proportions have been reported in the CAPRIE study, although CAPRIE data is skewed
by the selection process of the study (CAPRIE steering group 1996, Dormandy 1999d). It can
nevertheless be used to illustrate the overlap of different manifestations. (Figure 1). 
 
Figure 1:     Distribution of the three main manifestations of occlusive arterial disease
CVD       CHD CHD
CVD 
      
       15%             33%             24.6%                 29.9%
            13%             7.3%
           9%             3.3%
5% 3.8%
14%    11.9%
                    12%
      19.2%
        
     PAD                           PAD
Aronow & Ahn 1994 CAPRIE 1996 as modified by Dormandy
(Dormandy 1999d)
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In addition to the different sites of manifestation the degree of atherosclerosis and its symptoms differs.
The severity of the disease is of considerable importance as it influences treatment and prognosis.
Therefore various classifications have been developed. In coronary heart disease several classifications
have been developed, the most commonly used are the classification of the New York Heart Association
(The Criteria Committee of the New York Heart Association 1964, Goldman 1981) and the Canadian
Cardiovascular Society Grading Scale (Campeau 1976). These classifications grade the patients
according to the experienced fatigue and angina pectoris symptoms in different degrees of exercise
(Table 1).
Table 1: 
The New York Heart Association Functional Classification of Coronary Heart
Disease (NYHA-classification) and the Canadian Cardiovascular Society Grading
Scale for Angina Pectoris (CCS classification): 
NYHA CCS
Class I Patients with cardiac disease Ordinary physical activity does not 
but without resulting limitations cause angina: No angina occurs when  
of physical activity. walking or climbing stairs; angina
Ordinary physical activity does does occur with strenuous or rapid
not cause undue fatigue, palpitation or prolonged exertion at work or
dyspnoea or anginal pain. recreation
Class II Patients with cardiac disease resulting Slight limitation of ordinary activity:
in slight limitation of physical activity. when walking or climbing stairs 
They are comfortable at rest. rapidly; walking uphill; walking
Ordinary physical activity results in or stair-climbing after meals, in the
fatigue, palpitation, dyspnoea or anginal cold, in the wind, under emotional 
pain. stress, or only during the first few hours
after awakening; walking more than
two blocks on the level and climbing
more than one flight of ordinary stairs
at a normal pace and in normal
conditions.
Class III Patients with cardiac disease resulting Marked limitation of ordinary physical
 in marked limitation of physical activity: Angina occurs when walking
activity. They are comfortable at rest. one or two blocks on the level and 
Less than ordinary physical activity climbing one flight of stairs in normal
causes fatigue, palpitation, dyspnoea conditions and at a normal pace
or anginal pain.
Class IV Patients with cardiac disease resulting Inability to carry on any physical 
in inability to carry on any physical activity without discomfort: Anginal 
activity without discomfort. Symptoms syndrome may be present at rest.
of cardiac insufficiency or of the anginal 
syndrome may be present even at rest. 
If any physical activity is undertaken, 
discomfort is increased.
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Similar to the NYHA-classification, the complications of atherosclerotic cerebrovascular disease can be
classified according to severity. These have, however, very different ramifications compared to the
stages in cardiovascular disease, as the course and prognosis are much less predictable. Three main
stages of cerebral blood flow impairment can be distinguished. The most severe form is the irreversible
brain infarction, with symptoms differing according to the site of infarction. In cases with prolonged
ischaemic symptoms dissolving slowly within weeks, the term PRIND (prolonged reversible ischaemic
neurological deficit) has been used, but largely abandoned today. The least severe symptom of cerebral
blood flow impairment is the transient ischaemic attack (TIA) usually lasting only a few minutes, but
often being a prodromal sign of an eventual brain infarction (Goldstein 2001, Straus 2002).   
Altogether the varying degrees of the different manifestations can roughly be summarised as shown in
Table 2, with coronary infarction being equivalent to permanent brain infarction and tissue loss in the
leg, which could be understood as leg infarction. 
Table 2: Comparison of the main symptomatology in the main manifestations of atherothrombotic
disease
Coronary artery         NYHA§ II / NYHA III        NYHA IV   AMI*
Disease CCS ¤II / CCS III    CCS IV
Cerebrovascular           TIA$     PRIND£    Cerebral 
disease                infarction
Peripheral                       Claudication                       Rest pain        Ulcer/
vascular disease      Gangrene
Fontaine                         (Fontaine II)    (Fontaine III)     (Fontaine IV)
Classification
Rutherford            1-3             4       5-6  
Categories
§ NYHA= New York Heart Association functional class, ¤Canadian Cardiovascular Society
Classification, *AMI= acute myocardial infarction, $ TIA= transient ischaemic attack, $PRIND=
prolonged reversible ischaemic neurologic deficit
As the disease is a systemic one and the severity of one manifestation reflects the state of the total
vascular tree (Newman 1993b), it is clear that most of these patients are multimorbid. The other vascular
manifestations of atherosclerosis have to be taken into account when planning the treatment of PAD
(von Knorring 1995, Hertzer 1984). The existing coronary artery disease represents a major operative
risk and reflects the high in-hospital cardiac mortality during and after surgery for PAD in general
(Sprung 2000) and CLI in particular. 
The general nature of the disease, apart from causing different manifestations of the disease, affects the
survival of the patients with occlusive arterial disease. Patients suffering from claudication have a life
expectancy about 10 years less than the general population (Boyd 1962, Bloor 1961). Accordingly, the
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level of ankle brachial pressure indices (ABI) is reflected in the survival of the patients with increasing
mortality rates proportional to declining ABIs (Jelnes 1986, Mc Dermott 1994, Howell 1989). Patients
with an ankle brachial pressure index less than 0.9 have a significantly higher mortality than patients
with an ABI above 0.9 (Newman 1993a, Vogt 1993, Leng 1996 b). The cause of death is reported as
related to vascular causes in 53-80% percent of the patients with occlusive arterial disease (Jelnes 1986,
Leng 1996, Davey Smith 1990, Bainton 1994). Intermittent claudication increased the risk for
cardiovascular death with a relative risk of 2.67 (Leng 1996 a). CHD is reported to occur in persons with
PAD 2.5 times as often as in persons without PAD (da Silva 1990). Hertzer et al showed that patients
with PAD (either IC or CLI) had up to 90% coronary artery disease detectable by coronary angiography,
and 57% of it was classified as advanced or severe (Hertzer 1984). 
Seen from the reverse angle CHD is associated with 2.7 times the risk of developing IC than in the
general population (Murabito 1997). IC is developed 2.3 times more often in persons with previous
evidence of CHD than without CHD (da Silva 1990). In the presence of coronary artery disease PAD is
reported in 33% of elderly patients (Aronow 1994). The prevalence of PAD in patients with coronary
heart disease is in proportion with the severity of coronary lesions: In a study by Atmer 18% with mild
coronary artery disease were found to have PAD, measured using pressure measurements and digital
PVR, while 32% of those with marked coronary artery disease had detectable PAD (Atmer 1995).
 
Cerebrovascular disease (CVD) has been reported to exist in 15-57% of PAD-patients (Klop 1991,
Aronow 1994, Alexandrova 1996). Asymptomatic cerebrovascular disease has been found to be three
times as common as symptomatic CVD (Alexandrova 1996).
In obduction studies the atherosclerotic lesions seem to predominate in the proximal lower limbs, with
Rutherford Dow discovering an involvement of 100% in the superficial femoral arteries and popliteal
arteries, while coronary arteries showed an involvement of 75% and carotid arteries 58% (Rutherford
Dow 1925). In a Finnish autopsy study the femoral artery was involved in 73%, coronary arteries in 83%
and carotid arteries in 68% of the cases (Vankka 1967). These numbers are much higher than the
prevalence of symptoms caused by atherosclerotic manifestations (Figure 1) (Aronow 1994). It can be
speculated that coronary and cerebral circulation may be more vulnerable to atherothrombotic events
than the lower limb circulation. Whether this is due to better collateral formation, slower progression of
the disease, diameter of the vessel involved or differing tolerance for ischaemia of the various tissues, is
unclear.
 
 
6.2 Etiology of Critical leg ischaemia
6.2.1 Pathophysiology of atherosclerosis and its peripheral manifestations
Atherosclerosis is a complex process with several etiologic factors influencing its progression. Not all
etiologic factors are known, but some factors associated to atherosclerosis have been identified. It is not
merely a degenerative process of the vessel wall, but is promoted by chronic inflammation and
disturbing the function of the endothelium, an important factor in vascular autoregulation, growth and
anticoagulation (Davies 1993). The initiation of an atherosclerotic lesion is a result of increased shear
stress or endothelial damage, LDL migration into the intima and an inflammatory response to injury. 
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The endothelium is a layer of cells lining the inner surface of the vessel wall. It plays an important role
in maintaining vascular tone by secretion of several compounds participating in vasodilation and
vasoconstriction (Davies 1993). Prostanoids, nitric oxide and endothelium derived hyperpolarisation
factors mediate a local vasodilation while endothelin and vascular angiotensin II produce a
vasoconstriction (Davies 1993). Oxygen radicals inactivate nitric oxide and inhibit prostanoid synthesis,
acting as vasoconstrictors. Other features of the endothelium include interactions with the coagulatory
system, inflammatory response and regulation of vascular growth (Davies 1993). All these functions are
affected by endothelial damage, being both the cause and result of atherosclerosis. 
The increased shear stress existing in arterial branches and curvatures causes the architecture of the
endothelium to change. The endothelial cells become polygonal in shape and do not have any particular
orientation as opposed to the cells in linear flow environments, which are ellipsoid in shape and are
aligned according to the direction of the blood flow (Lusis 2000). The junctions of the polygonal cells
show an increased permeability, causing areas of increased shear stress to show a predisposition for
atherosclerotic lesions (Lusis 2000). 
Increased permeability or injury of the endothelial layer allows lipoprotein particles, predominantly
LDL, to accumulate in the intima. LDL particles diffuse passively through the endothelial layer,
especially when blood LDL-levels are elevated (Lusis 2000). 
In the intima, native LDL undergoes minimal oxidisation through lipoxygenases. This minimally
oxidised LDL is an inflammatory substance, which causes the endothelial cells to produce
proinflammatory and adhesion molecules such as M-CSF (macrophage colony stimulating factor),
selectins, and monocyte chemotactic protein. Monocytes will subsequently adhere to the endothelium
and migrate across the endothelial layer into the intima. Once the monocytes have reached the intima,
they will proliferate and differentiate into macrophages (Lusis 2000, Hiatt 2000). 
The LDL is further modified by oxidisation, lipolysis, proteolysis and aggregation in which the mast
cells located in the vessel wall seem to play an important role (Kovanen 1993). Myeloperoxidase,
produced by endothelial cells and macrophages, causes oxidisation of the LDL-particles through highly
reactive oxygen species. Secretory phospholipase promotes oxidisation while sphingomyelinase seems
to mediate aggregation of LDL. The hereby-modified LDL inhibits the production of nitric oxide in the
endothelial cells, hampering vascular autoregulation.
Unlike the native LDL, the modified LDL is readily taken up by macrophages via scavenger receptors.
The macrophages become foam cells (Lusis 2000, Hiatt 2000), which accumulate in the intima forming
fatty streaks (Kovanen 1993).
In the inflammatory process macrophages and T-lymphocytes secrete cytokines and growth factors,
which promote smooth muscle cell migration from the media and their proliferation (Lusis 2000). The
proliferation is further promoted by platelet-derived growth factor and angiotensin II produced by the
renin angiotensin pathway (Lusis 2000). The migrated smooth muscle cells transform from “contractile”
to “secretory” cells and secrete fibrous elements as the extracellular matrix (Hiatt 2000) thus producing a
fibrous plaque. Occasionally even smooth muscle cells may become engorged with lipid and become
foam cells as well (Hiatt 2000).
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The fibrous plaque will grow by accumulating more lipids and cells and by producing more extracellular
matrix. The growth is initially directed towards the adventitia and subsequently towards the lumen of the
vessel (Lusis 2000). Through growth of the plaque the lumen of the vessel becomes stenosed and will
occasionally occlude.
With the apoptosis of the foam cells, producing the necrotic core of the plaque, the fibrous plaque gains
complexity (Hiatt 2000). Its necrotic core consists of lipids and cell debris. It is rich of tissue factor, an
important trigger in the coagulation cascade, which is secreted by macrophages and endothelial cells
activated by oxidised LDL (Lusis 2000). Advanced plaques may also contain haemorrhages and
neovascularisation and finally vessel wall cells transforming into osteoblast-like cells. These secrete a
matrix scaffold, that calcifies resembling bone formation and results in plaque calcification (Lusis 2000,
Hiatt 2000).
Acute ischaemic events such as acute myocardial infarction or “acute on chronic”-ischaemia are usually
triggered by acute thrombosis caused by plaque rupture. Rupture usually occurs in plaques with thin
fibrous caps and increased numbers of inflammatory cells (Lusis 2000). The inflammatory cells inhibit
matrix production and produce proteases that degrade extracellular matrix (Lusis 2000). Thereby
inflammation plays an important role in plaque rupture and subsequent thrombosis. In addition to the
thrombogenic features of the atherosclerotic vessel wall, flow dynamics and the properties of the blood
itself play a significant role in the development and course of the atherothrombotic disease.
Critical leg ischaemia may be caused by several mechanisms, the most important of which is
atherosclerosis with superimposed thrombosis and resulting obstruction of the arterial inflow of the foot.
Other possible mechanisms are diabetic microangiopathy (Tooke 1995, Ubbink 1993) and inflammatory
diseases such as thromboangiitis obliterans (Olin 2000).
6.2.2 Risk factors for – and factors related to the progression of – occlusive arterial disease
The risk factors for general atherothrombotic diseases are associated with peripheral arterial disease.
Different risk factors have different areas of predilection. Hypertension is one of the main risk factors for
carotid artery disease and stroke (Cutler 1989), while the role of hypertension in the progression of the
lower limb arterial disease is much less pronounced. Dyslipidaemia is accepted as a main risk factor for
coronary heart disease, while its role in peripheral arterial disease is not yet established (Tasc 2000). In
contrast to that, smoking is the main risk factor for lower limb arterial disease, especially of the proximal
vessels (von Knorring 1992), while diabetes is the most important risk factor for distal PAD of the legs
(Kannel 1979) and development of critical leg ischaemia (Dormandy 1999c) (Figure 2).  
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Figure 2: The influence of different risk factors on the progression of PAD with subsequent development
of CLI (Dormandy 1999c)
 Smoking  
         x3 ABI <0.5         
         x3
         Diabetes   
              x4
Risk of developing CLI              
  ABI <0.7
      x2   
            Age>65
        x2    
     Dyslipidaemias 
x2
6.2.2.1 Diabetes
6.2.2.1.1 Diabetes and atherosclerosis
Diabetes mellitus is one of the most important risk factors causing PAD and the most important
etiologic factor in the development of CLI. It carries a 2-4-fold risk to develop PAD (Beckman 2002,
Kannel 1979) with one third of the diabetics being affected (von Knorring 1992). A 5-fold risk to
develop CLI (Fisher 1999), a 5-fold major amputation risk (Melliere 1999) and a 15 -24-fold risk to
undergo any amputation (Eggers 1999) have been reported. The duration of diabetes correlates with the
incidence of PAD (Beckman 2002) while in non-diabetic patients the incidence is strongly associated
with age. Diabetes affects mostly the distal arteries of the lower extremities (Beckman 2002, Mc Millan
1997, Chantelau 1984) and is in the first place regarded as a macrovascular disease (LoGerfo 1984). At
least a third of all CLI patients are reported to be diabetic (Bailey 2003, The Vascular Surgical Society of
Great Britain and Ireland 1995). Even up to 55% of critically ischaemic patients in surgical series have
been reported to be diabetics (Luther 1994)
Atherosclerosis is the main complication in diabetes. Like the risk of developing PAD, the risk for both
stroke and coronary heart disease is 1,5-4-fold in all age groups together (Beckman 2002, Pell 1970). In
the younger age group the stroke risk is reported to be about 10-fold (Beckman 2002). The prevalence of
silent myocardial ischaemia is reported to be 10% in insulin dependent diabetics and 8% in non-insulin
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dependent diabetics (Koistinen 1990). It is estimated to occur 2-3 times as often in diabetics than in non-
diabetics (Koistinen 1990), which as such is prone to cause difficulties in identifying and treating
diabetic patients with CHD in time. 
6.2.2.1.2 Mechanisms contributing to the development of PAD and CLI in diabetics
In diabetes, PAD and CLI, as well as other manifestations of atherothrombotic disease such as CHD, are
caused by several mechanisms: vascular autoregulation is impaired, atherogenesis is enhanced by
leukocyte migration and coagulation is increased. Furthermore, diabetes causes large artery stiffness
with peripheral flow reduction (Suzuki 2001) and ensuing mediasclerosis. 
Hyperglycaemia impairs nitric oxide-mediated vasodilation by blocking the endothelial nitric oxide
synthase (eNOS). Hyperglycaemia as well as insulin resistance increase the production of reactive
oxygen species, which also inhibit nitric oxide synthesis and decrease the synthesis of vasodilatory and
antiplatelet prostanoids (Beckman 2002). Furthermore, diabetes increases the production of
vasoconstricting substances, especially endothelin, which causes vasoconstriction, renal salt and water
retention, activation of the renin-angiotensin system and vascular smooth muscle hypertrophy. Other
vasoconstricting substances increased by diabetes are vasoconstrictor prostanoids and angiotensin II
(Beckman 2002). Vascular autoregulation is severely impaired by this, but systemic blood pressure may
be elevated as well.  
In addition to vascular autoregulatory impairment, diabetes participates directly in atherogenesis by
facilitating T-cell lymphocyte and monocyte migration into the intima. Proinflammatory mediators and
the expression of leukocyte adhesion molecules on the endothelial surface are enhanced by
hyperglycaemia induced increase of oxidative stress and advanced glycation end-products (AGE). The
resulting migration of leukocytes into the intima leads to fatty streak- and atheroma-formation (Beckman
2002). This is even enhanced by lipid abnormalities, which are often coexisting in diabetic patients.   
6.2.2.1.3 Diabetes and mediasclerosis
Diabetes is an important and common cause for mediasclerosis (Goss 1989, Chantelau 1984, Lepäntalo
2003) causing pseudohypertensive pressure values through incompressible arteries, and thereby
hampering the basic assessment of PAD- patients (Laing 1998). Arterial wall stiffness has been seen to
correlate with PAD symptoms, but not with pressure values (Taniwaki 2001). This is understandable, as
stiffening of the arteries and mediasclerosis is prone to distort the measured pressure values.
Mediasclerosis is most often affecting the larger arteries and predominantly the lower limb, but there is
evidence that mediasclerosis may affect brachial arteries as well (Edmonds 1982). Especially in patients
with diabetic neuropathy even the small arteries in the digits and toes are not always spared (Young
1993). The involvement of digital arteries is, however, rare and toe pressures can still be used as
alternative to ankle pressures in patients with pseudohypertensive ankle pressures (Young 1993). Early
mediasclerosis is seen to occur already in childhood as an elasticity reduction of the large arteries
(Pillsbury 1974, Mc Millan 1997). Arterial tissue damage in diabetes is thought to be directly mediated
through advanced glycation end-products (AGE) such as HBA1 (Mc Millan 1997, Yki-Järvinen 2000).
The ageing of the arterial collagen fibres is accelerated through production of matrix metalloproteinases
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(Beckman 2002) and elastin formation is slowed down by hyperglycaemia (Mc Millan 1997) resulting in
arterial wall stiffening. Later, the walls of elastic arteries thicken and eventually calcify, contributing
further to the stiffening of the arterial wall. The thickening of the basement membrane in diabetics has
been seen not to inhibit oxygen diffusion but to change the anatomy of the vessel (LoGerfo 1992)
6.2.2.1.4 Diabetes and atherosclerotic plaque formation 
The hampering of collagen production and accelerated ageing of collagen fibers causes, apart from
arterial wall stiffness, also plaque instability (Beckman 2002). It has been observed that in diabetics the
advanced atherosclerotic plaques have less smooth muscle cells than in controls (Beckman 2002).
Smooth muscle cells are supposed to produce collagen fibres to stabilise the plaque. Diabetes seems to
promote plaque instability by inhibiting smooth muscle cell migration and increasing smooth muscle cell
apoptosis (Beckman 2002). In addition to plaque instability in diabetes, the production of tissue factor, a
major procoagulant, is enhanced and the level of factor VII is increased, while the level of endogenous
anticoagulants such as antithrombin III and protein C are decreased (Beckman 2002). Furthermore,
intrinsic platelet activating features are enhanced, while platelet stabilising features are diminished in
diabetes (Beckman 2002). As a result, diabetic patients are particularly prone to develop thrombi and
have impaired fibrinolysis.
6.2.2.1.5 Other complications of diabetes
Other complications of diabetes such as diabetic neuropathy, diabetic retinopathy and diabetic
nephropathy may contribute to the development and progression of PAD in diabetic patients. 
Diabetic sensory neuropathy, which in vascular surgical patients is often not sufficiently investigated,
masks pain as a warning signal and is partly responsible for many small injuries occurring in daily life
(Mc Millan 1997, Pecoraro 1990, Laing 1996). These injuries may lead to neuroischaemic ulcers, if
nutritional flow is inadequate to support the inflammatory reaction necessary for wound healing. Due to
neuropathy these injuries and following ulcers often stay painless and the patient is frequently unaware
of their existence (Laing 1998) which, due to lacking treatment, may deteriorate the situation even
further. Additionally the neuropathy itself constitutes an independent risk factor for the development of
ulcers and thereby for the amputation risk (Adler 1999). Apart from sensory neuropathy Diabetes also
causes autonomic neuropathy (Laing 1998), which leads to impairment of the cardiac response (Hornung
1989), affects gastric and enteral motility and disturbs the vascular regulatory function, especially
reflectory vasoconstriction (Mc Millan 1997, Takahashi 1998). Loss of reflectory vasoconstriction can
produce orthostatic hypotension, as well as direct damage to the endothelium in the lower extremity
through elevated intra-arterial pressures in the foot (Tooke 1995). This is thought to be the mechanism
behind the unusually distal localisation of the atherosclerotic lesions in diabetic patients (Mc Millan
1997). Another feature in diabetic autonomic neuropathy is the opening of small peripheral
arteriovenous shunts - an ”autosympathectomy” - which, although increasing the overall blood flow in
the periphery, in fact decreases the nutritive blood flow to the tissue (LoGerfo 1992, Laing 1998,
Takahashi 1998, Lepäntalo 2000).
Diabetic retinopathy frequently deteriorates the eyesight of the patient through microaneurysm and
microvessel loop formation, haemorrhage and macular oedema (Mc Millan 1997). The loss of eyesight
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is prone to increase the risk of injuries in the legs, which may – in conjunction with impaired blood
supply – lead to critical leg ischaemia. 
Diabetes may cause renal insufficiency through thickening of the glomerular basement membrane and
collagen and high carbohydrate connective tissue deposition (Mc Millan 1997). It may lead to renal
failure and eventually to dialysis, additionally promoting the process of atherosclerosis. 
6.2.2.1.6 Diabetes in combination with other risk factors
Smoking in conjunction with diabetes increases the levels of leukocyte adhesion molecules more than in
non-diabetics, thus further promoting the development of intimal inflammation and atherogenesis
(Takeuchi 2002).
Adult type diabetes often coexists with dyslipidaemia (McMillan 1997) and hypertension, together
referred to as the metabolic syndrome with predominance for vascular complications (Isomaa 2001). 
6.2.2.1.7 Treatment of diabetic vascular manifestations
Although diabetes affects vascular function on every level, therapy may reduce the complication rate:
Insulin therapy in type II diabetics has been observed to improve vascular function (Vehkavaara 2000),
and intensive treatment has been observed to delay the development of complications and lower the
complication rate of type I diabetes  (Reichard 1993, The Diabetes Control and Complications Trial
Research Group 1993). 
Revascularisation procedures have been seen to succeed equally to procedures performed in non-diabetic
patients (LoGerfo1992). Even microcirculation has been observed to improve to a certain degree after
successful revascularisation (Arora 2002).
 
6.2.2.1.8 Diabetic microcirculatory disease
The evidence concerning microcirculatory changes in diabetics seems somewhat contradictory. It has
been generally accepted that microvascular lesions play a great role in the development of late vascular
diabetic complications (Tooke 1995). Conrad, however, found no difference in the number of small
vessel occlusions between diabetics and non-diabetics when examining amputated legs using casts of the
vasculature (Conrad 1967). Irwin even reported no difference in vascular blood flows between patients
with and without small vessel disease (Irwin 1988, LoGerfo 1992). Despite the absence of great
anatomical changes, the function of the microvasculature may be compromised with subdued
autoregulation. Diabetes is characterised by increased microvascular flow in peripheral tissues (Tooke
1995) resulting from loss of autoregulation. The increased flow and increased pressure (Sandemann
1992) results in increased shear stress in the vessels (Tooke 1995). The growing shear stress causes
tissue injury through increased permeability of the endothelium. With ongoing tissue injury, basement
membrane thickening and arteriolar hyalinisation develops, further interfering with microvascular
autoregulation (Tooke 1995). Additionally to the direct effects of microvascular disease on nutritive
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flow, some evidence suggests that it may participate in the development of diabetic neuropathy, which
initially seems to be an ischaemic disease (Tesfaye 1994).
Poor glycaemic control has been reported to compromise microcirculatory velocities (Jörneskog 1998),
while diabetes itself has been seen to increase microvascular blood flow (Ubbink 1993). In some of the
diabetic patients, capillary density seems to be lower (Ubbink 1993) than in non-diabetics, suggesting
that although anatomical changes are not present in all diabetic patients, they may be a significant
feature in a subgroup. 
6.2.2.2 Other risk factors
6.2.2.2.1 Smoking
Major adverse effects of cigarette smoking have been known for decades, and new evidence on the
adverse effects continues to be published. The association of tobacco smoking and claudication
symptoms has been reported as early as 1911 (Erb 1911). Still, in spite of recurring government
campaigns against smoking, as well as restrictions and taxes imposed on the selling of tobacco products,
the smoking of tobacco continues to be a major health problem in the Western World and a growing
problem in developing countries. Educational campaigns have, however, been shown to reduce smoking
in Finland (Leppo 2003). At the same time the cardiovascular mortality has markedly decreased in
Finland (Favilli 1998, Jousilahti 2003). Despite the widely spread knowledge of the adverse effects of
the use of tobacco products, smoking cessation rates are still very low and patients do not receive
enough support (Cassar 2003, Hobbs 2003).
Tobacco smoke contains nicotine that mediates vasoconstriction and causes a strong addiction, as well
as carbon monoxide, which causes hypoxia. A further variety of different substances are also contained
in tobacco smoke, some of which may damage the vasculature through induction of oxidative stress and
subsequent endothelial damage (Glasser 1996), while others are carcinogenic or are affecting the
coagulation system (Lassila 1989). Tobacco smoking is also believed to facilitate the migration of
leukocytes into the intima by increasing the level of circulating adhesion molecules, which has been
observed both in non-diabetic and especially in diabetic subjects (Ridker 1998, Takeuchi 2002). In this
manner smoking may directly promote inflammation, plaque formation and thrombosis.
   
Tobacco smoking is the strongest risk factor for peripheral occlusive arterial disease (Fielding 1985, von
Knorring 1992), which has been confirmed in several epidemiological studies (Murabito 1997, Bainton
1994, Meijer 1998, Fowkes 1992). Smoking is reported to double or almost triple the risk to develop
atherosclerosis, with the risk increasing with advancing age (Kannel 1985, da Silva 1990, TASC). The
risk is dose dependent and increases with the number of cigarettes smoked per day (Fielding 1985,
Lassila 1988). It is, however, noteworthy that occasional smokers also have an increased risk for
atherosclerosis in comparison to non-smokers (da Silva 1990, TASC). In contrast to diabetes, the
distribution of arterial lesions caused by smoking is more concentrated on the larger vessels (Vogt 1992)
although an independent association between smoking and stroke has been observed (Shinton 1989,
Wolf 1988). Interestingly, tobacco smoking seems to be more strongly associated with PAD than to
coronary heart disease (Heliövaara 1978, Fowkes 1992, Lepäntalo 1991). In comparison to non-smokers
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the development of symptomatic intermittent claudication is reported to be as high as 9-fold in all
smokers (Hughson 1978a), with the risk being 15-fold in men and 7-fold in women (Hughson 1978a).
 Figure 3: Relative risk of developing PAD when smoking (compared to non-smokers). 
Disease progression to rest pain and critical leg ischaemia is strongly associated with continued smoking
(Jonason 1986, Quick 1982). Ankle pressures have been shown to decline in persistent smokers
compared to the patient group having given up smoking (Quick 1982, Jonason 1986). Even a correlation
between smoking and amputation for ischaemia has been reported (Liedberg 1983). 
Claudication itself is associated with a reduced life expectancy, but even among claudicants smoking is
associated with an increased mortality (Reunanen 1982). Accordingly, smoking cessation has been
reported to improve the prognosis of claudicants (Hughson 1978b) with reduced mortality (Jonason
1987, Fielding 1985), lowering of amputation rates (Juergens 1960), improved graft patency (Smith
1996), improved walking distance (Quick 1982), improved ankle pressures (Quick 1982) and improved
symptoms (von Knorring 1992).
Additionally to being atherogenic itself, tobacco consumption has a synergistic effect in combination
with other risk factors (Fielding 1985, Lassila 1989). In the Edinburgh artery study tobacco smoking
increased the risk for PAD significantly in diabetic subjects (MacGregor 1999). Elevated non-HDL
cholesterol also had a greater influence on ABI pressure values in current smokers than in ex- and non-
smokers (Fowkes 1992).
Smoking is strongly associated with thromboangiitis obliterans (or Bürger’s disease) that involves
mainly small and medium sized vessels of the limbs. Although the aetiology itself is not known, tobacco
consumption seems to play an important role in the development and persistence of the inflammatory
and thrombotic process of Bürger’s disease (Olin 2000). Unlike atherosclerosis, Bürger’s disease
involves both arteries and veins and is characterised with marked cellular proliferation and inflammatory
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infiltrate in the thrombus (Olin 2000). Bürger’s disease occurs predominantly in young smoking men,
but the number of elderly women affected is increasing of late. It causes peripheral claudication and
peripheral trophic lesions and may therefore be mistaken for atherosclerosis. It even may coexist with
atherosclerosis making a distinction more difficult and may aggravate its course (Olin 2000). The main
therapeutic measure is complete abstinence of tobacco products – without it all other forms of therapy
can be regarded as palliative (Olin 2000).       
Tobacco consumption is also the main reason causing chronic obstructive pulmonary disease as well as
emphysema (Fielding 1985), lowering the pulmonary capacity and thereby additionally affecting the
oxygen supply of blood and tissue. Another common complication of smoking is coronary heart disease,
which together with a compromised pulmonary function poses an additional risk factor for perioperative
complications. 
6.2.2.2.2 Hypertension
The association between hypertension and PAD has been observed in several epidemiological studies
(Kannel 1985, Murabito 1997, da Silva 1990, Bainton 1994, Meijer 1998, Beach 1980), while in other
studies no association could be detected (Reunanen 1982, Davey Smith 1990). It may be speculated that
these differing results were influenced by factors like different age of the population studied, use of only
systolic pressure, or the method by which PAD has been identified. Arterial hypertension is not a single
feature but has different implications in different age groups. In a younger age group it is generally
accepted that elevation of the diastolic blood pressure poses a risk to the arterial vasculature as well as to
the heart itself  (Cutler 1989, MacMahon 1989). In elderly patients, however, the stiffening of the
arteries and isolated systolic hypertension seems to play a greater role in terms of cardiovascular risk
(Donnelly 2002). Therefore, more emphasis is to be directed to isolated elevation of systolic blood
pressure (Stokes 1989, MacGregor 1999) and ensuing high pulse pressure.
The localisation of arterial lesions caused by long lasting hypertension differs somewhat from the
distribution of lesions seen in diabetes. Hypertension damages the whole arterial tree with an emphasis
on the heart, the carotid and cranial arteries (Cutler 1989, Stokes 1989) as well as renal arteries (Whelton
1989). Thus the relative importance of hypertension as a risk factor for PAD and its progression to CLI
is not of the same magnitude as for CHD and especially for CVD. 
The risk to develop PAD increases proportional to the systolic pressure level (Kannel 1985). A diastolic
pressure above 95mmHg in men and 85mmHg in women is also associated with an increased risk to
develop PAD (Kannel 1985). Similarly, in a Danish study on 60-year-old subjects, elevated systolic or
diastolic pressures are both associated with an increased risk for PAD (Schroll 1981)
Hypertension is frequently associated with insulin resistance, hyperinsulinaemia, non-insulin dependent
diabetes, obesity, abnormalities in fibrinolysis and dyslipidaemia, especially with small density LDL
particles together comprising an entity called ”metabolic syndrome” (Reaven 1988, TASC 2000). All of
these risk factors are independently being associated with an increased risk for general atherosclerosis
(Grundy 2004). Peripheral vascular disease has been associated with metabolic syndrome (Costa 2004).
Metabolic syndrome has been found to correlate with a higher rate of coronary heart disease and smaller
LDL size (Isomaa 2001). In metabolic syndrome neuropathy seems to be related to small dense LDL-
particles (Isomaa 2001).  
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6.2.2.2.3 Thrombophilia
Thrombophilia has been increasingly associated with the development and progression of PAD (Burns
2001). In young PAD-patients as many as 76% have a hypercoagulable state (Burns 2001). Activated
protein C (APC)-resistance is mostly caused by a mutation in Factor V, which makes it more resistant to
activated protein C. Also pregnancy, contraceptive pills and antiphospholipid antibodies are known to
cause APC-resistance. It has been found to occur disproportionately often in patients with PAD (Burns
2001). Among those who have APC-resistance, graft occlusion occurs more often than in other patients
with bypass reconstructions (Ouriel 1996). Hyperfibrinogenaemia is present in 50% of patients with
PAD (Burns2001). Plasma fibrinogen levels have been found to correlate with mortality in stable
claudicants and may be used as a prognostic factor when assessing both claudiation patients as well as
critically ischaemic patients (Banerjee 1992, Doweik 2003). Hyperhomocysteinaemia has been found to
be associated with PAD (Mohan 1999a), it is suggested to influence endothelial function and platelet
activation and thus to promote PAD progression (Mohan 1999 b). It has even been speculated that
homocysteine may be a factor participating in the development of myointimal hyperplasia (Hansrani
2002). Its role as an independent risk factor is, however, still controversial (Pasterkamp 2002) and there
are suggestions that it may be more the result of, rather than the cause for advanced atherosclerosis and
reflecting renal function to some extent (Brattstrom 2000). 
6.2.2.2.4 Hyperlipidaemia
The role of hyperlipidaemia as a factor associated with the development of PAD and its progression has
not gained the same interest as in cardiac or neurologic assessment (Donnelly 2002). In future the
evidence on long-term effects and the effect of treatment on peripheral vascular diseases will increase
and assessment of blood lipoprotein levels may most probably become routine in vascular surgical
patients. The evidence of an existing association between blood lipoprotein levels and the development
of PAD has been inconclusive (Vogt 1992). In some studies, elevated blood cholesterol levels are a clear
risk factor (Kannel 1985, Schroll 1981), while in others an association could not be found (Hughson
1978a). Low HDL with elevated LDL as well as elevated triglyceride and lipoprotein levels have been
shown to be associated with occlusive arterial disease and its progression (da Silva 1990, Bainton 1994,
Fowkes 1992, Smith 1996, Greenhalgh 1971, Dionyssiou-Asteriou 2000). 
The imbalance of lipoproteins plays a role in developing endothelial dysfunction. The endothelial
damage caused by oxidised LDL and triglyderides maintains an inflammatory process in the
endothelium and inhibiting nitric oxide production, hampering the vasodilator function of the
endothelium (Glasser 1996, Laws 2004). When LDL and/or triglyceride excess is persisting, the
lipoproteins start to migrate into the endothelium causing an inflammatory process resulting in the
eventual calcification of the plaques in the vessel wall. The more dense particles of LDL are known to
be more atherogenic (Glasser 1996). 
Statins are, for the time being, the most frequently used antihyperlipidaemic drugs. They lower LDL
levels through inhibiting HMG CoA reductase activity in the liver. They also calm down the
inflammatory process by inhibiting the expression of pro-inflammatory cytokines (Laws 2004) and
thereby restore endothelial function. Statins also increase plaque stability by inhibiting LDL oxidation,
lipid accumulation, macrophage infiltration as well as matrix metalloproetinase expression, increasing
the collagen content of atherosclerotic plaques (Laws 2004). Dyslipidaemia is associated with
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hypercoagulability and increased platelet activity (Opper 1995). Statins decrease platelet activity and
improve the fibrinolytic response, also affecting coagulation (Laws 2004).  
Some short-term evidence suggests that atorvastatin-treatment reduces intima-media-thickness in the
carotid and femoral arteries (Youssef 2002), which may indicate that the lipid-controlling and anti-
inflammatory effect of statin treatment may contribute to the stabilisation and regression of
atherosclerotic plaques even in the lower extremities. The primary and secondary preventive effect of
statins and other lipid lowering drugs in coronary heart disease has been established (Scandinavian
Simvastatin Survival Study Group 1994, Salonen 1995, Lipid Research Clinics Program 1984) There is,
however, evidence that by treating hyperlipidaemia the progression of the atherosclerotic process may be
slowed down or reversed even in the lower limbs (Duffield 1983, Blankenhorn 1991, Pedersen 1998, de
Groot 1995, Olsson 1990).
Other drugs used for lipid lowering purposes are fibrates inhibiting the HMG CoA reductase activity,
activating a lipoproteinlipase-enzyme in the liver, muscles and the adipose tissue and thereby increasing
the reduction of VLDL and LDL. Drugs of the cholestyramine-type inhibit the absorption of bile acids
and reduce LDL levels. 
6.2.2.2.5 Renal insufficiency
Apart from calcification of the viscera, impairment of renal function causes calcification of the arteries,
partially through disturbances of the calcium and phosphorus metabolism (Parfitt 1969). Calcification of
the arteries in renal insufficiency occurs predominantly in the media of the artery (Parfitt 1969), which
makes renal insufficiency (Mäkisalo 1998, Leskinen 2002), together with diabetes and long lasting
systemic corticosteroid treatment, one of the main reasons for mediasclerosis. Arterial calcification in
uraemia usually begins either at ankle level or in the palmar and plantar arches (Parfitt 1969). The
distribution of the calcification is more diffuse than in atherosclerotic plaques. In the early stages of
mediasclerosis no narrowing of the arterial lumen is present but in advanced stages this may be the case
(Parfitt 1969). The medial calcification impairs the elasticity of the artery as well as its regulatory
function (Parfitt 1969), which may cause symptoms during exercise.
  
Apart from soft tissue calcification with mediasclerosis, vitamin D-related sclerosis of the intima may
participate in the development of PAD in uraemic patients (Parfitt 1969). PAD is a major source of
morbidity and mortality (Cheung 2000) in uraemic patients, with a reported prevalence of 22% in
predialysis patients, and 31% in dialysis patients (Leskinen 2002). Patients with renal transplantation
had a markedly lower prevalence of PAD (15%) (Leskinen 2002). Accordingly, amputation and survival
rates also have been observed to be more favourable in patients with functioning renal transplants
compared to dialysis patients (Eggers 1999). As diabetes is a frequent cause for renal insufficiency
(Eggers 1999), a major proportion of uraemic patients suffer both from complications related to uraemia
as well as diabetes (Eggers 1999).  For diabetic patients, nephropathy constitutes an additional threat in
terms of lower limb complications. Hill et al observed a 25% rate of foot problems among diabetic
patients with end-stage renal disease, while diabetics without renal complications has a 10% rate of foot
problems (Hill 1996). This may reflect an additional worsening of the vascular status and progression to
CLI, once renal insufficiency has developed, or the renal involvement may simply be an indicator for
advanced complications of diabetes as the underlying disease. Amputation rates among uraemics have
analogously been observed to correlate with the presence or absence of diabetes (Eggers 1999). 
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Patients with renal insufficiency undergoing vascular surgery for critical leg ischaemia are reported to
have an acceptable leg salvage (Peltonen 1998, Albers 2001), but a worse prognosis in terms of survival
than other critically ischaemic patients (Biancari 2002, Eggers 1999, Taylor 1991, Kimura 2003).
Especially patients with a manifestation of coronary heart disease in combination with critical leg
ischaemia and uraemia have a poor outcome (Biancari 2002).
 
6.2.2.2.6 Neuropathy
Diabetic neuropathy has been found an independent risk factor for the development of ulcers (Adler
1999).  Neuropathy contributes to lower limb problems playing a role in the development of ischaemic
lesions. It may alter foot architecture causing callosities to form with a subsequent risk of developing
neuropathic ulcers. Neuropathy, irrespective of its origin, also increases the risk for small injuries, which
can cause neuroischaemic ulcers in the presence of PAD. Peripheral neuropathy can be caused by
various factors such as diabetes, nephropathy, neurotoxic drugs (Argov 1979), vitamin deficiencies and
alcohol consumption, with diabetes being the most important cause in vascular surgical patients.
Neuropathy has been shown to be associated with a worse outcome in diabetic patients (Adler 1999),
possibly reflecting the advanced stage of vascular and neurologic complications produced by diabetes. In
fact, advanced neuropathy has been found to be an ischaemic process (Newrick 1986), while early
neuropathy is suspected to be mainly of metabolic origin and evolving similar to other types of
neuropathy (Myers1986, Mc Millan 1997).   
6.2.2.2.7 Other risk factors
6.2.2.2.7.1 Obesity 
Obesity is often associated with an unfavourable lipid profile, arterial hypertension and type 2 diabetes,
which are all independent risk factors for PAD. Weight reduction is an essential part in the therapy of
these diseases. Weight reduction improves glucose tolerance and lowers the blood pressure. However,
most studies have failed to show obesity to be an independent risk factor for PAD. (Beach 1980, Schroll
1981, Reunanen 1982, da Silva 1980). This might be explained partly by the weight reducing effect of
tobacco smoking (Fielding 1985). In epidemiological studies some of the normal weight may in fact
have a clearly increased risk for developing PAD because of tobacco smoking, thus producing a
confounding effect when assessing the correlation between weight and PAD. 
6.2.2.2.7.2 Gender 
Females are reported to develop PAD later in life than males (Kannel 1985) with an overall male/female
ratio of 1.27 (Criqui 1985). Males are twice as likely to develop IC (Murabito1997, Kröger 1999, Beach
1980). The female advantage disappears after menopause (Kröger 1999). Female gender combined with
diabetes has been observed to be associated with an adverse outcome of revascularsiation procedures
(Luther 1997b, AhChong 2002). Smoking is reported to diminish or eliminate the advantage of female
sex (Kannel 1985). The same phenomenon has been observed in diabetes in the development of
atherosclerosis and intermittent claudication (Mc Millan 1997, Kannel 1985). 
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6.2.2.2.7.3 Age 
Age as such is strongly associated with atherosclerosis and PAD (Roberts 1959, Schilling 1974, Vogt
1992). The incidence and prevalence of PAD increases sharply with age (da Silva 1990, Bainton 1994,
Kannel 1985, Meijer 1998). Age is also associated with the progression of PAD to CLI (Murabito 1997,
Reunanen 1982, Dormandy 1999c) as well as leg salvage and survival (Zdanovski 1998).
 
6.2.2.2.7.4 Physical inactivity 
Engström et al assessed the presence of PAD in men without evidence of claudication symptoms in the
Rose questionnaire, using ABI measurements and <0.9 as a cut-off point. They observed an association
between physical inactivity and a higher prevalence of PAD (Engström 2001).  Some connection
between physical exercise and endothelial vasodilatory function also has been observed (Glasser 1996).
Exercise is thought to alter the shear stress of the arterial wall in an oscillatory fashion, producing a
beneficial effect in terms of PAD development (Shearman 1999). Exercise additionally improves
cardiorespiratory status and results in positive changes to the lipid profiles (Tan 2000), which may
contribute to the favourable effect of physical training.
6.2.2.2.7.5 Infectious factors 
An association between chlamydia pneumoniae and coronary heart disease has been demonstrated
(Leinonen 2002). Similarly the progression of PAD in the lower limbs seems to be associated with a
chlamydia pneumoniae-infection (Lindholt 1999a), although the importance of this finding is not yet
understood (Lindholt 1999b). An infection leads to microthrombus formation and thereby worsens the
ischaemia by causing tissue necrosis (Lepäntalo 2000). In diabetic patients an ulcer has been seen to be
associated with a higher C-reactive protein (CRP) level as a general inflammation marker (Upchurch
1997). The CRP-level as such has been observed to be associated with postoperative outcome of bypass
surgery for CLI (Biancari 1999, Mätzke 2001).
6.3 Manifestations of lower limb arterial disease
6.3.1 Classifications of occlusive arterial disease
The first classification of occlusive arterial disease, still being in use, is the Fontaine classification, in
which the severity of the disease is divided into four main categories (Table 2). It is solely based on
symptomatic evidence, as are Rutherford’s categories, which distinguish between minor tissue loss and
major tissue loss as well as between mild, moderate and severe claudication (Ad Hoc Committee 1986)
(Table 2).
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6.3.2 Asymptomatic occlusive arterial disease
The occurrence of asymptomatic occlusive arterial disease is difficult to assess on population basis, as
an assessment requires individual pressure measurements at the least. Most of the large population-based
studies used only a questionnaire: the Framingham study, the Whitehall study, the Speedwell study and
the Finnish prevalence study (Kannel 1985, Murabito 1997, Davey Smith 1990, Bainton 1994,
Reunanen 1982). In these studies it is not possible to assess the occurrence of asymptomatic PAD, so
only the ”tip of the iceberg” i.e. the symptomatic PAD is included into the prevalence numbers. Some
studies have applied non-invasive measurement techniques: the Basle Study, the Edinburgh Study, a
Danish study and the Rotterdam Study (da Silva 1980, Fowkes 1991, Schroll 1981, Meijer 1998). In the
Basle Study angiographies were performed in addition to non-invasive haemodynamic assessment
(oscillometry). In the Edinburgh study ankle brachial indices and reactive hyperaemia tests were used
while the Danish study and the Rotterdam study relied on ankle brachial indices (Fowkes 1991, Schroll
1981, Meijer 1998). The proportion of asymptomatic PAD ranges in these studies between 4 and 11-fold
compared to symptomatic claudication (Table 3). 
Table 3:  Proportion of asymptomatic PAD in relation intermittent claudication
Author Method of proportion of asymptomatic
assessment PAD in relation to IC
da Silva 1980 A *+O#   7,4 : 1
Fowkes 1991 ABI¤ +RH&£   5,5 : 1  
Schroll 1981 AAR$ <90%   4,3 : 1
Meijer 1998 ABI¤ <0.9 10,9 : 1
*=angiographies
#=oscillometry
¤=ankle brachial indices
&=reactive hyperaemia
£=ankle brachial index <0.9 or reactive hyperaemia pressure drop >20%
$=ankle/arm ratio
The relation in these four studies is in the same order of magnitude except for the Rotterdam Study. The
absence of symptoms in asymptomatic occlusive arterial disease can mostly be explained by the missing
discrepancy between blood supply and demand. This may be the cause for the high prevalence numbers
of asymptomatic PAD in the Rotterdam study, where inhabitants aged 55-85 or older were assessed,
some of which lived in nursing homes and were likely to move around very little (Meijer 1998). The
slightly greater proportion of asymptomatic PAD in the Basle study, in comparison to the Danish and the
Edinburgh study, may result from the fact that angiography is a morphological assessment method not
being able to distinguish between haemodynamically significant and insignificant narrowing of the
arteries. It could be argued that the Basle study is thus slightly prone to overestimate the prevalence of
significant asymptomatic PAD.
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6.3.3 Intermittent claudication
Ischaemic pain occurring during exercise and dissipating swiftly during rest is called claudication, which
in Latin means “limping”. The patient may alter his/her gait and start to walk asymmetrically after the
onset of claudication pain, as he/she is thereby trying to decrease the amount of exercise performed by
the painful muscle group. More importantly, the patient has to stop and rest every now and then, which
makes the ambulation intermittent. 
Intermittent claudication presents itself as pain, weakness or numbness in the muscle group distal to the
diseased arterial segment. The symptoms are caused by accumulation of lactic acid as a product of
anaerobic metabolism, resulting from an imbalance between oxygen demand and supply during exercise,
when blood flow through the stenosed arterial tree or via a collateral network, is not sufficient. The
patient is forced to rest and the diminished need for increased blood flow restores the oxygen levels in
the muscle and the pain dissipates. Thus sufficient exercise is needed for the appearance of claudication
pain. A sedentary patient not moving around for whatever reason may have lesions severe enough to
cause symptoms of claudication without experiencing any significant pain. 
Ischaemic claudication may be difficult to distinguish from other disorders causing similar symptoms
(Fasih 2003). Spinal stenosis may cause similar pain that resolves after rest (Fasih 2003). Arthrosis of
the joints and rheumatic diseases may cause pain during exercise, although the pain is often present at
rest too. Neurological disorders such as neuropathies may cause pain, weakness and numbness in the
legs. Deep venous obstruction and chronic compartment syndrome may also cause claudication pain but
typically need more time to resolve than ischaemic claudication pain. (TASC 2000). 
In the assessment of intermittent claudication, non-invasive methods, such as ankle pressure
measurements at rest and after exercise or in a reactive hyperaemia test, should be used. Patients may
have typical ischaemic pain during exercise without having haemodynamical evidence of insufficient
blood flow at rest. This is well demonstrated in the Rotterdam study, where of 106 individuals with
claudication according to the Rose criteria 33 had an ABI above 0.9 ( Meijer 1998). 
The prevalence and incidence of intermittent claudication has been addressed in several epidemiologic
studies (Fowkes 1991, Bainton 1994, da Silva 1990, Reunanen 1982, Kannel 1985, Davey Smith 1990,
Stoffers 1996, Meijer 1998), some of which have a more or less selected population. In the Edinburgh
Study much effort was directed to create a population being as representative as possible. The subjects
were, however, recruited from several general practices, thereby excluding those never having attended
to such a general practice (Fowkes 1991). In the Whitehall Study and the Basle Study certain working
groups were included, prone not to reflect the structure of the general population (da Silva 1990, Davey
Smith 1990). In the Limburg Study a very complicated inclusion system was used, undoubtedly in order
to include all relevant patient groups, but as a result possibly increasing the effect of patient selection
(Stoffers 1996). Some studies have been conducted entirely on population basis. Unfortunately, in these
studies claudication prevalence was only investigated by means of a questionnaire (Reunanen 1982,
Kannel 1985). A questionnaire is prone not to include all patients with intermittent claudication, as
many patients have atypical claudication symptoms. Up to 87% of claudicants have been reported to
have atypical claudication (Ögren 2003). The Rotterdam Study was conducted in the population of a
suburb, the population of which may not be representative for the whole country. It used resting pressure
measurements to determine the presence of PAD. The population included was ≥ 55 years old.
The prevalence of IC has been reported to range between 1,2-6,6 % (Bainton 1994, Meijer 1998, Davey
Smith 1990, Reunanen 1982, Fowkes 1991, Stoffers 1996). 
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The overall 5-year incidence of intermittent claudication has been reported as 2% in men, while the
incidence at the age of 70 is 5 times as high as at the age of 40 (da Silva 1990). This is in accordance
with the 10-year incidence of 4% in men in the Speedwell Study age group (Bainton 1994) and the 4-
year incidence ranging between 0.4 and 2.5 in different age and gender groups in the Framingham Study
(Murabito 1997). 
 
6.3.3.1 Prognosis of intermittent claudication
Intermittent claudication itself can be regarded as an annoying and limiting complaint but not
threatening the viability of the leg. In most patients the symptoms remain stable or may even improve
(Coran 1966, Bloor 1961). In a study by Dormandy et al conservatively treated claudicants were
followed. All in all 5,6% deteriorated significantly and 1,6% required amputation within the first year
after diagnosis (Dormandy 1991). Similarly, in a study by Jelnes et al only about 7,5% of the patients
developed symptoms of critical leg ischaemia during the first year and 2,2% in the subsequent years
(Jelnes 1986). Thus, only a small proportion of claudication patients will deteriorate to an extent
resulting in a threat to the leg. Low toe pressures seem to point towards disease progression and worse
prognosis (Bowers 1993). Likewise there is evidence of continued smoking, diabetes,
hypertriglyceridaemia and coronary heart disease to be associated with disease progression (Smith 1996,
Dormandy 1999c).
Claudication is, however, associated with a reduced life expectancy and an annual mortality rate of 4.3%
(Dormandy 1991). The mortality rate has been reported to be twice as high as in the normal population
(Jelnes 1986), mainly due to other manifestations of the arterial disease (Jelnes 1986, Leng 1996). It is
estimated that claudication patients’ mortality rates resembles that of a general population being 10 years
older (Bloor 1961). In fact, in a historical study by Boyd, Ratcliffe and Bloor, the reduced life
expectancy has been found to represent a more significant issue for the prognosis of claudication
patients than the progression of the lower extremity symptoms (Bloor 1961). 
6.3.4 Critical leg ischaemia
The most severe form of occlusive arterial disease in the lower limbs is classified as critical leg
ischaemia. It is generally agreed that in critical leg ischaemia the viability of the leg is endangered,
unless some improvement of the arterial supply is undertaken, even if not all patients require major
amputation. Most often a symptomatic classification is applied to determine the existence of CLI (Table
2) but, as not all patients with rest pain, ulcers or gangrenes do have their leg immediately threatened,
more precise criteria for critical leg ischaemia have been developed. They are based on both symptoms
and objective pressure measurements (Second European Consensus Document 1992, Ad Hoc
Committee 1986, Rutherford 1997) (Table 4). 
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Table 4: Criteria for chronic critical leg ischaemia
      ankle pressures           toe pressures       symptoms
European        ≤ 50 mmHg  or       ≤ 30 mmHg       with      rest pain, ulcer 
criteria (Eur cons doc)      or gangrene
Criteria of the        < 40 mmHg  or       < 30 mmHg       with      rest pain
Ad Hoc Committee
(Rutherford 1997)        < 60 mmHg  or       < 40 mmHg         with      minor or major 
                      tissue loss
These definitions produce a more objective tool for research purposes but they still exclude patient
groups in which the term critical leg ischaemia would be justified and include patients whose leg is not
immediately endangered. Furthermore, these definitions do not include ABI-values as it is felt that the
absolute pressure and actual blood supply at ankle level is more relevant for the outcome of the foot than
the relative pressure (Rutherford 1997, Raines 1976). Single pressures are, however, more vulnerable
than pressure indices with greater variation according to the systemic pressures (Baker 1981, Lepäntalo
1983, TASC 2000). The problem in defining critical leg ischaemia is reflected in the differing results
achieved by treatment of CLI. In many series differences may be mainly caused by patient selection.
On population basis there is little information on the actual prevalence or incidence of CLI. CLI itself is
difficult to assess on population basis, therefore all calculations are based on different assumptions and
projections. As critical leg ischaemia is a more severe form of occlusive arterial disease than
claudication and results from more extended vascular lesions, it is intellectually appealing to assume that
the disease progresses from asymptomatic to claudication and from claudication to rest pain and
eventual tissue loss. Some calculations are indeed based on this stepwise progression of the disease and
are calculated from prevalence numbers obtained for symptomatic claudication (TASC 2000). The
incidence of CLI is estimated to be approximately 300/million/year using a claudication prevalence of
3% and assuming that 5% of these will deteriorate and develop CLI (TASC 2000). These estimates
exclude those asymptomatic patients, who never experience claudication but develop CLI without
preceding symptoms. The fact that an imbalance between the available blood flow and the demand
created by exercise is needed to develop symptoms of claudication, explains in part why critical
ischaemia is sometimes the first manifestation of occlusive arterial disease. Especially sedentary patients
often do not move enough to develop claudication pain (Dormandy 1999c). When considering the
possible effect of neuropathy and the large proportion of diabetics among CLI patients, even rest pain
may be absent and the initial symptom may be an ulcer or a gangrene (Jelnes 1986). Furthermore, there
is evidence that the severity of symptoms at the moment of occlusion of a proximal segment (for
instance superficial femoral artery) is determined by the distribution of pre-existing arterial lesions at
calf level (Aston 1992). Even asymptomatic patients may have lesions at calf level and their extension
determines the nature of the symptoms occurring later as the disease progresses (Aston 1992). Some
develop claudication and others rest pain (Aston 1992). Therefore the assumption of the linear
progression of the disease appears to be false, and the prevalence numbers calculated from the
prevalence of claudication are unavoidably too low. In a multicenter study by the I.C.A.I.-group in Italy
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14 % of critically ischaemic patients presented without preceding symptoms of claudication (I.C.A.I.-
group 1997).  
 
In a British survey based on the reports provided by a sample of vascular surgeons, the incidence of CLI
was estimated to be 400 /million /year (The Vascular Surgical Society of Great Britain and Ireland
1995). 
In Italy Maria Catalano calculated the incidence using three different methods: 1) a prospective 7-year
follow-up of 200 claudication patients and 190 controls, 2) a prospective three month sample on CLI-
hospitalisations in a number of hospitals and 3) a 6-month – 2-year encoding of major amputations in
two regions (Catalano 1993). In the group of claudication patients followed over a period of 7 years, 8
developed CLI, which equals 9 cases of CLI in a population of 1000 claudication patients per year.  She
used the assumption that 5% of the population above 45 years of age has peripheral arterial disease, as a
basis of CLI-incidence calculations. Based on the hereby-obtained CLI-incidence the major amputation
incidence was calculated on the assumption that 25% of all CLI-patients will eventually undergo
amputation. In the hospital sample 130 hospitalisations for CLI were recorded, which was extrapolated
to represent 2 320 CLI hospitalisations in the whole region. The incidence was calculated based on this
observation. In assessing the major amputations in two different regions, only the most extensive
amputation was included in order to avoid multiple inclusion of the same patient. During the study
period of 6 months, 71 major amputations were recorded in Lombardy and 235 were recorded during the
two-year-period in Emilia Romagna. According to the calculations the CLI incidence in a population of
>45 years of age ranged from 450-652/million/year and the amputation incidence ranged from 112-
172/million/year (Table 5). Although being based on several assumptions with inherent weaknesses,
these incidence estimations might be as close to reality as anyone has got up to now (Catalano 1993).
Table 5: Incidence of critical leg ischaemia according to Italian data (Catalano 1993)
Incidence  (number/million/year)
Population above 45 yrs CLI     major amputations amputations
 7-year follow-up of claudicants 450 112
Sample of hospital in Lombardy 652 160
Amputations in Lombardy 577 146 172
Amputations in Emilia Romagna 530 133 154
In the TASC-document it is proposed to calculate the CLI incidence using major amputation numbers,
assuming that 90% of all major amputations are performed for ischaemia and that 25% of all critically
ischaemic patients will ever require a major amputation (TASC 2000). 
Critical leg ischaemia is by and large caused by multisegmental disease with the vascular tree widely and
severely damaged. Reconstructive procedures in critically ischaemic legs can never restore the blood
flow to peripheral tissues completely. Intimal hyperplasia, late disease progression and technical
problems, thrombophilia as well as compromised runoff may cause the vascular or endovascular
revascularisation to occlude (Bergqvist 1996). This necessitates follow-up (Lundell 1995, Sumner
1995), graft corrections as well as new reconstructive procedures to avoid amputation. Nevertheless
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many patients end up being amputated when the possibilities for reconstructive procedures are exhausted
and the reconstructive procedures have merely been enough to delay the amputation. It has been
recommended that if there is a 25% chance to provide the patient a functional leg for a year by means of
reconstructive procedures it is worth trying (European Consensus Document 1992).
 
As critical ischaemia occurs mainly in the last decades of life, many patients are unable to adapt
themselves to the use of a prosthesis, due to comorbidities. Even factors such as depression, limited
rehabilitation resources, joint contractures as well as phantom pain may render prosthetic fitting more
difficult. Therefore a major amputation may lead to immobilisation and institutional care (Inderbitzi
2003). It has been shown that a very active reconstruction policy is able to diminish amputation rates
(Luther 1994), even in octogenarians, whose treatment results are similar to those of younger age groups
(Eskelinen 2003, Luther 1997b, O’Brien 1993, Nehler 1993). 
The mortality of critically ischaemic patients is high. The one-year mortality rates range between 20-
25%, 40-70% in five years (Dormandy 1999) and 76-88% in 10 years (Lassila 1986, De Weese 1977).
(see Table 10a-c in Chapter 6.6.2). Early amputation rates range between 10-40% (Dormandy 1999)
with ulcers and low pressure values indicating an adverse outcome (Wolfe 1997).  If the amputation can
be delayed by revascularisation, it may be possible to retain a functional leg for the short remaining
lifetime of the patient. A functional leg may ensure that the patient is able to lead an independent life at
home, instead of being confined to a wheelchair and being transferred to institutional care.
6.3.4.1 Subcritical leg ischaemia
There is a patient group, with or without claudication, but with no symptoms of CLI, that has objective
pressure measurements indicating decreased perfusion to an extent that critical leg ischaemia may occur
(Wolfe 1997). This group is sometimes classified as having subcritical leg ischaemia. These patients are
at the brink of developing CLI (Bowers 1993) and as soon as some small trauma occurs, the wound will
most probably develop into a non-healing ulcer. In these cases the blood supply is still able to maintain
the viability of the intact skin, but as soon as some defect is present, the capacity of the vasculature is not
large enough to enable the healing process. It is estimated that, in comparison to intact skin, an ulcer
needs a much larger nutritive flow to heal (Laing 1998, TASC 2000). In subcritical patients attention
should be directed towards skin care and measures should be taken to prevent small injuries of breaking
the skin barrier ( Bowers 1993). Maintaining an intact skin is crucial, as each ulcer constitutes a major
threat to the viability of the leg. 
Another patient group that might be classified as subcritically ischaemic comprises patients with
ischaemic wounds but pressure values above those stated in the Second European Consensus Document
or the Rutherford criteria. Clinically speaking, these patients may be critically ischaemic (Belch 1995,
Thompson 1993) but would be classified in research projects, complying with the consensus documents,
as only subcritically ischaemic. Therefore, revision of the definitions has been demanded (Thompson
1993) and as a result the most recent consensus document, the TASC-document, does not include
mandatory pressure values in the definition of CLI (TASC 2000). Thus the old Fontaine classification is
still practical for clinical purposes.
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6.3.4.2 Acute-on-chronic ischaemia
Acute ischaemia is caused by abrupt occlusion of the arterial tree. It produces a sudden deterioration of
the oxygen supply and nutritive flow of the leg. When the occluded segment is large and if no collaterals
exist, the viability of the leg is threatened and immediate treatment is needed. Acute-on-chronic
ischaemia is caused by thrombus formation in a diseased artery, and is to be distinguished from acute
ischaemia, caused by embolic occlusion of an often healthy vessel (Jivegård 1986). The distinction is
sometimes difficult (Kauhanen 1995, Takolander 1992). In a study by Kauhanen 48% of acute ischaemia
was categorised as embolic and 36% as thrombotic, while in 16% the distinction between the two could
not be made. Similar proportions were seen in a study in Great Britain where 41% of acutely ischaemic
legs were considered to be caused by a thrombosis, while 38% were deemed to be caused by emboli,
15% by occlusion of a bypass graft or angioplasty, 3% popliteal aneurysm, trauma in 2% and iatrogenic
reasons in 2% (Campbell 1998). A significant proportion (43%) of patients with acute-on-chronic
ischaemia are reported not to have any prior symptoms of PAD in a surgical series (Nypaver 1998),
which does not facilitate diagnosis. 
Over the years, the proportion of embolic events in acute ischaemia has been declining while the
proportion of acute-on-chronic ischaemia has been increasing (Swedvasc Steering Committee 1998,
Luther 1995). Improved diagnostic possibilities may in part account for this change, but some of it may
also have been caused by a genuine change in vascular morbidity.  For ischaemia, occurring acutely in a
prediseased artery, the same risk factors apply as to general PAD (Dormandy 1999b). Additional risk
factors, such as thrombophilia, low flow states and malignancies constitute a significant risk for
developing acute-on-chronic ischaemia (Dormandy 1999b).  Mortality rates range from 9.9% and 22 %,
while early amputation rates between 7.1 and 16% are reported (Nypaver 1998, Campbell 1998). In a
study by Luther et al early mortality was even higher i.e. 27%. One-year mortality was as high as 49%.
Early amputation rates were 14% in patents with emboli and 24% in patents with thrombosis (Luther
1995). Patients with an embolic event are reported to be at a higher risk of early death, due to the
underlying cause of embolism, while patients with acute-on-chronic ischaemia are more susceptible to
amputation (Kuukasjärvi 1994). In fact acutely ischaemic events cause a considerable proportion of all
major amputations. Eskelinen et al reported 16.5 % to be caused by acute ischaemia (Eskelinen, in
press).
 
6.4 Diagnosis of occlusive arterial disease and identification of limbs at risk
6.4.1 Diagnosis of PAD and CLI
Atherothrombotic disease leads to arteriosclerosis of the lower limbs. At first, the disease is
asymptomatic, but after its progression to such an extent that the arterial blood flow is significantly
compromised, it causes symptoms. The symptoms range from typical calf pain during exercise to rest
pain, pedal tissue loss and gangrene. Additionally the symptoms may as well present themselves as
numbness of the feet and calf, pain in the thigh or buttock, heaviness and tiring during exercise, coldness
or even burning sensation. 
In the assessment of vascular surgical patients patient history is of significant importance. In many
patients the nature of the disease can be evaluated and a diagnosis made, according to typical symptoms
together with typical findings. To confirm the diagnosis, and to distinguish the complaints from other
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conditions producing similar symptoms, objective assessment methods are mandatory (Lepäntalo 1997).
Ankle-brachial-indices have been shown as more closely associated to leg function than the symptom of
intermittent claudication (McDermott 2002). When assessing the possibility of PAD, different health
care levels have different access to assessment methods (Table 6)
Table 6: Diagnostic tools available
General practician (primary health care) clinical examination (pulse palpation), ABI-
measurement using CW-Doppler, (Ratschow-test)
General surgical outpatient clinic clinical examination (pulse palpation), ABI-
measurement, (Ratschow-test, duplex Doppler)
Vascular surgical clinic clinical examination (pulse palpation), ABI-
measurement, toe pressure measurement, pulse
volume recording, (treadmill test, reactive
hyperaemia test), duplex Doppler, angiography,
MRI, (TcPO2 or other microcirculatory assessment
methods) 
A part of the clinical evaluation of occlusive arterial disease is pulse palpation at different levels. Pulse
palpation has widely been used in everyday practice and many prevalence studies on arteriosclerosis rely
on pulse palpation as an assessment method. Although having the advantage of being easy to perform
without special equipment, serious concern regarding the reliability of pulse palpation has been
expressed. An absent pulse is not always a sign of atherosclerosis, in fact up to 12% of arteria dorsalis
pedis pulses have been reported to be congenitally absent (Barnhorst 1968). Only 18 % of pathologic
angiographic findings could be identified by absent pulses in the Basle study (da Silva 1980). Inter-
observer-agreement of pulse palpation has been reported as unacceptably low (Magee1992, Meade 1968,
Ludbrook 1962). When evaluating the presence of the disease a false negative finding is less acceptable
than a false positive finding (Dormandy 1992). The consequences of mistaking the pulses, and thereby
the vascular status, for normal in the presence of truly compromised vascular flow are much worse than
conducting additional vascular assessments after erroneously detecting missing foot pulses (Dormandy
1992).
6.4.2 Identification of patients at risk to lose their leg
In order to slow down disease progression by secondary preventive measures, it would be beneficial to
identify patients with PAD as early as possible. This may be difficult, as patients do not seek help unless
the symptoms of arterial occlusive disease are severe enough. If the symptoms have a slow onset, the
patient does not necessarily realise that it might be worthwhile to seek medical help early on. A sudden
onset on the other hand, usually causes the patient to see a doctor, especially if the pain is severe.
Patients having neuropathy, due to diabetes or other causes, may not experience pain caused by
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ischaemia during exercise (Jelnes 1986). They may even be totally unaware of the presence of an ulcer -
often developing after a small injury (Pecoraro 1990). Due to the large range of symptoms there may be
considerable delay in seeking medical help and appropriate measures cannot always be taken in time. 
If symptoms indicating critical leg ischaemia are present, measures to restore sufficient blood flow to the
ischaemic tissues should be undertaken in due course. According to a consensus statement the patient
should be sent to a vascular surgical unit within 24 hours for proper assessment and to receive possible
reconstructive measures (Audit Committee of the Vascular Surgical Society of Great Britain and Ireland
1996).  In everyday life patients are, however, seldom admitted within 24 hours, so treatment delay can
be considerable (Bailey 2003). Thus the identification of patients with limbs at risk is of utmost
importance at any level of the health care system.
 
In primary health care, where a large number of people present with a whole spectrum of symptoms, it
can be difficult to distinguish those patients in need for further assessment or even those who need
urgent evaluation and treatment. Pain during exercise may be interpreted as caused by orthopaedic
disorders such as arthrosis and spinal stenosis. Pain at rest may similarly be caused by arthrosis,
traumata, neuropathy, infections etc. and the ischaemic aetiology is often difficult to distinguish
properly. Even ulcers can be treated for months with antibiotics and local dressings before the vascular
status is evaluated, especially when an ulcer seems to have an innocent cause such as an injury. Early
diagnosis and treatment are mandatory in diabetic foot lesions as they carry a high risk for major
amputation (Lepäntalo 2000). In contrast, prompt multidisciplinary treatment of the underlying cause of
the diabetic foot lesions has produced encouraging results in terms of limb salvage (Lepäntalo 2000).
 
6.4.3 Vascular laboratory and angioradiology
6.4.3.1 History 
 
To study physiologic phenomena, plethysmographic measurement methods have been described already
in the 1600’s (Johnson 1932). To study vascular responses and physiology different plethysmographic
and oscillometric devices have been developed (Johnson 1932). The first arterial pressure measurement
was performed invasively on the carotid artery of a horse in 1733 by Stephen Hales (Pernow2002). Non-
invasive arterial pressure measurement, using external pressure together with a smygmograph, was first
introduced by Karl Vierodt in 1855 and developed further by Marey and others (da Silva 1990). Pressure
measurements gained wider acceptance when Sciapini Riva-Rocci demonstrated a cuff that was placed
around the arm in 1866 (Pernow 2002). The cuff was inflated to 200 mmHg and slowly deflated until the
pulsation of the radial artery reappeared. Nikolai Korotkoff modified the measurement using a
stethoscope and could by that means detect both the systolic and diastolic pressure (Pernow 2002). This
method could, however, not be reliably applied on the assessment of occlusive disease in the distal
arteries of the leg. Gärtner introduced in 1899 a method where the detection of distal systolic pressure
based on filling of the capillaries, but this method was not very reliable (Pernow 2002).  One of the first
pressure measurements on lower limbs to study arteriosclerosis has been performed by André Thomas in
1918 using a smygmograph (da Silva 1980). Ejrup seems to have been the first to introduce pressure
measurements after exercise using oscillographic methods (Ejrup 1948).  
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6.4.3.2 Methods
6.4.3.2.1 Pneumoplethysmographic measurement methods
Oscillometry is performed using a pair of cuffs attached to a pressure sensor and a plotter. The pressure
in the cuffs is inflated above the systolic pressure and lowered slowly while the oscillations are recorded.
For evaluation the maximal amplitude of the oscillations is measured and compared (Windus 1952,
Windus 1953). Before the widespread availability of routine angiography and Duplex-Doppler scanning,
segmental pressure measurements and oscillometry were used for determination of the level of arterial
disease. This method has been replaced widely by Duplex-Doppler scans.
 
Pulse volume recording (PVR) is the recording of pulse waves using pneumoplethysmography (Winsor
1957, Raines 1976, Darling 1972). PVR measurements are performed by inflating the cuff to 55-65
mmHg and by registering the pulse waves (Figure 4). The amplitude as well as different aspects of the
curve can be assessed. PVR was used to detect occlusive arterial disease. As the method has been seen
to be of limited reproducibility and susceptible to disturbances, its role today is mostly that of an
indicator for the reliability of pressure measurements (Lepäntalo 1997). 
Figure 4: A schematic illustration of pulse volume recording
A recent development of traditional pulse volume recording is the transfer function index measurement,
which utilises the philosophy of PVR recordings and compares the obtained curves by means of Fourier
analysis. PVR curves are recorded simultaneously at up to 10 different sites for a certain period of time.
The obtained curves are averaged, thus minimising the effect of beat-to-beat variability. The averaged
curve is compared with the curve obtained at the previous or brachial segment using Fourier
transformation and a transfer function index is calculated. This method offers promising features for
vein graft surveillance, as it has been shown to be reliable in detecting compromised graft flow (Ihlberg
2001), but further investigation is needed before its introduction into routine clinical use.
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6.4.3.2.2 Pressure measurements
Distal pressure measurements have established their role as the basic haemodynamic assessment method
for vascular patients. Measuring pressures is a quantitative assessment method and allows some
conclusions as to the severity of the disease (Carter 1968). They have been performed using different
plethysmographic methods (Carter 1968, Strandness 1964), as well as Doppler signals (Satomura 1959,
Strandness 1966, Yao 1969) to detect the reappearance of blood flow distal to an occluding cuff. The
pressure of the cuff is raised well above the systolic pressure, then released slowly to detect the pressure
level at which the blood flow signal reappears. To eliminate the confounding effect caused by the
variation of the systemic pressure, either an ankle-brachial index (ABI) (Yao 1969) or an ankle-brachial
gradient is calculated, of which the ABI has been found to be more reproducible (Baker 1981).  
Normally the systolic pressure of the leg exceeds the pressure of the aorta and brachial vessels due to
compliance of the vessel wall (Remington 1956); therefore the ABI of the normal leg should exceed 1.0.
When measured by experienced measurers, the measurement variability has shown to be reasonable with
0.15 representing a significant difference between two measurements (Baker 1981, Fowkes 1988). In
case of very low (<100 mmHg) as well as very high  (>200mmHg) systemic systolic pressures, the ankle
pressures have, however, to be handled with caution as they have been observed to be about 25% lower
than the aortic pressure without evidence of PAD (Belcaro 1989).
 
The most widely applied method for measuring the ankle pressures is using a CW-Doppler as the means
of detecting blood flow (Jeelani 2000) (Figure 5). It has the advantage of being relatively easy to
perform and provides the possibility of measuring pressures in each vessel separately. Furthermore the
devices needed are inexpensive and are usually included in the basic equipment of each hospital and
health care centre. The simplicity of the measurement technique is, however, deceptive and it has been
shown that up to 30 % of measurements performed by inexperienced measurers lie outside the accepted
range of variability of 0.15 in ABI measurements (Baker 1981, Ray 1994). In a Dutch study, where the
measurers were general practitioners (and their assistants), the measurement variation lay between 15-
20%, which is clearly higher than the generally accepted range of variability (Stoffers 1991). Therefore
the measurements of inexperienced measurers should not be used as quantitative, but only as qualitative
measurements. In the hands of an experienced measurer the CW-Doppler provides us with a useful,
reliable and reproducible assessment tool for measurement of peripheral systolic blood pressures (Baker
1981, Lepäntalo 1983). Reproducibility observations of ABI measurements have largely been made
either among healthy individuals (Fowkes 1988), unselected patients attending a vascular laboratory
(Ray 1994, Stoffers 1991) or claudicants (Baker 1981, Kaiser 1999, Fowkes 1988), not in patients with
CLI. All international consensus criteria, including non-invasive assessment for critical leg ischaemia
definition, use mainly absolute ankle pressures. ABI-measurements are, however, important for the
clinician both at the time of diagnosis and during follow-up (Ramsey 1983).
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Figure 5: A schematic illustration of ankle pressure measurements using a CW-Doppler probe
Using the Doppler technique it is only possible to measure the flow in larger vessels – toe pressure
measurements need either strain gauge plethysmography or photoplethysmography as means of detection
of the reappearing blood flow.
Toe pressure measurements with strain gauge plethysmography are performed using an elastic silicone
tube filled with mercury as an electric resistor. This silicone/silastic tube is placed tightly around the toe
distal to the occluding toe cuff. When the pressure in the cuff is lowered and blood flow reappears in the
toe the volume and circumference of the toe grows, the tube stretches and the resistance of the mercury
inside the tube changes and can be recorded. (Nielsen 1972, Lezack 1970, Gundersen 1971) The method
requires a stock of several strain gauges of different sizes, as a tight fit is necessary to perform the
measurement. It also requires some specialised equipment and expertise to achieve reliable results.
Using this method even non-pulsatile flow can be detected (Nielsen 1972, Lassen 1976) and thus very
low pressures can be measured.  Disadvantages of the method include the sole applicability on circular
body parts where close contact to the underlying tissue is maintained along the whole circumference
(Linde2002). Another disadvantage is the toxic quality of mercury, which poses a threat to the health of
employees and the environment (Linde 2002). Finally the strain gauge is temperature-sensitive, with its
resistance varying according to the surrounding temperature (Linde 2002).     
The strain gauge technique has been widely replaced by the photoplethysmographic technique (Figure
6), which has the advantage of being easier to interpret and having one probe fitting each toe, forefoot or
finger. The photoplethysmography probe sends infrared light into the tissue. It is reflected with varying
intensity depending on the presence of erythrocytes. With increasing erythrocyte content in the tissue,
the reflected light diminishes. Using the photoplethysmographic technique pulsatile blood flow is
needed, which makes the technique less sensitive than strain gauge plethysmography in detecting flow
signals at low pressure levels. At pressures below 30 mmHg Doppler waves become flat, lose their
pulsatility and are difficult to detect using the photoplethysmographic technique. 
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Figure 6: A schematic illustration of toe pressure measurements using photoplethysmographic technique
Pressure measurements can be performed in segments to determine the level of arterial lesions. Lower
limb pressure measurements above the ankle level have become scarce as the level and the morphology
of the changes is usually determined by Duplex-Doppler and angiography if the indication for a
reconstructive procedure is present. 
In the assessment of claudication, the walking distance has been used as the measure of severity of
lesions. The anamnestic walking distance is, however, very imprecise, as the estimate of the same
distance has been seen to be subject to huge variation (Watson 1998, Peräkylä 1998a). Therefore, more
standardised estimates of disease severity in claudicants are needed. Different exercise tests have been
developed: treadmill tests, heel raisings and plantar flexion of the foot (Strandness 1964, Myhre 1975b,
Winsor 1959, Amirhamzeh 1997) 
6.4.3.2.2.1 Stress tests
The most frequently used method is the treadmill exercise test with or without pressure measurements.
Using the treadmill, the actual walking distance can be measured, although the reproducibility of the
walking distance is very poor and a marked learning curve improving the walking distance in repeated
measurements has been observed (Peräkylä 1998b, Laing 1986, Guyatt 1984). The decrease in ankle
pressures following a short exercise with inclination has been seen as being more reproducible than the
walking distance itself (Laing 1980). A short exercise provides equally reliable results as longer
treadmill tests (Laing 1983, Laing 1986). When comparing different methods of evaluating the pressure
drop after exercise, expressing the ankle pressure change as a percentage of the absolute resting pressure,
has been shown to have the smallest variability (Amirhamzeh 1997).  As symptomatic occlusive arterial
disease is known to reflect the situation in the whole vasculature, a short treadmill exercise has the
additional advantage of not causing additional cardiac complications (Laing 1980). The treadmill test
may provide a rough estimate of the cardiac condition and may be useful in predicting peroperative
cardiac complications in PAD patients (von Knorring 1986, Mc Cabe 1981, Cutler 1979).
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In the case of a treadmill test not being feasible or available, a reactive hyperaemia test can be performed
instead. (Myhre 1975b, Hummel 1978) The reactive hyperaemia test is performed using a broad cuff at
thigh level. This cuff is inflated to 300 mmHg and the pressure is kept for 3-5 minutes in order to cause
an acute ischaemia in the limb. After pressure release the haemodynamic reaction in the lower limb is
measured using either pressure measurements at ankle level, maximal velocity time or other means of
measurement. During ischaemia vasoactive mediators are produced and the arteries are dilated (Fronek
1973). Therefore, the vascular resistance in the periphery is low in the reactive hyperaemia test, with an
increased demand of arterial flow. The flow past an occluded arterial segment or a significantly stenosed
artery with a diminished flow reserve will not be able to meet this increased demand and a pressure
drop, or an increased maximal velocity time, will be measurable. The reactive hyperaemia test has been
shown to be a reliable and reproducible substitute for the treadmill test (Peräkylä 1999, Hummel 1978),
but its applicability is restricted by the fact that it is often very painful (Carter 1968, Leng 1996).
6.4.3.2.3 Problems related to measurement techniques
There are several limitations to the use and interpretation of pressure measurements (Table 7). 
Table 7: Limitations of pressure measurement methods
Method Principle Problems
Ankle pressure: occluding cuff, distal detection mediasclerosis, cuff width,
systemic pressure, patient movement
-  CW-Doppler hand held probe, readily accessible operator dependent, especially 
flow signal quality evaluable with low signals
-  PPG probe attached to toe/forefoot, needs pulsatile flow
less operator dependent  
Toe pressure: occluding cuff at toe level low reproducibility, 
distal detection great physiogical variation
seldom affected by mediasclerosis susceptible to vasospasm
influenced by temperature changes
 
-strain gauge does not need pulsatile flow, low operator dependent, several
pressures measurable strain gauges needed, toxic
-PPG less operator dependent low pressures not reliably
one probe fits all measurable
CW= continuous wave
PVR= Pulse volume recording
PPG= Photoplethysmography
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Thigh, calf or ankle pressures can be falsely high if a too narrow cuff is used. The width of the cuff
should be at least 120% of the diameter of the measuring site. 
Similarly the pressure values will be falsely elevated if the wall of the vessel is stiffened because of
mediasclerosis. Such mediasclerotic vessels need a higher pressure to be compressed or can be even
non-compressible. Mediasclerosis is mainly caused by diabetes, uraemia or systemic corticosteroid
treatment (Goss 1989, Leskinen 2002, Mc Millan 1997). Most of all it affects the larger vessels of the
lower limbs, but brachial vessels are sometimes affected as well (Edmonds 1982). It affects the elasticity
of the artery, destroying the autoregulation of the vessels. Although non-invasive pressure values seem
to be normal or good, blood flow can be severely impaired. If the ABI is clearly elevated (>1.3) or the
vessels are incompressible, it is easy to recognise a falsely elevated ankle pressure value (Carter 1985). It
is even recommended to suspect pseudohypertensive elevation of ankle pressures when ABI exceeds
1.15 (Takolander 1995). Routine performance of pulse volume registrations is recommended (Carter
1968, Goss 1989) as well as routine toe pressure measurements. When a discrepancy between pressure
values and the amplitude and shape of the PVR curve is present, the pressure values are interpreted to be
pseudohypertensive and unreliable. Mediasclerosis does, however, produce also partially incompressible
arteries and does therefore elevate ankle pressures at all pressure levels (Young 1993, Goss 1989,
Emanuele 1981), which is difficult to detect if the values are still compromised in conjunction with
flattening of the PVR curves. As the vessels of the toes are in general not affected by mediasclerosis -
although exceptions may occur (Young 1993) - toe pressures should be used instead in these cases. 
Toe pressures have, however, some pitfalls of their own. Blood flow in the small vessels of the toes
underlies great physiological variation (Burton 1939). These vessels are more prone to vasospasm than
larger vessels. Consequently, significantly lower pressure values are measured with toe temperature at
10 degrees Celsius, as opposed to measurements performed at room temperature (Sawka 1992).
Significant vasospasm has been shown to exist even at room temperature in routine measurement
conditions (Sawka 1992). In order to minimise the effect of vasospasm the patient is to rest in a warm
room or under a warming blanket prior to toe pressure measurements. Additionally the feet may need to
be heated before the measurement, especially in winter.
Another proposed measurement technique for the assessment of patients with assumed low pressures but
pseudohypertensive ankle pressures is the so-called pole test (Smith 1994, Sambraus 1996, Beyenal-
Ögmen 1999). The pole test is performed with the patient in supine position using the CW Doppler to
listen to the signal of a dorsal artery. Instead of using a cuff, the leg is elevated slowly and the level at
which the signal disappears is read using a vertical centimetre scale on a pole (cm H2O). After that the
pressure values (mmHg) can be calculated. Pressure measurements have been observed to have a good
correlation with pressure measurements using a cuff (Hiller 1998).
 
The patient’s inability to hold still or severe pain at the site of the cuff may be a problem in the technical
performance of the measurements, sometimes causing all attempts to obtain a measurement to fail.
Similarly, atrial fibrillation or other cardiac arrhythmias may hamper the gathering of reliable
measurements. 
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6.4.3.2.4 Microcirculatory measurement techniques
Additional microcirculatory assessment techniques, such as transcutaenous oxygen tension (TcPO2)
measurements, laser Doppler fluxmetry and nailfold microscopy (Fagrell 1999) can be used to determine
tissue viability and predict outcome (Ubbink 1999, Wahlberg 1993), especially in critically ischaemic
patients if pressure measurements cannot be performed (Ubbink 1993). TcPO2 measurements have low
reproducibility in critically ischaemic legs, even if being well applicable in healthy legs (Lukkari-
Rautiainen 1989). Overall the reproducibility of microcirculation assessment methods does not seem to
be as good as the reproducibility of measurement methods for macrocirculation (Lukkari-Rautiainen
1989, Ubbink 2000) and none of these have achieved large clinical use. This may be explained by the
great physiologic autoregulatory function of the microcirculation (Shore 1993). The microcirculation
responds more readily to exogenous and endogenous vasoconstricting and vasodilating stimuli.
Therefore the conditions in which microcirculation is measured have to be strictly standardised (Larsen
1990, Fagrell 1999, Ubbink 2000) and additional standardised stimulation tests such as reactive
hyperaemia or oxygen inhalation should be used (Jacobs 1992, Bongard 1988, Diamantopoulos 1994).
The method of microcirculatory measurement seems to be of importance as different methods measure
different aspects of the microcirculation: capillary microscopy is limited to the nutitive capillary flow,
while both laser Doppler fluxmetry and TcPO2 seem to measure also the thermoregulatory flow (Fagrell
1999). A combination of methods such as laser Doppler fluxmetry and capillary blood cell velocity
measurement with an index of these two may produce the most reproducible results (Fagrell 1999).
Laser Doppler fluxmetry has, additionally to the resting flux, been seen to oscillate over time in relation
to vascular autoregulation (Fagrell 1999). Normally only low frequency oscillations are visible, but in
critically ischaemic patients also high frequency oscillations are observed (Anvar 2000). This
phenomenon is not affected by oedema or limb position (Anwar 2000) and it may be the more
significant feature when measuring microcirculatory flux, using it to determine the degree of ischaemia
(Fagrell 1999).
6.4.3.2.5 Other assessment methods
Among other techniques that have been used for vascular assessment are temperature measurements and
the dilution of radioactive Xenon (Lassen 1972). Skin temperature is, however, influenced by many
factors such as room temperature, humidity, metabolic state, nervous and vasomotor activity and
nicotine (Fronek 1985). It is difficult to standardise all influencing factors and measure only the effect of
vasclar blood supply on the skin temperature (Fronek1985). Also the correlation between blood flow and
skin temperature is non-linear, which further decreases the applicability of temperature measurements in
vascular assessment (Fronek 1985). Radioactive nuclide dilution techniques have failed to provide sharp
endpoints and as they are time consuming and expensive, they have been abandoned in routine patient
evaluation (Moore 1985, Nicolaides 1985)
 
6.4.3.2.6 Duplex Doppler
For further assessment of the vasculature of the lower limbs, duplex Doppler is available as a technique
combining flow velocity measurement using a pulsed Doppler and morphological assessment by means
of ultrasound sonography (Woodcock 1980). Unlike the continuous wave Doppler, the pulsed Doppler
utilises a time frame for determination of the target depth (Walker 2002). The transducer determines the
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time needed for the Doppler waves to reach target depth and to be reflected from there to the detecting
device. Only waves fitting into the time frame will be analysed while all other Doppler-information will
be excluded (Walker 2002). The method is thereby suitable for selected velocity measurements. With
increasing depth the width of the signal broadens and the resolution deteriorates. Transducers with short
wavelengths have an excellent axial and lateral resolution but limited ability to measure velocities while
longer wavelengths have a worse resolution, but are able to measure greater velocities (Walker 2002).
Concerning the angle of Doppler-derived velocity measurements it would be ideal if it were possible to
place the transducer/receiver in line with the blood flow and have the blood cells moving directly
towards the probe (Johnston 1977, Walker 2002). As this is not possible a mathematical correction is
used, provided that the angle of insonation is known (Walker 2002). Angle compensation will produce
reliable results only to a certain degree and measurement error will increase with decreasing insonation
angle. Mostly, in order to standardise the technique, an angle of 60-degrees is used, as it provides
acceptable measurement results and is usually achievable in everyday use. 
The duplex-Doppler, and the so-called triplex-Doppler with a colour coded flow signal, provides a tool
for noninvasive evaluation of the arterial flow. Especially in the assessment of and follow-up of vein
grafts, as well as in areas of complicated anatomy and arterial bifurcations, the duplex-Doppler has
shown its advantages (Sumner 1995). The duplex-Doppler is an operator-dependent non-invasive
method with acceptable reproducibility in the hands of experienced technicians (Ihlberg 2000, Müller
2001). 
6.4.3.2.7 Angiography
Angiography, whether it is performed using a conventional technique, using magnetic resonance
imaging or processing computed tomography information, does still have an important role in the
assessment of the preoperative patient. A good quality angiogram, with the vessels visualised down to
the pedal arch, gives an excellent overall picture of the morphological changes in the vascular tree.
Selective antegrade digital subtraction angiography (DSA) is the “gold standard” in visualising the
arterial tree, especially prior to invasive therapy.  However, the role of duplex-Doppler is increasing as a
preoperative tool as well (Koelemay 2001, Luján 2002). Angiography is usually not a method for the
initial assessment of the vascular patient, as it is expensive, invasive (with potential complications) and
does not provide information on the actual haemodynamic state of the limb. Thus vascular laboratory
and radiological data supplement each other.
6.4.3.3 Identification of patients with critical leg ischaemia
The identification of critical leg ischaemia is mostly based on symptoms such as rest pain, leg ulcers and
tissue necrosis (gangrene). Again many other disorders may produce similar symptoms and the
ischaemic complaints have to be distinguished from these (TASC 2000). Rest pain may be caused by
injuries, arthrosis, arthritis, neuropathy as well as infections. Ulcers are usually caused by injuries,
infections or venous hypertension, irrespective of the presence of an impairment of the arterial blood
flow. Indeed, most ulcers are of a non-ischaemic origin and it may be difficult to recognise ischaemic
ulceration at an early stage, especially as many confounding factors may be present and other causes for
ulcers may coexist.  Most gangrenes are of ischaemic origin but heat, cold, toxins and infections may
cause gangrenes as well. 
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To distinguish between different etiologic factors contributing to rest pain, ulcers and gangrene non-
invasive resting measurements may be used. 
Ankle-brachial index measurements in combination with pulse volume recordings and toe pressure
measurements are the most frequently used non-invasive measurement methods for CLI diagnosis. For
identification of critical leg ischaemia various pressure limits have been proposed (Rutherford 1997,
European Consensus Document 1992). 
In CLI flow signals are often very low, making pressure measurements prone to measurement error
(Ubbink 2000). The multimorbidity often present in critically ischaemic patients may cause difficulties,
for instance through cardiac rhythm disorders, shortness of breath in supine position, leg oedema, ulcers,
infections etc.
In some obvious cases of CLI and in situations where revascularisation is to be undertaken without
delay, the extent of the vascular lesions is primarily investigated using Duplex-Doppler, angiography or
MRI-angiography. Preceding haemodynamic assessment with non-invasive measurement methods may
not always be available, although baseline data for follow-up purposes may be beneficial and
recommendable. 
6.5 Outcome assessment
6.5.1 Outcome assessment in claudication patients at risk to develop CLI
As intermittent claudication itself seldom poses a threat to the viability of the leg but is associated with a
decreased life expectancy due to involvement of the whole vascular tree (Bloor 1961), outcome
assessment in intermittent claudication is bound to concentrate on functional improvement, graft
patency, mortality reduction, disease progression and quality of life assessment. 
The treatment of intermittent claudication may be directed towards local improvement of the blood flow
in the diseased arterial segment through surgical or endovascular procedures, and probably regular
exercise, or towards disease and arteriosclerosis stabilisation through smoking cessation and risk factor
control. Treatment of the risk factors and possible concomitant coronary disease may improve mortality
and overall prognosis (Donnelly 2002).
The outcome assessment can be classified as objective outcome with walking distance and pressure
value improvement, symptomatic outcome with pain relief, general quality of life outcome, disease
specific quality of life outcome and postrevascularisation outcome with patency of the revascularised
segment (TASC 2000).  
Objective outcome measuring functional amelioration is often measured using improved walking
distance. Although deemed as the most appropriate objective measure of success of treatment of IC
(TASC 2000), this technique is very imprecise as the reproducibility of the walking distance is poor
(Peräkylä 1998b, Laing 1986). It has been suggested that after therapy an increase of 50-60% in the
walking distance would be needed for the change to be regarded as significant. It should exceed the
improvement achieved using placebo at least by 30% (Heidrich 1992). Quick found a mean increase of
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40% of the maximum walking distance on a flat treadmill in claudicants after smoking cessation (Quick
1982). When using two standard deviations, an 84% improvement or decrease would be needed for a
significant change when measuring the maximum walking distance on a flat treadmill, according to
Peräkylä. On a flat treadmill the initial walking distance change would have to be as much as 62% to
achieve significance. On a graded treadmill the reproducibility is reported as slightly better with two
standard deviations of 36% for the maximum walking distance and 58% for the initial walking distance
respectively (Peräkylä 1998b). 
Ankle pressures are suggested to be more reliable in determining improvement of blood circulation after
treatment (Peräkylä 1998b). A significant difference should be calculated for each laboratory separately.
In general an ankle brachial index change of 0.15 is widely used (Baker 1981, Ray 1994), but the use of
0.1 has been recommended too (Ad Hoc committee on reporting standards 1986, Rutherford 1997). Of
these the latter appears to be based on consensus rather than on referred published data. Haemodynamic
success of a procedure will not be guaranteed automatically if the graft, or endovascularly treated
segment, is patent but can be assumed if the ankle brachial pressure index is improved significantly.
Symptomatic outcome and general quality of life outcome may be assessed using different
questionnaires. The surgeon’s impression of the patient’s symptoms, as well as walking distance and
ankle pressures, have been shown to have a poor correlation with the results in standardised quality of
life assessments (Pell 1995, Barletta 1996, Currie 1995, Hicken 2000, Slevin 1988, Pearlman 1988).
Quality of life assessments with subjective pain relief and subjective functional improvement are to be
used as a measure for therapeutic success (Garratt 1993). They will gain more and more importance due
to limited health care resources (Myhre 1989) where the need for evidence based medicine is
emphasised (Fisher 1999). 
Generic quality of life assessments have been suspected to be less sensitive to treatment results in
vascular patients than disease specific scores (Mehta 2003, Cassar 2003). The use of additional disease-
specific scores, such as the walking impairment questionnaire, the VascuQoL and the ICQ may be
helpful in assessing vascular treatment results (Hiatt 1995, Morgan 2001, Chong 2002). 
Postrevascularisation outcome concentrates on graft and PTA-patency and should ideally be assessed
using imaging techniques (TASC 2000).   
6.5.2 Outcome assessment in critical leg ischaemia
The outcome assessment measures in critical leg ischaemia are generally the same as in intermittent
claudication: graft patency, mortality reduction and quality of life assessment. However, as critical leg
ischaemia is a condition endangering the viability of the leg and is associated with considerable co-
morbidity and ensuing mortality, the main outcome measures are above- and below- knee amputation
rates and survival. It is important to make a clear distinction between small amputations, i.e. toe or even
metatarsal amputations and major amputations at calf level or higher. If a necrotic toe is amputated and
the rest of the foot remains viable as a result of treatment, the treatment is to be deemed successful. Thus
minor amputations should be understood to be comparable to wound excisions or debridements
(Lepäntalo 2002). The assessment of CLI outcome and amputation rates can therefore be grossly
generalised as “counting the heels”. Ideally major amputations and mortality should be combined in
outcome analyses, as the major concern ought to be how many patients are alive with a leg at a given
moment of time.
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Additional outcome measures such as pain relief, wound healing, primary and secondary graft patency,
minor amputations, leg functioning, wheelchair use, ability to live independently, walking without
support and need for institutional care may be used. Furthermore in this era of limited health care
resources coupled with growing demand, cost-descriptions and quality of life assessments are being
performed and quantifications such as cost-effectiveness, cost-utility and cost-benefit calculated.
Mortality may be the variable with the most complete coverage, as most countries have some kind of
registry to register mortality and death causes. Obtaining amputation data may already be more difficult
and will usually rely on the accuracy of hospital records. 
Other variables will not be automatically recorded into any registries and demand more explicit study
regimens and mainly prospective recording of data. 
Collecting data to determine treatment costs includes selection of the data and decisions, which costs are
to be included. Very different approaches can emerge and different studies may not be comparable.
Some studies include only direct costs for operative treatment, other studies include medical treatment
cost, rehabilitation cost, loss of working capacity, costs for re-operation, amputations and institutional
care (Luther 1997c).   
Quality of life has been shown to correlate with the degree of ischaemia (Klevsgård 1999, Luther 2002).
Quality of life (QoL) assessments for critical leg ischaemia are an important feature in the assessment of
critical leg ischaemia as a condition. The assessment will, however, be most probably difficult to
accomplish in an unselected critically ischaemic population. Many critically ischaemic patients are very
old and a major proportion of them are already demented, which makes them prone to failing to
complete the questionnaire (Currie 1995). Meaningful quality of life assessment will be difficult to
obtain in these patients and a quality of life assessment done by a proxy such as a relative or hospital
personnel can only be of very limited value (Hicken 2000). Hernández-Osma et al performed a generic
quality of life assessment among critically ischaemic patients without previous reconstructive surgery.
More than 30% had to be excluded from the analysis because they were unable to complete the
questionnaire and another 14% did not comply (Hernández-Osma 2002). Exclusion of such a major
sample will most probably produce selected material, which cannot be regarded to represent all critically
ischaemic patients. Although this patient material was selected, representing the less severe CLI-
patients, a worse baseline QoL than the reference population was recorded for all QoL dimensions. The
quality of life was compared between three groups receiving either revascularisation or amputation or
conservative treatment. No differences between these three groups existed, which may be explained by
the fact that the co-morbidities, present in most critically ischaemic patients, affect the quality of life to a
considerable extent. 12 months after initial treatment the quality of life had in fact decreased in all three
groups owing probably to the fact that the overall morbidity of these patients continues to deteriorate
regardless of the treatment modality used. (Hernández-Osma 2002). In contrast to this, Thorsen et al
conducted a Nottingham health profile investigation among critically ischaemic patients scheduled for
an arterial reconstructive procedure. He found a significant improvement that maintained 12 months in
pain and sleep scores after treatment (Thorsen 2002). Albers et al assessed the quality of life of critically
ischaemic patients dividing the patients into three groups: one with successful arterial reconstruction
(15), one with arterial reconstruction but secondary major amputation (7) and one with primary below
knee amputation (16). These patient groups were followed for 12 months and were assessed using the
Spitzer QL-INDEX. The quality of life score was initially worse in the amputated group than in the
reconstructed group. This difference, however, subsided within 12 months while the patient group with
secondary amputation had the worst quality of life-score throughout the study (Albers 1996).    
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6.6 Outcome of CLI
6.6.1 Factors influencing the outcome 
Critical leg ischaemia is not a single disease with a uniform outcome for all patients, but rather the result
of advanced atherosclerosis caused by different risk factors, which influence the prognosis to a major
extent. A wide range of symptoms and underlying arterial lesions is included in the definitions of critical
leg ischaemia (Rutherford 1997, Second European Consensus Document 1992). This causes the patient
group to be heterogeneous. Although the classification of critical leg ischaemia implies a threat for the
viability of the involved tissue, the amputation risk is very different in different subgroups of critical leg
ischaemia. Not all patients with CLI require amputation (Ubbink 2000). Suggestions to divide critical
leg ischaemia into two categories have been put forward: those with rest pain only and those with
ischaemic tissue loss (Thompson 1993). On the other hand the definitions tend to exclude patients, who
have a similar threat to lose their leg but do not fulfil the CLI-criteria (Belch 1995, Ubbink 2000).
Despite these attempts to widen or narrow the CLI-criteria, the amputation risk and outcome will differ
substantially within the patient group.
For ethical reasons the natural outcome of the whole population of critical leg ischaemia cannot be
assessed today.  Historic studies like the study by Bloor, Boyd and Ratcliffe (Bloor 1960) and the study
by Juergens et al (Juergens 1960) give us some hint as to the outcome in this patient group. The
advances in both medical and surgical treatment make these series not entirely representative of the
patient population today. The outcome of CLI patients will be influenced by both local factors and
systemic factors. The mean age is higher today, the overall treatment of the underlying cardiovascular
disease bears more possibilities and additional influence can be directed towards the treatment of
different risk factors. On the other hand surgical and endovascular treatment have undergone an
evolution influencing the overall outcome in CLI. 
The adoption of an aggressive reconstruction policy has been shown to reduce amputation rates by 25-
63% (Lindholt 1994, Luther 1994, Eickhoff 1993, Eskelinen 2003), which is bound to influence the
overall outcome of the patients. In most studies the reductions are reported in absolute major amputation
rates without taking into consideration the increasing risk due to ageing of the population. In 1988
Pohjolainen estimated an increase of 50% in amputation rates within the next 20-30years (Pohjolainen
1988). Despite that, an overall decrease in amputation incidence of 41% has been observed from 1984 to
2000 (Eskelinen 2004). Compared to the estimates made by Pohjolainen, the overall decrease achieved
by vascular reconstructive procedures was 52% (Eskelinen 2004). 
   
Opposing to the adoption of an aggressive reconstruction policy, a failed bypass graft has been suspected
of having an adverse effect on amputation levels (Stirnemann 1992), but this suspicion could not be
confirmed (Ebskov 1999, Panayiotopoulos 1997, Tsang 1991). 
As to the influence of successful bypass surgery: the patency of a bypass graft has been seen to correlate
well with the overall clinical outcome of the leg, but exceptions may occur (Watson 1999). Some
critically ischaemic legs end up being amputated in spite of a patent graft. This is typically observed in
patients with large, deeply infected tissue lesions (Lepäntalo 2002) On the other hand not all graft
occlusions necessitate amputation (Watson 1999). Especially in cases in which the bypass flow has
enabled the lesion to heal, later graft occlusion may be well tolerated (Mätzke 1997, Zdanovski 1998).
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Different risk factor profiles may affect the outcome. Diabetes may be the most obvious risk factor with
a reported 10-fold mortality rate and a 5-fold amputation rate compared to other PAD-patients (Meillère
1999). In a recent British study the proportion of revascularisations was similar in diabetics and non-
diabetics, but the major amputation rate at follow-up was 26% in diabetics and 8% in non-diabetics
(Bailey 2003). Apart from diabetes, other risk factors may contribute to differing results as well. 
The outcome as such may be influenced by referral practices, as diagnostic difficulties and referral
patterns can delay the treatment. Patients with CLI often have symptoms for many weeks before being
seen by a specialist: the duration of symptoms ranged between 2 weeks to 1,5 years in a British study
(Bailey 2003), which is in discordance with the recommendation on the referral of CLI patients (Audit
Committee of the Vascular Surgical Society of Great Britain and Ireland 1996). 
Similarly, socio-economic factors, can influence the outcome in PAD, as has been seen in cardiovascular
diseases (Salomaa 2001, Engström 2000, Morrison 1997). Socio-economic factors may be speculated to
influence the outcome through differences in the risk profile as such, but also through the patients’
readiness to seek medical help, their compliance, disease treatment and prevention as well as hospital
funding.   
Finally the reporting of results can influence the outcome figures, making results from different series
not comparable. Especially the time frame and carrying out of follow-up, influences the results reported.
Likewise, the nature of the underlying data influences the results. Only population-based data is likely to
be comparable. Institutional series always include selection bias. This was clearly seen in comparison of
amputation rates as a measure of surgical outcome of CLI in hospital and population based data (Luther
1996) 
 
6.6.2 Outcome 
Amputation rates in CLI-patients depend on age, proportion of diabetes and degree of ischaemia. Before
the era of arterial surgery, in a series of Juergens from the years 1939-1948 with non-diabetic patients
younger than 60 years of age, 5-year amputation rates were reported to be 3.8 % for patients with rest
pain or neuropathic pain and 19.8% for patients with ulcers or gangrene (Juergens 1960).  In a series
from the years 1947-1953 Boyd, Ratcliffe and Bloor assessed claudication patients (Bloor 1960, Boyd
1962). These patients were mainly treated conservatively or received nonreconstructive surgery
(sympathectomies and tenotomies of the achilles tendon). In the first and third year after diagnosis
critical leg ischaemia developed in 8.3% and 3.0% respectively, the deterioration being dependent on the
age of the patient group. Of these critically ischaemic patients 23-57% required major amputation (Table
8).
Table 8: Amputation rates in CLI patients (Bloor 1960) with CLI determined clinically
Age Mid-thigh amputations (annual% (average of 5 yrs))
35-44 38.4
45-54 23.3
55-64 42.0
65-74 41.0
75+    57.0
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The amputation figures reported by Juergens are substantially lower than those reported by Bloor. The
patient group in the studies was, however, different. Bloor included diabetic patients into his patient
population, while Juergens excluded them. Additionally, Juergens’ patients were all younger than 60. In
Juergens’ series it seems that only pulse palpation was used to establish the diagnosis of PAD, while
Bloor used pulse palpations, walking tests and oscillometry in the diagnosis. All these factors may
contribute to the differing amputation rates through differing patient populations. 
In Bloor’s material 4% of the original claudicants were diabetics, but he does not report the proportion
of diabetics in the patient group developing CLI.
Table 9: Amputation incidences /million inhabitants
Region  year major minor BK/AK
amputations amputations
Pohjolainen 1988* Southern Finland 84-85 271 124 0.64
Lääperi 1993* Southern Finland 89 200 59 0.58
Sayers 1993£ Leicestershire, GB 74-90 79 - -
“ “ 74 80 - -
“ “ 90 52 - -
Luther 1994 # Vaasa, Finland 70-74 137 - 0.53
“ “ 75-79 194 - 0.56
“ “ 80-84 317 - 0.39
“ “ 85-89 276 - 0.33 
“ “ 90-91 142 - 0.17
Pell 1994#@ Scotland, GB 90 142¤ - - 
Michaels  1994# Oxford region, GB ? 149 - 1.76
Ebskov 1994 # Denmark 83 345 - -
“ “ 90 250 - -
Lindholt 1994* Viborg, Denmark 86-87 409 - 0.75
“ “ 89-90 309 - 0.87
Gutteridge 1994&¤ West Berkshire, GB 83-87 480 198 1.01
“ “ 88-91 320 267 1.04
Trautner 1996 252
Luther 1996* Vaasa, Finland 80-91 274 - 0.27
Karlström 1997# Varberg, Sweden 85-88 342 - 2.89
“ “ 89-92 274 - 1.99
Mattes 1997# Western Australia 80-92 103§ - -
Feinglass 2000#¤ Northern Illinois, US 93-97 208 - 1.16
Eskelinen 2004* Southern Finland 2000 154 0.76
*= includes amputations both for vascular and other reasons
#= only vascular amputations
&= only vascular amputations (all amputations performed by an orthopaedic surgeon were excluded on the assumption that they were performed for other
reasons)
¤= age adjusted incidences 
§= population extrapolated
£= only amputations registered as PAD-amputations were included, amputations performed for diabetes without the PAD diagnosis were not included
@= only amputations registered as PAD-amputations were included
Other series assessing the outcome in patients unsuitable for revascularisation or with failed bypass
attempts produced major amputation rates ranging between 32-50% at six months of follow-up (Klomp
1999, Norgren 1990, UK Severe Limb Ischaemia Study Group 1991). Only few studies have a follow-up
longer than six months. In another study by Jivegård et al the amputation rate at 18 months was reported
to be 54% and so was the major amputation rate at 2 years in the study by Klomp et al (Jivegård 1995,
Klomp 1999).
49
In surgical series with vascular and endovascular treatment for critical leg ischaemia, major amputation
rates ranging between 5 to 26% at 1 year and 14% to 49% at 2 years have been reported (Table 10c). In
conservative and nonsurgical series major amputation rates ranged between 20% and 46% at one year
(Table 10a,b). 
Although the need for amputation is not imminent in all critically ischaemic patients, the general long-
term outcome of critically ischaemic patients is quite poor. Mortality in this patient group is very high
due to co-morbidities and cardiovascular manifestations of arterial disease (Hertzer 1984, Aronow
1994). In a study conducted in 1983 by Lassila et al the cumulative 10-year survival of CLI patients was
58% (Lassila 1986). Similarly, according to a recent review by Dormandy et al the one-year-mortality is
approximately 20% while the 5-year mortality ranges somewhere between 40-70% (Dormandy 1999a). 
In selected patients deemed unreconstructable, mortality rates between 11and 23 % have been reported
after a follow-up of 6 months, while Jivegård reported a mortality of 30% after 18 months of follow-up
(Table 10a,b). 
In surgical series in-hospital mortality rates of 14% (Vascular Surgical Society of Great Britain and
Ireland 1995), one-year mortality between 18 to 29% as well as mortality rates up to 88 % at 10 years
have been reported (Table 10c).   
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Table 10a: Outcome of CLI (rest pain and ischaemic tissue loss): Conservative treatment
Author patients follow-up major  mortality dm age [mean]
amp (range)
at follow-up at follow-up
Randomised studies with prostanoid treatment [CI] or epidural stimulation as treatment [CE] 
(here only the patients with placebo or conservative treatment included)
Belch  1983 [CI](FIII+IV)      13 6 mo 0 3 (23%) 0 69
Norgren 1990 [CI](FIV)      53 6 mo 24(45%) 8 (15%) 18 (34%) -
UKslisg¤1991[CI](FIII+IV)     71 2 weeks 21(30%) 2   (3%) 35 (49%) 73 (37-89)
“           “ 3 mo 27(39%) 7 (10%) “ “
 “       “ 6 mo 33(47%) 8 (11%) “ “
Jivegård 1995 [CE](FIII+IV)    26 18 mo 14(54%) 8 (30%) 5  (19%) [73]
Klomp 1999 [CE](FIII+FIV)    60 6 mo 18(32%) 9 (15%) 23(38%) 72
“       “ 2 yrs 29(54%) 41(68%)    “  “
Amann 2003 [CE] [FIII+FIV] 39 1 yr 18(46%) 0 (31.7%)§ [68](37-88)§
*=median, ¤=UK severe limb ischaemia study group, # =number of procedures, not pts, §=Patient demographics of the whole patient
population
F= Fontaine classification
Table 10b: Outcome of CLI (rest pain and ischaemic tissue loss): Non-reconstructive treatment
Author patients follow-up major  mortality dm age [mean]
amp (range)
at follow-up at follow-up
Randomised studies with prostanoid treatment [CI] or epidural stimulation as treatment [CE] 
(here only the patients WITH prostanoid and epidural stimulation treatment included)
Belch  1983 [CI](FIII+IV)      13 6 mo 0 3  (23%) 0 69
Norgren 1990 [CI](FIV)      50 6 mo 16(32%) 5  (10%) 15 (30%) -
UKslisg¤1991[CI](FIII+IV)     80 2 weeks 15(21%) 2    (3%)  25(31%) 73 (33-89)
“       “ 3 mo 19(26%) 3    (4%)  “ “
”       “ 6 mo 23(31%) 4    (5%)  “ “
Jivegård 1995 [CE](FIII+IV)   25 18 mo 9  (36%) 8  (30%) 5  (19%) [73]
Klomp 1999 [CE](FIII+FIV)    60 6 mo 19(34%) 9  (15%) 22(37%) [73]
“       “ 2 yrs 25(48%) 39(65%)    “  “
Jacobs 1990 [E] [FIII+FIV]      20 immediate 2  (10%) 0 7  (35%) [72](52-84)
“       “ 1yr     (20%) “ “ “
“       “ 2 yrs     (44%) “ “ “
Amann 2003 [CE] [FIII+FIV] 73 1 yr 21(29%) 0 (31.7%)§ [68](37-88)§
*=median, ¤=UK severe limb ischaemia study group, #= number of procedures, not pts, §=Patient demograpics of the whole patient
population
F=Fontaine classification
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Table 10c: Outcome of CLI (rest pain and ischaemic tissue loss): vascular surgical series
Author patients follow-up primary reconstr major  mortality dm age[mean]
(legs) (median) amputation or pta amp (range)
at follow-upa at follow-up
Surgical series (with either all pts with reconstructive procedures [S] or some treated conservatively as well [S+C])
DeWeese1971 [S] 61(67) 5 yrs 0 100% 24 (36%) 38 (62%) 25 (25%) (29-87)
DeWeese 1977 [S] 61(67) 10 yrs 0 100% 25 (37%) 54 (88%) 25 (25%) (29-87)
Veith 1981 [S] 755 5 yrs 76(10%) 679(90%) -  (52%)@ (>60%) [70]
“ “ 1 mo “ “ 152 (20%) 29(4%) “ “
Lassila 1986 [S+C]      84 10 yrs - - - 64(76%) - -
Wolfe 1986 [S+C] 409(429) 1 yr 17% 61% 26% 18% - -
Griffith 1988 [S] 402 2 yrs 148 260(65%) 197(49%) 54 (21%)@ - 73* (37-87)
“ “ 1 mo “ “ - (9%) - “
Hickey 1991 [S] 315(329) 8-68 mo 45 315(88%) - 41% 5yrs© 76 (24%)         [73] (46-93)
“ “ 1mo “ “ - (7%) “ “
Taylor 1991 [S] 498(627) 1-114 mo$ 14(2%) 484(613 legs) 55(9%) 146 (30%)@ 212(43%)        [68](24-97)
“ “ 1yr “ “ (97%) 32(5%) 71(15%)@ “ “
“ “ 2yss “ “ 37(6%) 96(20%)@ “ “     
“ “ 5yrs “ “ 51(8%) 146(30%)@ “ “
VSSGBI§ 1995[S+C] 679 on discharge 107(16%) 427(63%) 146(22%) 92 (14%) 204(30%) -
Luther 1996b [S] (151) 1 yr 0 100% 13% 17% 39% [69]
“ “ 3 yrs “ “ 18% -
“ “ 5 yrs “ “ 23% 52%
ICAI 1997 [S+C] 522 2 yrs 49(9%) 232(44%) 72(14%) 165(32%) 157(30%) 71*
Luther 1997a [S] 99(109) 1 mo 0 100% 14(13%) 4 (4%) 81 (74%) 75*
“ “ 1yr “ “ - 20%© “ “
” “ 2yrs “ “ - 31%© “ “
“ “ 3yrs “ “ - 46%© “ “
Luther 1997b [S] 188 (209) 1 yr 0 100% 19%£ 33 / 5%Θ 89(47%) -
“ “ 3 yrs “ “ 24%£ 55 / 20%Θ “ -
“ “ 5 yrs “ “ 29%£ 58 / 29%Θ “ -
Holdsworth 1997[S+C] 319(436e) 12 mo 78(18%) 187(43%) - 127(29%) 115(26%) [73]
Kantonen 1998 [S] 1761# 1 mo 0 100% 7,5% 4,7% 41% [70,5]
Luther 1997c [S] 117 1 mo 51(44%) 66(56%) - 16 (14%) 62 (53%) 81/75*%
“  “ 1 yr “ “ - 35 (30%)
“ “ 2 yrs “ “ - 45 (38%)
“ “ 3 yrs “ “ - 60 (51%)
“ “ 5 yrs “ “ - 76 (65%)
Biancari 2000 [S] 62 (66) 1 mo 0 100% 3% - 52(79%) [67](63-93)
“ “ 1 yr “ “ 12% - “ “
“ “ 2yrs “ “ 12% 28% “ “
Van Damme 2003 [S] 81(90) ° 5 yrs 0 (28amp) 100% 11% 33% 35 (43%) [70](37-93)
Bailey 2003 [S+C] 129(130) 3-15 mo (9) 11(7%) 62# 17(13%) 39 (27%) 39 (30%) 81*(31-98)
Vayssariat 2004 [S+C] 57                     1,5-49mo (20) 1 (2%) 35(61%) 10 (18%) 25 (44%) 23 (40%) 76(43-96)
© = cumulative data (mortality or amputation)
@=mortality of operated (bypass) pts only
-= information not available
*=median age 
¤=UK severe limb ischaemia study group, 
#= number of procedures, not pts, 
§=Vascular Surgical Society of Great Britain and Ireland
$=mean 21 months
a=major amputation at follow-up: both primary amputations and secondary amputations
%=median age of primarily amputated pts/ median age of reconstructed pts
£=only autogneous vein bypass procedures, prosthetic grafts excluded
Θ=mortality diabetics / non diabetics
e= admissions
°= includes 4 cases with claudication
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Table 11a: Patients alive with leg: Conservative or non-reconstructive series 
Randomised studies with prostanoid treatment [CI] or epidural stimulation as treatment [CE] 
Author patients follow-up alive with leg dm mean age
at follow-up (range)
Klomp 1999 [CE](FIII+FIV)   120 2 yrs (27%) 32 (27%)
UKslisg¤1991[CI](FIII+IV)     71 6 mo (30%) 35 (49%) 73 (37-89)
UKslisg¤1991[CI](FIII+IV)     80 6 mo (49%) 25 (31%) 73 (33-89)
Table 11b: Patients alive with leg: Vascular surgical series
Author patients dm [mean] age alive with leg alive with leg
(range) at 1 year at 2 years
Veith 1981 [S] 755 (>60%) [70]        (68%)       (54%) 
Griffith 1988 [S] 208 - 73* (37-87) 152 (73%) 137(65%)
Hickey 1991 [S] 315(329) 76 (24%) [73] (46-93) 212 (64%) 177(54%)
Luther 1997a [S] 99(109) 81 (74%) 75* 50   (50%) 20  (20%)
Biancari 2000 [S] 62 (66) 52 (79%) [67] (63-93)        (70%)       (66%)
*median age
As the both amputation risk and mortality are high in critically ischaemic patients, the proportion to
survive with a viable limb will be relatively small. In an Iloprost study from the UK, 42% of the
conservatively treated patients were alive with an intact leg at 6 months, while in Klomp's study 57%
survived with an intact leg at 6 months (Klomp 1999, UK severe limb ischaemia study group 1991).
The proportion retaining the leg and surviving for 2 years was 34% in the latter study (Klomp 1999). 
Although data of different series are not directly comparable and no recent data concerning the true
natural outcome of critically ischaemic patients exist, the bleak prognosis for these patients seems
evident. 
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7. AIMS OF THE PRESENT STUDY 
The main aim of this study was to investigate how well the legs at risk to be amputated due to critical leg
ischaemia can be identified and what their outcome on population basis is. 
The specific aims were to assess:
1) The accuracy of ankle brachial index measurements in CLI
2) The usefulness of ABI-measurements in leg viability evaluation
3) To assess the proportion of IC preceding CLI
4) The natural outcome of critical leg ischaemia
5) The mode of organising vascular surgical service and the need of major amputations in Uusimaa
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8.  MATERIAL AND METHODS
All of the studies included critically ischaemic patients either from the Department of Vascular Surgery
at the Helsinki University Central Hospital or its catchment area. The patients were critically ischaemic
according to the Fontaine classification. Some fulfilled the additional pressure criteria of the Second
European Consensus Document. All in all 42% of the patients investigated in the Vascular Surgical
Department were diabetics, partly owing to the fact, that the treatment of critically ischaemic patients
with additional risk factors such as diabetes was concentrated to the Helsinki University Hospital. The
population based study V relied mostly on registry data, which made the assessment of possible diabetes
and pressures impossible. The ethical committee approved all studies. In the studies I and III informed
consent was obtained from each patient participating in the study.  The patient characteristics in the
different studies are summarised in Table 12. 
Table 12: patient characteristics in the different studies
Study  I    II    III    IV    V
No of pts 55 110  100  105   1243
Males 31   51   60   47    609
Females 24   59   40   58    634
Diabetics 12   56    44 53    NA
Rest pain 61%  83% 63%    
Ulcer                  100% 63%  70% 61%     100%
Gangrene 18%  37% 18%    
Previous amputation# 0%   5%    7%   6%
Mean ABI [median] 0.37[0.39]&          0.30[0.31]                0.55[0.43]&              0.34[0.31]&   NA
ABI-range 0-1.44&               0.3-0.47 0-1.77& 0-2.28&    NA
Eur cons doc* 100% 95% 82% 100%    NA
TASC 100%                100%                 100% 100%    NA
*patients complying with the European consensus document criteria for CLI
&= pseudohypertensive pressure values not excluded
#=  previous major amputations
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Study I: Reproducibility of ABI measurements
In order to assess the accuracy and repeatability of pressure measurements in critical leg ischaemia, the
pressure measurements were performed in a situation resembling the widespread clinical practice in this
country. The pressures of 19 consecutive patients with 22 critically ischaemic legs were measured by 4-7
different measurers (part A). The measurers had variable experience in performing measurements and
the patients were all measured on the ward while they were waiting for angiography, consultation or
operative treatment. The measurers had ample time for their measurements and the occluding cuffs were
already in place. All measurements were performed using a CW-Doppler with earphones (9,5 MHz,
model 806-CB Parks Medical Electronics, Oregon, United States) and the measurement variability of
ankle brachial indices was calculated. To compare the results, a second subset of 30 patients with 33 legs
was included into the study and measured by two experienced vascular technicians (part B) and the
inter-observer agreement calculated. Patients with incompressible arteries were excluded, as were
patients who had large ulcers at the site of the cuff precluding repeated pressure measurements. 
 
Study II: Predictive value of pressure measurements
The pressure measurements and ABI-values of 110 critically ischaemic patients with 145 critically
ischaemic legs measured at admission, were assessed. These patients had been excluded from operative
treatment due to technical reasons or increased operative risk in the years 1988-1993. The positive and
negative predictive values of the pressure measurements were calculated in terms of amputation risk
within 3 months of admission. In order to assess the influence of changing treatment policies throughout
time, the patients were divided into two groups and analysed separately: the ones having attended the
vascular outpatient clinic in the years 1988-1990 and those in the years 1991-1993. 
Study III: The proportion of claudication prior to CLI
 
In order to assess the course and development of critical leg ischaemia, 100 patients were included into
the study. They had been referred to the vascular surgical outpatient clinic. Most patients fulfilled the
criteria for critical leg ischaemia according to the European Consensus Document, which were rest pain,
ulceration or gangrene together with ankle pressures <50 mmHg or toe pressures <30 mmHg. Some
additional patients were included if they presented with an ulceration or gangrene together with ankle-
brachial indices < 0.5 or toe-brachial indices <0.2 (Ramsey 1983). All of these patients were interviewed
to assess the presence of claudication symptoms before developing symptoms of CLI. The interviewer
filled in an additional questionnaire. The questionnaire was focused on the order of appearance of the
various symptoms of PAD, their treatment and duration (appendix I). Special attention was paid to the
presence of conditions preventing the patient to experience claudication pain. The influence of diabetes
was assessed as well as the distribution of different symptoms. 
To analyse the potential bias affecting the outcome by treatment delay, a subset of 68 CLI-patients was
analysed separately to assess the effect of treatment delay on the amputation risk. In these patients the
referring physician suspected critical leg ischaemia to be the underlying cause for the symptoms. Proper
vascular laboratory assessment with toe pressure measurements, Doppler-measurements from each ankle
vessel and pulse volume recordings were carried out. A vascular surgeon clinically evaluated the
patients. The length of the time period in which the symptoms indicating CLI had been present, was
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calculated and the association with amputations within 1 year was assessed using the Students t-test for
comparison of means.
Study IV: Outcome of unreconstructed CLI
105 patients with critical leg ischaemia according to the European Consensus Document had been
considered unsuitable for reconstructive procedures, either due to technical reasons or in combination
with increased operative risk. Technical reasons precluding operative treatment included occlusive
lesions extending well below the distal poplitea, as femoropedal bypass procedures were not performed
at that time. Also, the need of extensive surgery together with a high operative risk was among the
exclusion criteria. All in all 54% of the patients had been excluded from operative treatment due to
technical reasons alone, or in combination with an increased operative risk, and 33% due to an increased
operative risk alone. The remaining 6% were excluded due to their refusal. The one-year-outcome was
assessed retrospectively by tracing down their hospital records from different hospitals, as well as their
records in local health care centres. The eventual amputation date as well as the amputation levels was
recorded. Similarly, in case of death, copies of death certificates were obtained from the Finnish
Statistical Office and the cause and date of death recorded. Survival analyses in terms of leg survival,
patient survival and survival with leg were made.  
Study V: Comparison of vascular surgical service models
An analysis of the treatment efficacy and outcome of critical leg ischaemia was performed in the
hospital district of Uusimaa in the years 1991-1997. The population in the hospital district was 702 260
at the beginning of the study period and 800 640 at the end. All information on vascular surgical
operations, amputations and subsequent care performed during that period was extracted from the
hospital discharge register kept by the National Research and Development Centre for Welfare and
Health. Reliable data on endovascular procedures was not uniformly available and was therefore
omitted. The patients having been treated for critical leg ischaemia were identified using the nationwide
register for vascular surgical procedures, Finnvasc. At the end of the time period, one of the participating
hospitals had ceased to report its cases into the Finnvasc database. Its hospital records on vascular
surgical procedures performed in the years 1996-1997 had to be reviewed by the investigators in order to
identify all critically ischaemic patients in the region. The identification of patients with primary
amputation, as well as follow-up data concerning hospital care and care in other institutions, was
provided from the hospital discharge register. The different municipalities, in which the patients were
registered, were divided according to their referral system in three different groups: a centralised system,
a decentralised system and a hybrid system (Fig 7). Age- and sex-adjusted incidences were calculated
for major amputations, hospital days, mortality and femorodistal bypasses. 
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Figure 7:  Vascular surgical service models
Decentralised Centralised Hybrid
health care model health care model health care model
health care centres health care centres health care centres
District hospital District hospital District hospital
with primary
vascular service 
District hospital
with primary
Academic Academic vascular service
referral centre referral centre
with vascular with vascular
surgical service surgical service
Academic 
referral centre
with vascular
surgical service
To evaluate the effect of differing socio-economic features of the population on CLI- and amputation
incidences, the differences between the municipalities included into the study were assessed. Poisson
regression analyses were carried out. 
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9.  RESULTS
Study I: Reproducibility of ABI measurements
ABI measurements performed by experienced vascular nurses in appropriate surroundings did not differ
from each other by more than 0.14. The mean coefficient of variation was found to be 3.15. In contrast
to this, measurements performed in surroundings resembling the situation in many hospitals by
measurers with variable experience showed a mean coefficient of variation of 56.1. 19% of the ABI
values differed more than 0.15 and 28% more than 0.10 from the mean ABI.
Study II: Predictive value of pressure measurements
After a follow-up-period of three months 36 (25%) legs had been amputated either at thigh or calf level.
Of the patients having rest pain, i.e. Fontaine III 16% were amputated, whereas of patients having
ischaemic tissue loss, i.e. Fontaine IV 28% were amputated (NS). Neither did the result of those legs
having only low ankle pressures (amputation rate 25%) differ significantly from those who had both low
ankle and toe pressures (amputation rate 37%). Only isolated acral ischaemia was connected to a better
leg salvage: 11% were amputated if only the toe pressure indicated CLI (p < 0.025).
Although the pressure ranges were almost identical in the amputated and nonamputated group (Table
13), there were significant differences in ankle pressures (p = 0.01), toe pressures (p = 0.02) as well as
ABI (p =0.009) between the amputated and nonamputated group (Figures 8-10)
Figure 8: Frequencies of measured ankle pressures  (mmHg) 
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Figure 9: Frequencies of measured toe pressures (mmHg) 
Figure 10: Frequencies of measured ankle brachial pressure indices 
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There were, however, no clear cut-off levels for pressure values indicating risk for major amputation
(Tables 14a-c). 
Table 13: Pressures in the amputated and nonamputated groups
        Major amputation          No major amputation Significance
Mean Median Range Mean Median Range
Ankle pressures    32    34 0-56    42    45 0-59 p<0.05
Toe pressures    16    17 0-30    20    20 0-30 p<0.05
ABI   0.26  0.24      0.03-0.47  0.31  0.32        0.1-0.5 p<0.01
Table 14a: Predictive values of ankle pressure in terms of amputation at three months
Ankle pressures <30 <40 <50 <60
Sensitivity 0.31 0.5 0.67 0.89
Specificity 0.93 0.78 0.57 0.28
PPV 0.58 0.43 0.34 0.29
NPV 0.8 0.83 0.84 0.89
Overall accuracy 0.77 0.71 0.59 0.43
Table 14b: Predictive value of toe pressures in terms of amputation at three months
Toe pressures <10 <20 <30
Sensitivity 0.14 0.5 0.93
Specificity 0.93 0.77 0.16
PPV 0.40 0.42 0.28
NPV 0.76 0.82 0.87
Overall accuracy 0.72 0.70 0.36
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Table 14c: Predictive value of ankle brachial indices in terms of amputation at three months
ABI <0.3 <0.4 <0.5
Sensitivity 0.57 0.8 0.94
Specificity 0.61 0.37 0.18
PPV 0.32 0.29 0.27
NPV 0.81 0.85 0.91
Overall accuracy 0.60 0.47 0.37
PPV = positive predictive value
NPV= negative predictive value
At any level of pressure whether measured on toe or ankle level either sensitivity or specificity was poor
in predicting amputation. Neither could any difference in Fontaine-classification, mean pressure values
or the age of the patients be seen.
Study III: The proportion of claudication prior to CLI
Sixty-three patients out of 100 had experienced symptoms of claudication prior to developing CLI.
Twelve of them reported that the claudication symptoms had been relieved before developing symptoms
of CLI. Six of them had had previous endovascular or surgical reconstructive procedures whereas the
other six did not walk enough to develop claudication. 
Thirty-seven patients had CLI as the initial symptom of peripheral arterial disease. CLI developed after a
small trauma (26 patients), through gradually increasing pain and subsequent ulceration or gangrene (8
patients), or gangrene of the toe without prodromal signs of occlusive arterial disease (3 patients). 20
patients without earlier signs of PAD (54%) had diabetes, four of which with previously diagnosed
neuropathy, whereas 38% of those with previous sings of PAD had diabetes, none with known
neuropathy.
The patient groups did not differ from each other in terms of age, diabetes, coronary heart disease,
hypertension, cerebrovascular disease, renal disease, previous reconstructive procedures or current
smoking habits (Table 15). In terms of recent smoking, non-smoking, diabetes and the distribution of
rest pain or ulcers the two groups did differ. Patients with previous claudication had a greater proportion
with recent smoking and a lower proportion of non-smokers than the patient group without previous
claudication. Diabetes was less common in the group with previous claudication, and so was the
presence of ulcers. Rest pain was in contrast more common in the group with preceding claudication
(Table 15). 
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Table 15: Patient characteristics of 100 interviewed patients
Previous claudication no previous claudication p-values
Number of patients 63 37
Current claudication 51 0
Male/female (%) (65/35) (51/49) 0.17
Mean age 71 72 0.62
Current smoker 17 (27) 10 (27) 0.99
Recent smoker (cessation< 5yrs) 14 (22) 1    (3) 0.008
Ex-smoker (cessation< 5yrs) 14 (22) 8   (22) 0.94
Non-smoker 18 (29) 18 (49) 0.043
Diabetes 24 (38) 20 (54) 0.12
Rest pain 58 (92) 25 (68) 0.016
Ulcer 37 (59) 33 (89) 0.013
Gangrene 24 (38) 13 (35) 0.76
Pressures: mean [median]{range}
Ankle* 66 [59]{0-202} 103 [90] {37-197}
Toe 15  [0] {0-78}  22  [15] {0-117}
( ) = percentage within the group
* = pseudohypertensive pressures excluded
Six patients with acute-on-chronic-ischaemia could be identified in those patients with earlier symptoms
of PAD. Of the patients with acute on chronic ischaemia, three had undergone previous reconstruction
and two of these did not have claudication anymore.
Nineteen of the previously asymptomatic patients (12 nondiabetics and 7 diabetics) did not walk enough
to develop symptoms of claudication. In 14 of these, other disorders, such as hemiparesis, arthrosis,
cardiac failure etc. were observed as the cause for limited ambulation, whereas five patients presented
with no obvious reason for limited exercise or the awareness of any factor restricting their walking. In
five additional patients the reason for not developing claudication remained unclear; they did not declare
to have very limited ambulation nor were there any co-morbidities or a sudden onset of pain explaining
the absence of previous symptoms. 
In the subgroup of 82 patients with pressure defined CLI there were 32 patients (39 %). In the subgroup
of 18 patients with index defined CLI, five patients (28 %) had never experienced claudication. In the
former subgroup 23 patients (5 with and 18 without previous claudication) and in the latter subgroup
two patients (1 with and 1 without previous claudication) did not move enough to develop claudication.
The symptoms of claudication had been relieved due to previous reconstructive procedures in three
patients in each subgroup. There were no significant differences in the patient characteristics between
the two subgroups. Only a tendency towards a larger proportion of non-smokers among the patients
without claudication could be seen. (p=0.054) 
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In the additional subset analysis of 68 patients with CLI-suspicion at their first admission to the vascular
outpatient clinic and subsequent interview with vascular assessment, 3 patients were not considered to
have vascular disease severe enough to account for the symptoms indicating CLI. The symptoms were
regarded as caused by other disorders than vascular disease and they were excluded from the study. In
the remaining 65 patients the time period between the first notion of pain or tissue loss due to CLI and
the arrival at the vascular outpatient clinic ranged from 1 day to 12 months. Twelve patients underwent a
major amputation within one year after presentation. The mean duration of CLI-symptoms was 109 days
(SD 88.9) (range 1 day to 12 months) in the patients without amputation and 89 days (SD 98.7) (range
30 days to 12 months) with amputation. No significant difference between these could be detected
(p=0.516). Furthermore, there was no difference between the treatment delays of various groups.  
Study IV: Outcome of unreconstructed CLI
Of all 136 legs with critical leg ischaemia according to European criteria 81% were saved at one month,
70% at 3 months, 58% at 6 months and 54% at 1 year. Five patients were lost to follow-up during the
first month and further six were lost up to 1 year. Both mortality and amputation rates were high in the
study population (Figure 11). 72% of the patients deceased, died of cardiovascular reasons. Of all 105
patients 93%, 77% and 46% were alive at 1, 3, and 12 months, respectively. The 1 year survival of an
age and sex adjusted population would have been 93%. A favourable outcome was observed in 71%,
51% and 28% of the patients, who were alive and not amputated at 1, 3 and 12 months (Figure. 9).
Figure 11: Patientwise survival and leg preservation
Survival (--), Preservation of the leg (-◊-), Survival preserving the leg (--)
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Diabetics were found to fare worse than nondiabetics in terms of survival (p<0.01) (Figure 12a), but not
in terms of preserving the leg (Figure 12b). 
Figure 12: The association between diabetes and a) leg preservation and b) patient survival
Diabetics (--); Nondiabetics (--)
Patients with bilateral CLI had a worse prognosis for survival (p<0.01) and leg preservation (p<0.05)
than those with a unilateral CLI at presentation. 
If the operation was rejected due to technical reasons alone or in combination with a high operative risk,
preserving the leg and patient survival were the same as in patients rejected solely for high operative risk
(NS) (Figures 13a,b). 
Figure 13: The association between the reason for being excluded from operative treatment and a)
preserving the leg and b) survival: technical reason (--), high operative risk (--)
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Three of the seven patients with a clinically borderline CLI deceased during the study year although
none of them lost their leg. Of the six patients, who refused operative treatment three died and one was
amputated in within one year. Known coronary heart disease did not significantly affect the outcome of
limb salvage or survival rate (Figure 14 a,b).
Figure 14: The association between known coronary heart disease and a) preserving the leg (NS) and b)
survival (NS)
   a)               b)
CHD (--), no CHD (--)
Study V: Comparison of vascular surgical service models
1 243 patients with critical leg ischaemia were identified in the years 1991-1997. After the diagnosis of
critical leg ischaemia they had 2 993 in-patient hospital stays in all, during which they spent 65 289 days
in hospital.
During the study period 732 patients were amputated at calf or thigh level, all in all 967 major
amputations were performed. The mean annual major amputation incidence was 136 per million
inhabitants.
As the intention was to assess the development through the years, age- and sex-standardised major
amputation annual incidences within one year of the diagnosis were calculated. The major amputation
incidences showed considerable annual variation (Figure 15), although with a visible overall tendency of
declining with the years (Table 16, Figure 16). 
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Figure 15: Annual age and Sex standardised amputation incidences within one year of diagnosis
(/ 100 000 inhabitants aged 40 years and older)
Figure 16: Annual age standardised major amputation incidences in Uusimaa (/100 000 inhabitants) (in a
population of 40 years and older)
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Table 16: Major amputations in the Uusimaa Hospital District 
Year                    Amputated patients    incidence* in the total population
1991 124        167
1992 105        139
1993 120        157
1994   88        113
1995 116        148
1996 102        129
1997   77          96
*= incidence of amputated patients / million inhabitants
No difference in major amputation incidences between the different service models could be detected.
Therefore the following incidence calculations were made on the basis of hospital subdistricts. Age and
sex-standardised incidences on mortality (Figure 17), major amputations (Figure 17), vascular
procedures and hospital utilisation showed considerable differences within the referral models (Lohja,
Jorvi and Peijas = decentralised model; Porvoo and Tammisaari = centralised model; Hyvinkää = hybrid
model). 
Figure 17: Major amputations and mortality in the different hospital subdistricts within one year after
diagnosis (age- and sex standardised incidences /100 000 aged 40 and over)
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When calculating age and sex-standardised incidences of critical leg ischaemia within every of the six
hospital subdistricts a similar distribution could be seen (Figure 18). All in all 43% of the patients in the
centralised service model and 60% in the hybrid model never had the possibility of vascular surgical
consultation prior to the first amputation (Figure 18).
Figure 18: CLI incidences in the different hospital subdistricts (age- and sex standardised incidences/100
000 aged 40 and over)
0
100
200
300
400
500
600
700
800
Lo
hja
Po
rv
oo
Pe
ija
s
Ta
mm
isa
ari
Hy
vin
kä
ä
Jo
rvi
vascular consultation possibility in academic referral centre 
vascular consultation possibility in district hospital
no vascular consultation
69
Assessment of the socio-economic features in the region showed the highest percentage of academic
education, the highest tax income/inhabitant and the smallest invalidity pension incidence due to
vascular diseases in the particular hospital subdistrict (Jorvi hospital) with the smallest CLI-incidence. In
the subdistrict with the highest CLI-incidence (Lohja hospital) as well as the highest amputation
incidence, the percentage of academic education as well as the tax income per inhabitant was among the
lowest in the region whereas the disability pension incidence was among the highest. (Table 17). 
Table 17:  CLI incidences and socio-economic differences between health care areas 
Jorvi
Peijas
Porvoo
Tammisaari
Lohja
Hyvinkää
    mean tax         % population invalidity pension
    income with due to vascular
  (FIM/inh)         academic education/ diseases/1000 inh
        trained professionals
       14200 25 / 34       3.88
       14337 21 / 34       4.52
       15034 21 / 30       4.78
       15248 23 / 32       4.11
       17304 26 / 34       3.97
       21871 39 / 30       2.79
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10.  DISCUSSION
10.1 Limitations of the study
Generally most clinical studies are not free from certain limiting factors and selection bias. This study
was conducted in a normal clinical environment under typical limitations. No ideal conditions were
present and some patient selection inevitably has occurred. An account on the limitations of the different
parts of the study is given below.  
Study I: Reproducibility of ABI measurements. 
In part A of the study, no standards, such as measurements performed by an experienced vascular
technician, were available which may cause some bias and limits the scientific value of the material.
Therefore the median of the measurements in each vessel had to be used as a standard and the difference
from this median was calculated for each measurement. 
Study II: Predictive value of pressure measurements
As this study is conducted on conservatively treated patients, an apparent patient selection is present. At
the time of the study, however, no femoropedal bypasses or bypasses to the distal calf arteries were
performed and a major proportion of the patients included in the study had distal lesions. They were
consequently excluded from operative treatment due to technical reasons. Therefore the patient
population can be estimated to represent the overall CLI patient population to a considerable extent. 
As only the relationship between pressure values and amputation risk is assessed in this study, the
selection may be considered unimportant.
Study III: The proportion of claudication prior to CLI
This study was conducted in the outpatient clinic of an academic referral centre, which may cause some
selection bias. The proportion of patients without symptoms of claudication prior to developing critical
leg ischaemia may not reflect the situation in the general population. Therefore the results of this study
used as a basis for incidence calculations may have some bias. The study merely quantifies the
phenomenon frequently seen by vascular surgeons in their daily practice.  
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Study IV: Outcome of unreconstructed CLI
The study material partly consists of the same patients as those included in study II – therefore the same
problem with a selected patient material exists. Similar selection bias can be observed when comparing
amputation and mortality rates in vascular surgical and conservative series (see Tables 10a-c in Chapter
6.6.2). It is considered unethical to randomise patients receiving reconstructive or conservative treatment
in the era of reconstructive vascular surgery. Since most of the critically ischaemic patients are being
revascularised today, the opportunities for carrying out a study assessing the natural outcome of critical
leg ischaemia have become even fewer. Still, the drawbacks of historical series and the applicability of
their results are well known, and this study is by no means free of such limitations.
Study V: Comparison of three vascular surgical service models. The regional incidence of critical leg
ischaemia and major amputations – impact of service models, their implementation and socio-economic
factors.
In this study the onset of CLI is set arbitrarily to the date of admission on the first hospital visit for the
treatment of CLI. Still, slowly progressing symptoms of CLI may have been present up to a year before
the date of admission.
     
The retrieval of data is based on different registries, which are apt to register only certain types of
patients. Those, who have not received any operative care for CLI, or did not undergo an amputation but
died before that, are therefore not included into the study. The number of these patients is estimated to
be quite limited, due to the far-reaching Finnish social health care system, and will not have much
impact on the evaluation of the different health care models for treating CLI.   
This study is based on registries alone and can therefore only be as accurate as the original registries are.
Registry-derived data has its own pitfalls regarding inclusion of all patients and validity of the data
(Bergqvist 1998). The validity of the Finnvasc-registry has been evaluated using a random sample and
has been found to have a mean agreement of 93% with the original hospital records (Kantonen 1997).
The Hospital discharge register kept by the National Centre of Welfare and Health is a direct copy of the
electronic hospital data, the accuracy of which has not been evaluated so far. 
Another feature limiting the value of this study is the fact that no endovascular procedures were included
into the study. Endovascular procedures were not recorded into the hospital discharge register during the
time of the study and the hospitals were not able to provide any data on them either. Therefore no
incidences on endovascular procedures could be calculated. To give an overall picture of the
endovascular activity in the region, percutaneous transluminal angioplasties performed for critical leg
ischaemia at the referral centre and other hospitals of the region were counted (Table 18).
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Table 18: Infrainguinal endovascular procedures performed for critical leg ischaemia
Year 1991 1992 1993 1994 1995 1996 1997
RC*  15   27   24   32   28   29   33
other    2    9   12   11     9     4     3
total  17  36   36   43   37    33    36
*= referral centre
10.2 Discussion
With limitations already dealt with, the results of this study have in general provided some answers to
actual clinical problems, and may contribute to decision making within the vascular service influencing
organisational decision-making. 
A number of guidelines on how to classify and diagnose CLI are available (Ad Hoc Committee on
Reporting Standards 1986, European Consensus Document 1992, Rutherford 1997, TASC 2000). The
identification of ischaemic legs is, however, far more complicated. Generally defined rules do not
necessarily fit into everyday clinical practice. This is particularly true in critical leg ischaemia. Therefore
this study investigated the problems involved in the detection and recognition of CLI. To be able to refer
patients to vascular surgical assessment and treatment in time, the suspicion of ischaemic aetiology of
rest pain or ulcers has to arise in primary health care at an early stage. The presence of preliminary
symptoms can be helpful and the aim was to assess the occurrence of such symptoms. The threshold to
suspect vascular involvement should be low and whenever suspicion arises, objective methods to
determine the existence of haemodynamically significant impairment of the blood supply are needed.
Ankle pressure measurements using a Doppler-probe are recognised as the basic method of
measurement for vascular surgical patients as they are non-invasive, easy to perform and as no elaborate
equipment is needed. They are recommended as a basic tool even for general practitioners (Jonason
2002) and most institutions have the equipment needed readily available. The purpose of this study was
to assess the reproducibility of Doppler derived pressure measurements in critically ischaemic patients in
particular. The key question was whether arbitrary measurers are able to provide reliable distal pressure
data and whether the pressure data is able to predict amputation risk. 
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An additional aim of the study was to investigate the fate of critically ischaemic patients, once critical
leg ischaemia is diagnosed, as well as the outcome of treatment in different clinical settings. To
accomplish this, the outcome of patients not receiving reconstructive surgery was assessed and the
population-based outcome of treatment in different regions was evaluated. Specific therapeutic
approaches are well studied and not within the scope of this study.
Study I: Reproducibility of ABI measurements
The results clearly show that the current measurement policy in many smaller vascular surgical units in
this country, with the occasional physician, surgeon or nurse being appointed to perform ankle-brachial-
pressure indices, is inadequate to provide reliable high quality measurements. Similar results have been
reported previously by Kaiser who used claudication patients and Ray who used an unselected patient
population to determine the reliability of measurements performed by inexperienced measurers (Kaiser
1999, Ray 1994). Specialised vascular nurses/technicians should be educated to reach internationally
agreed levels of measurement accuracy, stating a clear case for vascular laboratories (Lepäntalo 1997).
Measurements performed by inexperienced personnel can be regarded as qualitative assessments and
should only be used to get a rough idea of the vascular status.
 
Study II: Predictive value of pressure measurements
Although pressure values have been seen to be associated with leg outcome (Vayssariat 1997), single
pressure measurements proved to be inadequate for predicting the leg outcome in the present study.
Likewise, it has been impossible to predict amputation stump healing with pressure measurements
(Lepäntalo 1982, Lepäntalo 1987). Pressure measurements may give only supplementary information to
clinical judgment (Lepäntalo 1988).
Study III: The proportion of claudication prior to CLI
The often used assumption in describing the course of PAD, that the symptoms of PAD progress slowly
from asymptomatic, to claudication and finally to symptoms indicating critical ischaemia is incorrect
according to the present study (Figure 19). Although the underlying PAD lesions may be severe enough
to cause symptoms of claudication, there are various reasons causing the patient not to experience them.
Therefore a significant proportion of the patients presenting to the doctor with symptoms of critical leg
ischaemia, may not have experienced previous symptoms of claudication. Their complaints may be
mistaken as caused by some other aetiology, thereby delaying the correct diagnosis and treatment. 
74
Figure 19: The development of critical leg ischaemia 
(Based on Figure 14 in the TASC document and modified according to the data of this study.)
300 asymptomatic 100 claudicants 100 with claudication  
patients presenting to the symptoms not seeking
doctor medical help
in 75 claudication in 25 claudication
will stabilise or will deteriorate
improve
4 will develop 5 claudicants 1 will 
CLI will develop CLI present with CLI 
to the doctor
The duration of symptoms indicating CLI as such seemed not to play a significant role in determining
amputation risk, as in the subset analysis no correlation was found between the risk of amputation and
the length of symptoms. This is a surprising finding, as international literature often stresses that it is
essential to provide proper vascular treatment to critically ischaemic patients within 1-2 days (Audit
Committee of the Vascular Surgical Society of Great Britain and Ireland 1996, TASC 2000), to avoid
unnecessary deterioration of the condition of the leg due to treatment delay, which may possibly result in
major amputations that could have been prevented if treated earlier. 
One explanation of this finding may be that it is not possible to assess the nature and the progression of
symptoms well enough by means of a simple questionnaire and interview. Etiological factors of the
disease such as diabetes, presence of infection or neuropathy, concomitant diseases and activity differ.
Furthermore the definition of CLI is only a recommendation that doesn’t fully describe the clinical
situation (TASC 2000). The definition of CLI contains ischaemia of varying severity. An elderly
sedentary patient may have a slowly occluding vascular tree in the calf with an occasional small trauma
and a wound, which does not heal. As long as this ulcer remains dry and non-infected, and it is not
extensively debrided, the progression of the ulcer may be very slow. It may take months until the patient
shows the ulcer to a physician. It may even take considerable time for the patient to realise the existence
of an ulcer, if it does not cause any pain. This is a quite common phenomenon in diabetic patients with
diabetic neuropathy. The opposite example would be a patient who may have had a similar trauma as
above but whose wound subsequently becomes infected, causing severe pain and becoming larger within
days. Such a patient is likely to seek medical help without delay and is likely to be referred to specialist
care. Likewise the outcome of an ulcer classified according to the Armstrong classification, as 2c may be
different to an ulcer classified as 3d (Armstrong 1998).
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According to the results of this subset analysis it may be assumed that the present health care systems
seem to be able to recognise the patients with a more fulminant course of the disease, sending them to
receive vascular assessment and treatment in due course. 
Study IV: Outcome of unreconstructed CLI
The annual amputation rate of critically ischaemic patients in the classic study of Bloor ranged between
23-57% with an increasing amputation rate at increasing age (Bloor 1961). When comparing these
results to our series, with conservatively treated CLI patients followed up for 1 year before the era of
femoropedal bypass surgery, the limb salvage rates were in accordance with Bloor’s results (Lepäntalo
1996). Our one-year limb salvage was 54% in a patient group aged 40-96 with a mean age of 75 years.
In Bloor’s material 4% of the original claudicants were diabetics, but no report on the proportion of
diabetics in the patient group developing CLI was available. In our material the proportion of diabetic
patients was, however, much higher (50%). This probably mirrors the improvement of diabetes care
leading to an increased life expectancy of diabetics and thereby developing an increasing number of
vascular complications (Eskelinen 2004). The fact that in our study these patients constitute a patient
group deemed unreconstructible, in conjunction with the high proportion of diabetics might worsen the
outcome results. Because the study was conducted before the era of femoropedal bypass surgery, some
of these patients would possibly have been evaluated operable today. 
More recent series dealing with unreconstructed critical leg ischaemia have produced amputation rates
ranging between 32 and 50% at 6 months of follow-up (Klomp 1999, Norgren 1990, UK Severe Limb
Ischaemia Study Group 1991).  These are similar to the rates achieved at one year in our study,
indicating that in these studies the influence of patient selection may play an even greater role than in
our study. 
Mortality in patients with severe impairment of peripheral blood flow is high, due to the extent of the
vascular disease and the large number of comorbidities frequently seen in this patient group. In
unreconstructable patients mortality rates between 5 and 23% at six months have been reported (Belch
1983, Norgren 1990, UK Severe Limb Ischaemia Study Group 1991, Klomp 1999). In surgical series on
critical leg ischaemia mortality rates between 15 and 30 % have been reported at one year (Wolfe 1986,
Taylor 1991, Luther 1996b, Luther 1997a, Luther 1997c), which are much smaller than the mortality rate
in our own study, where cumulative survival at one year was only 46%. This emphasises the difference
in the patient materials and the fact that in our study some of the patients were excluded from surgical
treatment due to high operative risk, which is bound to increase mortality.
As both the amputation risk and the mortality are high in critically ischaemic patients, the proportion to
survive with a viable limb will be relatively small. In the present study the proportion of CLI-patients
being alive with a preserved leg was only 28% at one year. In comparison, in an Iloprost study from the
UK, 42% of the conservatively treated patients were alive with an intact leg at 6 months (UK Severe
Limb Ischaemia Study Group 1991), while in an epidural stimulation study by Klomp et al 57% survived
with an intact leg at 6 months. At 2 years the proportion retaining the leg and surviving was 34%
(Klomp 1999). Although being better than the figures of the present study, these percentages illustrate
the bleak prospect of critically ischaemic patients. 
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Study V: Comparison of vascular surgical service models 
Each country, and often even each health care region, has its own solution for organising its health care.
In order to modify the system according to the changing needs of the population (as well as dwindling
financial resources), different systems should be subjected to scrutiny and evaluation. As resources are
limited, each municipality seeks for the most effective and convenient way to provide its population
with sufficient health care. Finland runs a very decentralised health care system, as every municipality
does arrange their health care service the way it sees fit. Therefore the health care models can be
different even within the catchment area of one single university hospital. 
The success in preventing or delaying major amputations in patients with CLI seems to be tied to an
aggressive policy of performing bypass procedures to crural and pedal vessels (Luther 2000, Eickhoff
1993, Eskelinen 2003), which require specialist skills and are provided in vascular centres. As failure to
provide adequate vascular services for critically ischaemic patients inevitably results in increased
amputation rates, the effectiveness of different service strategies could, at least in theory, be easily
compared. It has been shown that patients undergoing an amputation utilise twice as much health care
resources than those subjected to reconstructive procedures for CLI (Luther 1997c). 
During the time period chosen for the present study the Finnvasc register provided fairly reliable data,
having been evaluated for the first 4 years of this period (Kantonen 1997, Paaske in press). Later on the
commitment to participate in the collection of data subsided in several centres. The Finnvasc data was
complete up to the year 1996, but already in 1997 the data of one centre in Uusimaa was deficient and
had to be retrieved from hospital records. In 1998 the data was even more incomplete and therefore the
years 1991-1997 were selected for the study. Many hospitals have since founded own registries, which
are not compatible with each other and do not cover the whole country. Data on all hospital stays of all
patients is still recorded in the national discharge register, but as the ICD 10-coding, which is currently
in use, does not differentiate between claudication and critical leg ischaemia, this data will not be of
assistance, when assessing the fate of critically ischaemic patients.
In the present study major amputation rates were used as population-based age- and sex-adjusted
incidences as a measure of the effectiveness of vascular surgical services in treatment of CLI (Luther
1996a). No clear difference in amputation rates between the three health care models could be detected,
although the centralised model showed an association to lower amputation incidences in the regression
analysis. The variation from year to year was considerable and so was the variation between the
hospitals within the same health care model, even though the incidences were age- and sex standardised.
This might be due to too small population samples. Similarly, the large differences between hospitals
within the same referral model may also reflect the confounding influence of population differences,
provision of vascular consultations and treatment delay.
The key observation of the study was, however, that the vascular referral strategies were not
implemented properly. The hospitals preferred to maintain a fair amount of independence in their
decision-making and decisions to amputate were made without vascular consultation. At that time
Finland did not have vascular surgery as a speciality in its own right – the speciality was first established
in 2000. Many patients were never seen by a vascular surgeon but were amputated primarily. Thus it is
understandable that the active treatment policy of the academic referral centre did not seem to show any
results on population basis. The present data emphasise the importance of an active implementation of
referral strategies and an active treatment policy on every level of the treatment chain in order to achieve
an improvement in amputation incidences (Lepäntalo 2000).  Heikkinen et al (Heikkinen 2000) have
shown that amputation rates are lowest in those municipalities that use vascular surgical services the
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most. Furthermore, in a small region of some 170 000 inhabitants a well-organised vascular service has
produced a magnificent decrease in amputation rates in association with increased vascular surgical
activity (Luther 2002). 
The influence of socio-economic factors has been shown for cardiovascular diseases (Salomaa 2001,
Jousilahti 1998, Morrison 1997) and a similar association may be assumed to exist for peripheral
vascular disease. In an attempt to explain the great differences in CLI-incidences in hospital subdistricts
within the same referral model, a few socio-economic features of the municipalities in the study area
were assessed. Some interaction between socio-economic factors and CLI-incidence was seen, which
indicates that amputation rates do not only depend on the modality and efficiency of vascular surgical
services, but on socio-economic factors as well. 
Proper implementation of vascular referral and service strategies is necessary to decrease the amputation
rates further, guaranteeing equal treatment to all patients and further enabling socio-economic- and cost-
effectiveness studies in future.
In this study the actual costs of CLI treatment on population basis were intended for calculation. The
calculations were to be based on the number of days spent in hospital, costs of the actual procedure,
visits at the outpatient clinic, costs of the radiological and endovascular procedures as well as the days
spent in intensive care. Additionally, the costs of the days spent in rehabilitation and nursing homes were
to be calculated. The costs having occurred in the different vascular service models were to be compared
with each other.
Only one hospital was able to provide all the information necessary for the calculations. Most of the
other hospitals were not able to provide data on either the days spent in intensive care units, the
outpatient clinic visits or the procedures performed in the radiology department. Additionally the task of
determining the costs for each item proved to be impossible. At the beginning of the period all hospitals
were charging their costs according to the days spent in hospitals without differentiating between
intensive care, operative treatment or any other items. In one of the hospitals this was changed to
calculating all items separate for a short time period (3 years) before joining the DRG-pricing (Diagnosis
Related Groups). All other hospitals switched from the overall ward price to the DRG-system so that
they were unable to determine separate prices for the items needed. It was also impossible to determine
in retrospect which in-patient period belonged to which DR-Group, using the information provided from
the hospital discharge register. However, the information on the costs actually charged to the patients’
home municipality for each hospital visit was stored in a central coordinating and development centre of
the hospital administration. The database had been designed for administrative purposes. Unfortunately
part of the information on earlier years had been erased and backup tapes wiped, so that only
information on the last year of the study period was available. In essence, the calculation of any relevant
costs – especially the long-term costs – had been made impossible.
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11.  CONCLUSIONS
Critical leg ischaemia is comparable to a ”malignant” disease causing considerable morbidity. It is
typically a disease of the elderly, but some risk factors such as diabetes can cause it to occur even in the
middle-aged population. Tissue loss in ulcers and gangrene can be regarded to represent a similar
condition in the foot, as myocardial infarction is for the heart, while rest pain is similar to unstable
angina pectoris with the impending danger of losing some of the still viable tissue. It is indeed a
manifestation of the same disease, as impairment of the arterial blood supply in the leg reflects the
situation of the whole arterial tree. Therefore, patients with critical leg ischaemia often have several co-
morbidities and the mortality is very high. 
79
12.  ACKNOWLEDGEMENTS
I would like to thank:
My mentor and supervisor professor Mauri Lepäntalo, who has been like a father to me. Without his
enthusiasm, endurance and never failing faith in my ability to accomplish the task, this dissertation
would never have been completed. Together with his team, I had the luck to be allowed to participate in
his work on pressure measurements and critical leg ischaemia. A quest that has continued for more than
20 years. 
My co-authors: Martine Franckena, Anders Albäck, Mikael Railo, Miika Linna, Ilkka Mäenpää, Juha
Pitkänen, Henrik Sell, Martti Kekomäki and Mats Brommels for their advice and contribution to my
work.
Tuija Ikonen and Hannu Savolainen for their friendship, as well as for providing their time and
knowledge as reviewers, making this dissertation printable.
Olof Lindfors for seeing the potential in me, and introducing me to Mauri Lepäntalo, as well as for his
ever-lasting support.
Professor Hans Olav Myhre, who kindly has agreed to act as my opponent. 
The late professor Juhani Ahonen, who never failed to encourage me although at times I was unable to
believe in success.
Professor Anssi Sovijärvi for giving me the possibility to study clinical physiology and nuclear medicine
in his unit.
Lauri Kyllönen for helping me to get started and for designing the macro that I used for the analysis of
my first study. 
Professor Johan Edgren for his support and his role as the chairman of the Kurt and Doris Palander
Foundation, as well as the Karin and Einar Stroem Foundation.
The staff of the vascular laboratory: Maritta von Bell, Sirpa Myllynen, Jussi Jalkanen and Tarja Tuokko-
Ahola, Maria Merilahti, Helena Saikkonen, Satu Nenonen for performing the pressure measurements
and among them Päivikki Määttälä in particular, who has also provided every other additional help she
was able to give (including helping me move).
Lea Hagman for her friendship and patience in re-introducing me to the world of computers after I had
sworn never to touch a computer again.
My husband Martin Berka, who has played the role of a housewife better than I could ever have done
and has shouldered a major responsibility in raising our children. In addition to all the support he has
given me, he has drawn the illustrations and performed the language revision of my dissertation, for
which I am very grateful. 
80
Research nurses and secretaries: Anita Mäkelä, Elina Malkki, Päivi Hiltunen, Leena Multanen, Leena
Sipilä and Sari Hirvonen, with whom I have had the pleasure to work with, and who always were
prepared to lenda helping hand whenever I needed it.
Timo Pessi and Jukka Ollgren for performing the statistical analysis in the second article. 
Other colleagues and teachers: Ilkka Kantonen, Pekka Aho, Fausto Biancari, Petteri Kauhanen, Tarja
Peräkylä, Michael Luther, Aarno Lehtola, Elina Eskelinen, Leo Ihlberg, Sirje Peltonen, Ulla-Stina
Salminen, Milla Kallio, Eeva-Maija Hietala, Wolf-Dieter Roth, Juha-Pekka Salenius, Johan Lundin,
Harri Lindholm, Tuula Lindholm, Liisa Näveri, Tuomo Lantto, Esa Leppänen, Yrjö Salorinne, Petri
Haapalahti, Anu Koskela, Juha Vakkilainen, Heli Räty, Jukka Schildt, Aapo Ahonen, Kalevi Kairemo,
Sirkka-Liisa Karonen, and many others for their help and support during the many years I have spent
working on my dissertation. 
The nurses and staff in the Clinical Physiology and Nuclear Medicine departments of Meilahti Hospital,
Laakso Hospital, Malmi Hospital and Maria Hospital. 
The staff of the hospital record archives in the Surgical Hospital and Meilahti Hospital as well as the
nurses from ward 5, 6 and 7 in the Surgical Hospital and 62 and 61 in Meilahti Hospital, the surgical
outpatient clinics at the Surgical Hospital and Meilahti Hospital.
Professor Robert B. Rutherford for his kind help as chairman of the first international session I had the
honour to attend, and present my work in.
My children Loja Berka, Miloš Berka, Béla Berka and Roman Berka for all their patience with me and
my often long working hours. In moments of despair they have kept me going and given me a reason to
continue with my work.
My parents Anneli Mätzke and Peter Mätzke, as well as my brother Che Mätzke and his wife Anja
Mätzke for their support.
The staff, friends and fellow students at the Medical University of Lübeck and especially Carol Falk
MD, without whom I never would have reached my medical degree.
The teachers at the German School of Helsinki for their understanding and patience they gave me, in
spite of my slowness.
All the friends and relatives whom I have not mentioned separately.
The Finnish Society of Angiology; The Kaiko Anniversary Fund, Clinical Research Institute HUCH Ltd;
The Kurt and Doris Palander Foundation; The Karin and Einar Stroem Foundation and The Special
Governmental Subsidy for Health Sciences Research in Finland for financing parts of this study.
81
13.  REFERENCES
1. Ad Hoc Committee on Reporting Standards. Suggested standards for reports dealing with lower
extremity ischaemia. J Vasc Surg 1986; 4: 80-94.
2. Adler AI, Boyko EJ, Ahroni JH, Smith DG. Lower-extremity amputation in diabetes: The
independent effects on peripheral vascular disease, sensory neuropathy and foot ulcers. Diabetes
care 1999; 22(7): 1029-1035.
3. AhChong AK, Chiu KM, Wong M, Yip AWC. The influence of gender difference on the
outcomes of infrainguinal bypass for critical limb ischaemia in Chinese patients. Eur J Vasc
Endovasc Surg 2002; 23: 134-139. 
4. Albers M, Fratezi AC, De Luccia N. Walking ability and quality of life as outcome measures in a
comparison of arterial reconstruction and leg amputation for the treatment of vascular disease. Eur
J Vasc Endovasc Surg 1996; 11: 308-314.
5. Albers M, Romiti M, Bragança Pereira CA, Fonseca RLA, da Silva Júnior M. A meta-analysis of
infrainguinal arterial reconstruction in patients with end-stage renal disease. Eur J Vasc Endovasc
Surg 2001; 22: 294-300.
6. Alexandrova NA, Gibson WC, Norris JW, Maggisano R. Carotid artery stenosis in peripheral
vascular disease. J Vasc Surg 1996; 23: 645-649.
7. Amann W, Berg P, Gersbach P, Gamain J, Raphael JH, Ubbink DTh for the SCS-EPOS study
group. Spinal cord stimulation in the treatment of non-reconstructable stable critical leg ischaemia:
results of the European peripheral vascular disease outcome study (SCS-EPOS). Eur J Vasc
Endovasc Surg 2003; 26: 280-286. 
8. Amirhamzeh MMR, Chant HJ, Rees JL, Hands LJ, Powell RJ, Campbell WB. A comparative
study of treadmill tests and heel raising exercise for peripheral arterial disease. Eur J Vasc
Endovasc Surg 1997; 13: 301-305.
9. Anwar MD, Khiabani HZ, Kroese JA, Stranden E. Patterns of skin flowmotion in the lower limbs
of patients with chronic critical limb ischaemia (CLI) and oedema. Eur J Vasc Endovasc Surg
2000; 20: 536-544.
10. Argov Z, Mastaglia FL. Drug-induced peripheral neuropathies. Br Med J 1979; 1: 663-666.
11. Armstrong DG, Lavery LA, Harkless LB. Validation of a diabetic wound classification system.
Diabetes Care 1998; 21(5): 855-859. 
12. Aronow WS, Ahn C. Prevalence of coexistence of coronary artery disease, peripheral arterial
disease, and atherothrombotic brain infarction in men and women ≥ 62 years of age. Am J Cardiol
1994; 74: 64-65.
13. Arora S, Pomposelli F, LoGerfo FW, Veves A. Cutaneous microcirculation in the neuropathic
diabetic foot improves significantly but not completely after successful lower extremity
revascularisation. J Vasc Surg 2002; 35: 501-505.
82
14. Aston NO, Lea Thomas M, Burnand KG. The distribution of atherosclerosis in the lower limbs.
Eur J Vasc Surg 1992; 6: 73-77.
15. Atmer B, Jogestrand T, Laska J, Lund F. Peripheral artery disease in patients with coronary artery
disease. Int Angiol 1995; 14 (1): 89-93.
16. Audit Committee of the Vascular Surgical Society of Great Britain and Ireland. Recommendations
for the management of chronic critical lower limb ischaemia. Eur J Vasc Endovasc Surg 1996; 12:
131-135.
17. Bailey CMH, Saha S, Magee TR, Galland RB. A 1year prospective study of management and
outcome of patients presenting with critical lower limb ischaemia. Eur J Vasc Endovasc Surg
2003; 25: 131-134.
18. Bainton D, Sweetnam P, Baker I, Elwood P. Peripheral vascular disease: consequence for survival
and association with risk factors in the Speedwell prospective heart disease study. Br J Heart J
1994; 72: 128-132.
19. Baker JD, Dix DE. Variability of Doppler ankle pressures with arterial occlusive disease: an
evaluation of ankle index and brachial-ankle pressure gradient. Surgery 1981; 89: 134-137.
20. Banerjee AK, Pearson J, Gilliland EL, Goss D, Lewis JD, Stirling Y, Meade TW. A six year
prospective study of fibrinogen and other risk factors associated with mortality in stable
claudicants. Thrombosis & Haemostasis 1992; 68 (3): 261-263.
21. Barletta G, Perna S, Sabba C, Catalano A, O’Boyle C, Brevetti G. Quality of life in patients with
intermittent claudication: relationship with laboratory exercise performance. Vasc Med 1996; 1(1):
3-7. (*)  
22. Barnhorst DA, Barner HB. Prevalence of congenitally absent pedal pulses. New Engl J Med 1968;
278(5): 264-265.
23. Beach KW, Strandness DE jr. Arteriosclerosis obliterans and associated risk factors in insulin-
dependent and non-insulin-dependent diabetes. Diabetes 1980; 29: 882-888.
24. Beckman J, Creager M, Libby P. Diabetes and atherosclerosis: Epidemiology, pathophysiology an
management. JAMA 2002; 287 (19): 2570-2581.
25. Belcaro G, Nicolaides AN. Pressure index in hypotensive or hypertensive patients. J Cardiovasc
Surg 1989; 30: 614-617.
26. Belch JJ, McArdle B, Pollock JG, Forbes CD, McKay A, Leiberman P, Lowe GDO, Prentice
CRM. Epoprostenol (prostacyclin) and severe arterial disease. Lancet 1983; 1: 315-317.
27. Belch JJF, Diehm C, Söhngen M, Söhngen W. Critical limb ischaemia: A case against consensus
II. Int Angiol 1995; 14 (4): 353-356.
28. Bergqvist D, Karagacil S, Lindblad B. Is there evidence in favour of vein graft surveillance? A
randomised trial. In: Greenhalgh RM, Fowkes FGR (Eds). Trials and Tribulations of Vascular
Surgery; WB Saunders, London, Philadelphia, Toronto, Sydney, Tokyo. 1996: pp 289-304. 
83
29. Bergqvist D, Troëng T, Elfström J, Hedberg B, Ljungström K-G, Norgren L, Örtenwall P.
Auditing Surgical Outcome. Ten years with The Swedish Vascular Registry – Swedvasc. 1998;
164: suppl 581.
30. Beyenal-Ögmen B. Bioelectrical impedance smygmography for hydrostatic toe pressure
measurement: a new non-invasive method to assess limb ischaemia. VASA 1999; 28: 15-18. 
31. Biancari F, Albäck A, Kantonen I, Luther M, Lepäntalo M. Predictive factors for adverse outcome
of pedal bypasses. Eur J Vasc Endovasc Surg 1999; 18: 138-143.
32. Biancari F, Kantonen I, Albäck A, Ihlberg L, Lehtola A, Lepäntalo M. Popliteal-to-distal bypass
grafts for critical leg ischaemia. J Cardiovasc Surg 2000; 41: 281-286.
33. Biancari F, Kantonen I, Mätzke S, Albäck A, Roth W-D, Edgren J, Lepäntalo M. Infrainguinal
endovascular and bypass surgery for critical leg ischaemia in patients on long-term dialysis. Ann
Vasc Surg 2002; 16 (2): 210-214.
34. Blankenhorn DH, Azen SP, Crawford DW, Nessim SA, Sanmarco ME, Selzer RH, Shircore AM,
Wickham EC. Effects of Colestipol-Niacin therapy on human femoral atherosclerosis. Circulation
1991; 83: 438-447. 
35. Bloor K. Natural history of arteriosclerosis of the lower extremities. Ann Roy Coll Surg Engl
1961; 28: 36-52.
36. Boeckstyns ME, Jensen CM. Amputation of the forefoot. Predictive value of signs and clinical
physiological tests. Acta Orthop Scand 1984; 55 (2): 224-226. (*)
37. Bongard O, Krähenbühl B. Predicting amputation in severe ischaemia. The value of
transcutaneous PO2 measurement. J Bone & Joint Surg 1988; 70-B (3): 465-467.
38. Bowers BL, Valentine RJ, Myers SI, Chervu A, Clagett GP. The natural history of patients with
claudication with toe pressures of 40 mmHg or less. J Vasc Surg 1993; 18: 506-511.
39. Boyd AM. The natural course of arteriosclerosis of the lower extremities. Proc Roy Soc Med
1962; 53.: 591-593.
40. Brattstrom L Wilcken DEL. Homocysteine and cardiovascular disease: cause or effect? Am J Clin
Nutr 2000; 72 : 315-23. 
41. Breek JC, Hamming JF, De Vries J, Aquarius AEAM, van Berge Henegouwen DP. Quality of life
in patients with intermittent claudication using the World Health Organisation (WHO)
questionnaire. Eur J Vasc Endovasc Surg 2001; 21: 118-122.
42. Burns PJ, Mosquera DA, Bradbury AW. Prevalence and significance of thrombophilia in
peripheral arterial disase. Eur J Vasc Endovasc Surg 2001; 22: 98-106.
43. Burton AC. The range and variability of the blood flow in the human figures and the vasomotor
regulation of body temperature. Am J Physiol 1939; 127: 437-445.
84
44. Campbell WB, Ridler BMF, Szymanska TH. Current management of acute leg ischaemia: Results
of an audit by the Vascular Surgical Society of Great Britain and Ireland. Brit J Surg 1998; 85
(11): 1498-1503.
45. Campeau L. Grading of angina pectoris. Circulation 1976; 54:522-523.
46. CAPRIE steering group. A randomised, blinded trial of clopidogrel versus aspirin in patients at
risk of ischaemic events. Lancet 1996; 348: 1329-1338. 
47. Carter SA. Indirect systolic pressures and pulse waves in arterial occlusive disease of the lower
extremities. Circulation 1968; XXXVII:624-637.
48. Carter SA. Role of pressure measurements in vascular disease. In: Bernstein EF, ed. Noninvasive
diagnostic techniques in vascular disease. St Louis: Mosby, 1985: 513-544.
49. Carter SA. The challenge and importance of defining critical limb ischemia. Vasc Med 1997; 2:
126-131.
50. Carter SA, Tate RB. The value of toe pulse waves in determination of risks for limb amputation
and dateh in patients with peripheral arterail disease and skin ulcers or gangrene. J Vasc Surg
2001; 33: 708-714.
51. Cassar K, Bachoo P, Brittenden J. The effect of peripheral percutaneous transluminal angioplasty
on quality of life in patients with intermittent claudication. Eur J Vasc Endovasc Surg 2003; 26:
130-136.
52. Cassar K, Coull R, Bachoo P, Macaulay E, Brittenden J. Management of secondary risk factors in
patients with intermittent claudication. Eur J Vasc Endovasc Surg 2003; 26 (3): 262-266.
53. Catalano M. Epidemiology of critical limb ischaemia: north Italian data. Eur J Med 1993; 2 (1):11-
14.
54. Chantelau E, Lee KM, Jungblut R. Distal arterial occlusive disease in diabetes is related to medial
arterial calcification. Exp Clin Endocrinol Diabetes 1997; 105 (Suppl 2): 11-13.
55. Cheung  AK, Sarnak MJ, Yan G, Dwyer JT, Heyka RJ, Rocco MV, Teehan  BP, Levey AS.
Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients. Kidney Int 2000; 58
(1): 353-362.
56. Chong PFS, Garratt AM, Golledge J, Greenhalgh RM, Davies AH. The intermittent claudication
questionnaire: A patient-assessed condition specific health outcome measure. J Vasc Surg 2002;
36: 764-771.
57. Conrad MC. Large and small artery occlusion in diabetics and nondiabetics with severe vascular
disease. Circulation 1967; 36: 83-91.
58. Coran AG, Warren R. Arteriographic changes in femoropopliteal arteriosclerosis obliterans. New
Engl J Med 1966; 274 (12):643-647.
85
59. Costa LA, Canani LH, Lisboa HRK, Tres GS, Gross JL. Aggregation of features of the metabolic
syndrome is associated with increased prevalence of chronic complications in Type 2 diabetes.
Diabetic Medicine 2004; 21: 252-255.
60. Currie IC, Wilson YG, Baird RN, Lamont PM. Treatment of intermittent claudication: The impact
on quality of life. Eur J Vasc Surg 1995; 10: 356-361.
61. Cutler BS, Wheeler HB, Paraskos JA, Cardullo PA. Assessment of operative risk with
electrocardiographic exercise testing in patients with peripheral vascular disease. Am J Surg 1979;
137: 484-490.
62. Cutler JA, MacMahon SW, Furberg CD. Controlled clinical trials of drug treatment for
hypertension. A review. Hypertension 1989; 13: (suppl I): I-36 – I-44.
63. da Silva A, Widmer LK. Occlusive peripheral arterial disease. Early diagnosis, incidence, course,
significance. Hans Huber Publishers Bern 1980.
64. Davey Smith G, Shipley MJ, Rose G. Intermittent claudication, heart disease risk factors, and
mortality. The Whitehall study. Circulation 1990; 82: 1925-1931.
65. Davies MG, Hagen P-O. The vascular endothelium, a new horizon. Annals of Surgery 1993; 218
(5): 593-609.
66. de Groot E, Jukema JW, van Boven JA, Reiber JHC, Zwinderman AH, Lie KI, Ackerstaff RA,
Bruschke AVG and the REGRESS study group. Effect of Pravastatin on progression and
regression of coronary atherosclerosis and vessel wall changes in carotid and femoral arteries: A
report from the Regression Growth Evaluation Statin Study. Am J Cardiol 1995; 76: 40C-46C.
67. DeWeese JA, Rob CG. Autogenous venous bypass grafts five years later. Ann Surg 1971; 174:
346-355.
68. DeWeese JA, Rob CG. Autogenous venous grafts ten years later. Surgery 1977; 82 (6): 775-784.
69. Diamantopoulos EJ, Stavreas NP, Roussis DP, Charitos DN, Vasdekis SN, Raptis SA.
Simultaneous laser doppler and transcutaneous oxygen tension measurements in claudicant
patients. Int Angiol 1995; 14 (1): 53-59.
70. Dionyssiou-Asteriou A, Papastamatiou M, Vatalas I-A, Bastounis E. Serum Lp(a) lipoprotein
levels in patients with atherosclerotic occlusive disease of the lower extremities. Eur J Vasc
Endovasc Surg 2000; 20: 57-60.
71. Donnelly R, Yeung JMC. Management of intermittent claudication: the importance of secondary
prevention. Eur J Vasc Endovasc Surg 2002; 23: 100-107.
72. Dormandy JA. Palpation of periheral pulses: a difficult art. Ann R Coll Surg Engl 1992; 74: 155.
(*)
73. Dormandy J, Heeck L, Vig S. The fate of patients with critical leg ischaemia. Sem Vasc Surg
1999; 12: 142-147. – a –
86
74. Dormandy J, Heeck L, Vig S. Acute limb ischaemia. Seminars in Vascular Surgery 1999; 12:  (2):
148-153. – b –
75. Dormandy J, Heeck L, Vig S. Predicting which patients will develop chronic critical leg ischemia.
Sem Vasc Surg 1999; 12: 138-141. – c – 
76. Dormandy J, Heeck L, Vig S. Lower-extremity arteriosclerosis as a reflection of a systemic
process: Implications for concomitant coronary and carotid disease. Sem Vasc Surg 1999; 12: 118-
122. – d – 
77. Dormandy JA, Murray GD. The fate of the claudicant – A prospective study of 1969 claudicants.
Eur J Vasc Surg 1991; 5: 131-133.
78. Doweik L, Maca T, Schillinger M, Budinsky A, Sabeti S, Minar E. Fibrinogen predicts mortality
in high risk patients with peripheral artery disease. Eur J Vasc Endovasc Surg 2003; 26: 381-386.
79. Duffield RGM, Miller NE, Brunt JNH, Lewis B, Jamieson CW, Colchester ACF. Treament of
hyperlipidaemia retards progression of symptomatic femoral atherosclerosis. A randomised
controlled trial. The Lancet 1983; 2: 639-642. 
80. Ebskov LB, Hindsø K, Holstein P. Level of amputation following failed arterial reconstruction
compared to primary amputation – a meta-analysis. Eur J Vasc Endovasc Surg 1999; 17: 35-40.
81. Ebskov LB, Schroeder TV, Holstein PE. Epidemiology of leg amputation: the influence of
vascular surgery. Br J Surg 1994; 81: 1600-1603.
82. Edmonds ME, Morrison N, Laws JW, Watkins PJ. Medial arterial calcification and diabetic
neuropathy. Br Med J 1982; 284:928-929.
83. Eggers PW, Gohdes D, Pugh, J. Nontraumatic lower extremity amputations in the medicare end-
stage renal disease population. Kidney International 1999; 56 (4): 1524-1533.
84. Eickhoff JH. Changes in the number of lower limb amputations during a period of increasing
vascular surgical activity. Results of a nation-wide study, Denmark, 1977-1990. Eur J Surg 1993;
159: 469-473.
85. Ejrup B. Tonoscillography after exercise. Acta Med Scand 1948; 130: suppl 211. (*)
86. Emanuele MA, Buchanan BJ, Abraira C. Elevated leg systolic pressure and arterial calcification in
diabetic occlusive vascular disease. Diabetes care 1981; 4(2): 289-292.
87. Engström G, Tydén P, Berglund G, Hansen O, Hedblad B, Janzon J. Incidence of myocardial
infarction in women. A cohort study of risk factors and modifers of effect. J Epidemiol
Community Health 2000; 54: 104-107.
88. Engström G, Ögren M, Hedblad B, Wollmer P, Janzon L. Asymptomatic leg atherosclerosis is
reduced by regular physical activity. Longitudinal results from the cohort ”men born in 1914”. Eur
J Vasc Endovasc Surg 2001; 21: 502-507.
89. Erb W. Zur Klinik des intermittierrenden Hinkens. Münchner Med Wochenschr 1911; 2: 2486-
2488.
87
90. Eskelinen E, Lepäntalo M, Hietala E-M, Sell H, Kauppila L, Mäenpää I, Pitkänen J, Salminen-
Peltola P, Leutola S, Eskelinen A, Kivioja A, Tukiainen E, Lukinmaa A, Brasken P, Railo M.
Lower limb amputations in southern Finland in 2000 and trends up to 2001. Eur J Vasc Endovasc
Surg 2004, 27: 193-200.
91. Eskelinen E, Luther M, Eskelinen A, Lepäntalo M. Infrapopliteal bypass reduces amputation
incidence in elderly patients: a population-based study. Eur J Vasc Endovasc Surg 2003; 26: 65-
68.
92. Fagrell B. Assessment of the microcirculation in critical limb ischemia. In: Branchereau A, Jacobs
M (eds). Critical limb ischemia. Futura Publishing, New York 1999, p 39-48.
93. Fasih T, Pickin M, Cushieri RJ. Non-vascular claudication: A clinical conundrum. Int J Clin Pract
2003; 57(2): 87-89.
94. Favilli S, Corrao G. Epidemiology of cardiovascular diseases. In: Battaglia L. Ed. Vascular
emergencies 1998. Edizioni Luigi Pozzi, Rome. pp 1-14.
95. Feinglass J, Kaushik S, Handel D, Kosifas A, Martin G, Pearce W. Peripheral bypass surgery and
amputation: Nothern Illinois demographics 1993-1997. Arch Surg 2000; 135 (1):75-80.
96. Fielding JE, Smoking: Health effects and control. New Engl J Med 1985; 313: 491-498.
97. Fisher RK, Harris PL. Epidemiological and economic considerations in the critically ischemic
limb. In: Branchereau A, Jacobs M (eds). Critical limb ischemia. Futura Publishing, New York
1999, p 19-25.
98. Fowkes FGR, Housley E, Cawood EHH, Macintyre CCA, Ruckley CV, Prescott. Edinburgh artery
study: Prevalence of asymptomatic and symptomatic peripheral arterial disease in the general
population. Int J Epidemiol 1991; 20: 384-392.
99. Fowkes FGR, Housley E, Macintyre CCA, Prescott RJ, Ruckley CV. Variability of ankle brachial
systolic pressures in the measurement of atherosclerotic peripheral arterial disease.  J Epidemiol
Comm Health 1988; 42: 128-133.
100. Fowkes FGR, Housley E, Riemersma RA, Macintyre CCA, Cawood EHH, Prescott RJ, Ruckley
CV. Smoking, lipids, glucose intolerance, and blood pressure as risk factors for peripheral
atherosclerosis compared with ischemic heart disease in the Edinburgh artery study. Am J
Epidemiol 1992; 135 (4): 331-340. 
101. Fronek A. Noninvasive evaluation of the cutaneous circulation. In: Bernstein EF Ed. Noninvasive
diagnostic techniques in vascular disease. C.V.Mosby. St. Louis, Toronto, Princeton. 1985 pp.
694-707.
102. Fronek A, Johansen KH, Dilley RB, Bernstein EF. Noninvasive physiologic tests in the diagnosis
and characterisation of peripheral arterial occlusive disease. Am J Surg 1973; 126: 205-214.
103. Garratt AM, Ruta DA, Abdalla MI, Buckingham JK, Russell IT. The SF 36 health survey
questionnaire: an outcome measure suitable for routine use within the NHS? Br Med J 1993; 306:
1440-1444.
88
104. Glasser SP, Selwyn AP, Ganz P. Atherosclerosis: risk factors and the vascular endothelium. Am
Heart J 1996; 131: 379-384. 
105. Goldman L, Hashimoto B, Cook EF, Loscalzo A. Comparative reproducibility and validity of
systems for assessing cardiovascular functional class: Advantages of a new specific activity scale.
Circulation 1981; 64 (6): 1227-1234.
106. Goldstein L, Adams R, Becker K, Furberg CD, Gorelick PB, Hademenos G, Hill M, Howard G,
Howard VJ, Jacobs B, Levine SR, Mosca L, Sacco RL, Sherman DG, Wolf PA, del Zoppo GJ.
Primary prevention of ischemic stroke. A statement for healthcare professionals from the Stroke
Council of the American Heart Association. Stroke 2001; 32: 280-299.
107. Goss DE, de Trafford J, Roberts VC, Flynn MD, Edmonds ME, Watkins PJ. Raised ankle/brachial
pressure index in insulin-treated diabetic patients. Diab Med 1989; 6: 576-578.
108. Greenhalgh RM, Rosengarten DS, Mervart I, Lewis B, Calnan JS, Martin P. Serum lipids and
lipoproteins in peripheral vascular disease. Lancet 1971: 947-950.
109. Griffith CD, Callum KG. Limb salvage surgery in a district general hospital: factors affecting
outcome. Ann Roy Coll Surg Engl 1988; 70: 95-98.
110. Gundersen J. Diagnosis of arterial insufficiency with measurement of blood pressure in fingers and
toes. Angiology 1971; 22: 191-196.
111. Gutteridge B, Torrie P, Galland B. Trends in arterial reconstruction, angioplasty and amputation.
Health Trends 1994; 26: 88-91.
112. Guyatt GH, Pugsley SO, Sullivan MJ, Thompson PJ, Berman LB, Jones NL, Fallen EL, Taylor
DW. Effect of encouragement on walking test performance. Thorax 1984; 39: 818-822.
113. Hansrani M, Gillespie JI, Stansby G. Homocysteine in myointimal hyperplasia. Eur J Vasc
Endovasc Surg 2002; 23: 3-10.
114. Heidrich H, Allenberg J, Cachovan M, Creutzig A, Diehm C, Gruss J, Kriessman A, Reiger H,
Rudofsky G, Trampisch HJ, Weidinger P, Widmer LK. Guidelines for therapeutic studies on
peripheral arterial occlusive disease in Fontaine stages II-IV. VASA 1992; 21 (4): 339-343.
115. Heliövaara M, Karvonen MJ, Vilhunen R, Punsar S. Smoking, carbon monoxide, and
atherosclerotic diseases. Br Med J 1978; 1: 268-270.
116. Hernández-Osma E, Cairols MA, Martí X, Barjau E, Riera S. Impact of treatment on the quality of
life in patients with critical limb ischaemia. Eur J Vasc Endovasc Surg 2002; 23: 491-494.
117. Hertzer NR, Beven EG, Young JR, O’Hara PJ, Ruschhaupt III WF, Graor RA, Dewolfe VG,
Majovec LC. Coronary artery disease in peripheral vascular patients. A classification of 1000
coronary angiograms and results of surgical management. Ann Surg 1984; 199 (2): 223-233.
118. Hiatt WR, Cooke JP. Atherogenesis and the medical management of atherosclerosis. In:
Rutherford RB. Vascular Surgery. Fifth Edition. WB Saunders, Philadelphia, London, Sydney,
Toronto 2000: 333-350. 
89
119. Hiatt WR, Hirsch AT, Regensteiner JG, Brass EP and the Vascular Clinical Trialists. Clinical
trials for Claudication. Assessment of exercise performance, functional status and clinical end
points. Circulation 1995, 92: 614-621.
120. Hicken GJ, Lossing AG, Ameli FM. Assessment of generic health-realted quality of life in patients
with intermittent claudication. Eur J Vasc Endovasc Surg 2000; 20: 336-341.
121. Hickey NC, Thomson IA, Shearman CP, Simms MH. Aggressive arterial reconstruction for
critical lower limb ischaemia. Br J Surg 1991; 78: 1476-1478
122. Hill MN, Geldman HI, Hilton SC, Holechek MJ, Ylitalo M, Benedict GW. Risk of foot
complications in long-term diabetic patients with and without ESRD: A preliminary study. ANNA
J 1996; 23: 351-356. (*)
123. Hiller B, The hydrostatic measurement of systolic toe blood pressure: a preliminary validation of
the method. VASA 1998; 27 (4): 229-232. (*) 
124. Hobbs SD, Bradbury AW. Smoking cessation strategies in patients with peripheral arterial disease:
An evidence-based approach. Eur J Vasc Endovasc Surg 2003; 26 (4): 341-347.
125. Holdsworth J. District hospital management and outcome of critical lower limb ischaemia:
comparison with national figures. Eur J Vasc Endovasc Surg 1997; 13: 159-163.
126. Holstein P. The distal blood pressure predicts healing of amputations on the feet. Acta Orthop
Scand 1984; 55(2): 227-233. (*)
127. Hooi JD, Stoffers HEJH, Kester ADM, Rinkens PELM, Kaiser V, van Ree JW, Knotterus JA.
Risk factors and cardiovascular diseases associated with asymptomatic periphera arterial occlusive
disease. The Limburg PAOD study. Scand J Prim Health Care 1998; 16: 177-182.
128. Hornung RS, Mahler RF, Raftery EB. Ambulatory blood pressure and heart rate in diabetic
patients: an assessment of autonomic function. Diabetic medicine 1989; 6: 579-585.
129. Howell MA, Colgan MP, Seeger RW, Ramsey DE, Sumner DS. Relationship of severity of lower
limb peripheral vascular disease to mortality and morbidity: A six-year follow-up study. J Vasc
Surg 1989; 9: 691-697.
130. Hughson WG, Mann JI, Garrod A. Intermittent claudication: Prevalence and risk factors. BMJ
1978; 1: 1379-1381 – a –
131. Hughson WG, Mann JI, Tibbs DJ, Woods HF, Walton I. Intermittent claudication: factors
determining outcome. Br Med J 1978; 1: 1377-1379. – b – 
132. Hummel BW, Hummel BA, Mowbry A et al. Reactive hyperaemia vs treadmill excercise testing in
arterial disease. Arch Surg 1978; 113: 95-98.
133. Ihlberg L, Albäck A, Roth W-D, Edgren J, Lepäntalo M. Interobserver agreement in duplex
scanning for vein grafts. Eur J Vasc Endovasc Surg 2000; 19 (5): 504-508.
90
134. Ihlberg LHM, Mätzke S, Albäck A, Roth W-D, Sovijärvi ARA, Lepäntalo M. Transfer function
index of pulse volume recordings – a new method for vein graft surveillance. J Vasc Surg 2001;
33 (3); 546-553.
135. Inderbitzi R, Buettiker M, Enzler M. The long-term mobility and mortality of patients with
peripheral arterial disease following bilateral amputation. Eur J Vasc Endovasc Surg 2003; 26: 59-
64.
136. Irwin ST, Gilmore J, McGrann S et al Blood flow in diabetics with foot lesions due to small vessel
disease. Br J Surg 1988; 75: 1201.
137. Isomaa B, Henricsson M, Almgren P, Tuomi T, Taskinen M-R, Groop L. The metabolic syndrome
influences the risk of chronic complications in patients with type II diabetes. Diabetologia 2001;
44: 1148-1154.
138. Jacobs MJHM, Ubbink DT, Kitslaar PJEHM, Tordoir JHM, Slaaf DW, Reneman RS. Assessment
of the microcirculation provides additional information in critical limb ischaemia.  Eur J Vasc
Surg 1992; 6: 135-141.
139. Jeelani NUO, Braithwaite BD, Tomlin C, MacSweeney ST. Variation of method for measurement
of brachial artery pressure significantly affects ankle-brachial pressure index values. Eur J Vasc
Endovasc Surg 2000; 20: 25-28.
140.  Jelnes R, Gaardsting O, Hougard Jensen K, Bækgaard N, Tønnesen KH, Schroeder T. Fate in
intermittent claudication: outcome and risk factors. Brit Med J 1986: 293: 1137-1140.
141. Jivegård L, Holm J, Schersten T. The outcome in arterial thrombosis misdiagnosed as arterial
embolism. Acta Chir Scand 1986; 152: 251-256.
142. Jivegård LEH, Augustinsson L-E, Holm J, Risberg B, Örtenwall P. Effects of spinal cord
stimulation (SCS) in patients with inoperable severe lower limb ischaemia: A prospective
randomised controlled study. Eur J Vasc Endovasc Surg 1995; 9: 421-425.
143. Johnson CA. Studies on peripheral vascular phenomena. A new device for the study of peripheral
vascular phenomena in health and disease. Surg Gyn Obstet 1932; 55: 731-737.
144. Johnston KW, Halliday ML, deMorais D, Kostuik JP, Harris WR. Clinical criteria and ankle
pressure measurements in predicting healing of below-knee amputations. Canadian J Surg 1982;
25 (2): 201-204. (*)
145. Johnston  KW, Maruzzo BC, Cobbold RSC. Errors and artifacts of Doppler flowmeters and their
solution. Arch Surg 1977; 112: 1335-1342.
146. Jonason T. Övriga analysmetoder för bedömning av den arteriella cirkulationen. In: Jogestrand T,
Rosfors S. eds. Klinisk fysiologisk kärldiagnostik. Studentlitteratur, Lund, 2002, p. 131-138.
147. Jonason T, Bergstöm R. Cessation of smoking in patients with intermittent claudication. Effects on
the risk of peripheral vascular complications, myocardial infarction and mortality. Acta Med
Scand 1987; 221: 253-260. 
91
148. Jonason T, Ringqvist I. Changes in peripheral blood pressures after five years of follow-up in non-
operated patients with intermittent claudication. Acta Med Scand 1986; 220: 127-132. 
149. Jousilahti P. Cardiovascular disease mortality trend in Finland. Suomen Lääkäril 2003; 58: 2969-
2971.
150. Juergens  JL, Barker  NW, Hines EA. Arteriosclerosis obliterans: review of 520 cases with special
refrence to pathogenic and prognostic factors. Circulation 1960; 21: 188-195.  
151. Jörneskog G, Brismar K, Fagrell B. Pronounced skin capillary ischemia in the feet of diabetic
patients with bad metabolic control. Diabetologia 1998; 41: 410-415.
152. Kaiser V, Kester ADM, Stoffers HEJH, Kitslaar PJEHM, Knotterus JA. The influence of
experience on the reproducibility of the ankle-brachial systolic pressure ratio in peripheral arterial
occlusive disease. Eur J Vasc Endovasc Surg 1999; 18: 25-29.
153. Kannel WB, McGee DL. Diabetes and cardiovascular disease. JAMA 1979; 241: 2035-2038.
154. Kannel WB, McGee DL. Update on some epidemiologic features of intermittent claudication: The
Framingham study. J Am Geriatr Soc 1985: 33: 13-18.
155. Kannel WB, Skinner JJ, Schwartz MJ, Shurtleff D. Intermittent claudication. Incidence in the
Framingham study. Circulation 1970; 41: 875-883.
156. Kantonen I, Lepäntalo M, Luther M, Salenius J-P, Ylönen K and the Finnvasc study group. Factors
affecting the results of surgery for chronic critical leg ischemia – a nationwide  survey. J Vasc
Surg 1998; 27: 940-947.
157. Kantonen I, LepäntaloM, Salenius J-P, Forsström E, Hakkarainen T, Huusari H, Jaakolla A,
Kaarne M, Kaartinen P, Kivivuori R, Kostiainen S, Lehtonen J, Loponen P, Luther M, Mäenpää I,
Nikula P, Riekkinen H, Rissanen K, Vilkko P, Ylönen K and the Finnvasc Study Group. Auditing
a nationwide vascular registry – The 4-year Finnvasc experience. Eur J Vasc Endovasc Surg 1997;
14: 468-474.  
158. Karlström L, Bergqvist D. Effects of vascular surgery on amputation rates and mortality. Eur J
Vasc Endovasc Surg 1997; 14: 273-283.
159. Kauhanen P, Peräkylä T, Lepäntalo M. Clinical distinction of acute and acute on chronic leg
ischaemia. Ann Chir Gynaecol 1995; 84: 335-338.
160. Kimura H, Miyata T, Sato O, Furuya T, Iyori K, Shigematsu H. Infrainguinal arterial
reconstruction for limb salvage in patients with end-stage renal disease. Eur J Vasc Endovasc Surg
2003; 25: 29-34.
161. Klomp HM, Spincemaille GHJJ, Steyerberg EW, Habbema JDF, van Urk H. Spinal-cord
stimulation in critical limb ischaemia: a randomised trial. Lancet 1999; 353: 1040-1044.
162. Klop RBJ, Eikelboom BC, Taks ACJM. Screening of the internal carotid arteries in patients with
peripheral vascular disease by colour-flow duplex scanning. Eur J Vasc Surg 1991; 5: 41-45.
92
163. Koelemay MJW, Legemate DA, de Vos H, van Gurp AJ, Balm R, Reekers JA, Jacobs MJHM.
Duplex scanning allows selective use of arteriography in the management of patients with severe
lower leg arterial disease. J Vasc Surg 2001; 34: 661-667.
164. Koistinen MJ. Prevalence of asymptomatic myocardial ischaemia in diabetic subjects. Br Med J
1990; 301: 92-95.
165. Kovanen PT. The Mast cell – a potential link between inflammation and cellular cholesterol
deposition in atherogenensis. Eur Heart J 1993; 14 suppl K; 105-117.
166. Kröger K, Suckel A, Hirche H, Rudofsky G. Different prevalence of asymptomatic atherosclerotic
lesions in males and females. Vasc Med 1999; 4: 61-65.
167. Kuukasjärvi P, Salenius JP, The Finnvasc Study Group. Perioperative outcome of acute lower
limb ischaemia on the basis of the national vascular registry. Eur J Vasc Surg 1994; 8: 578-583.
168. Laing P. The development and complications of diabetic foot ulcers. Am J Surg 1998; 176 (Suppl
2A): 11S-19S.  
169. Laing SP, Greenhalgh RM. Standard exercise test to assess peripheral arterial disease. Br Med J
1980; 280: 13-16.
170. Laing S, Greenhalgh RM. The detection and progression of asymptomatic peripheral arterial
disease. Br J Surg 1983; 70: 628-630. 
171. Laing S, Greenhalgh RM. Treadmill testing in the assessment of peripheral arterial disease. Int
Angiol 1986; 5: 249-252.
172. Lantsberg L, Goldman M. Laser Doppler flowmetry, transcutaenous oxygen tension measurements
and Doppler pressure compared in patients undergoing amputation. Eur J Vasc Surg 1991; 5: 195-
197. 
173. Larsen JF, Jensen BV, Christensen KS, Egeblad K. Forefoot transcutaneous oxygen tension at
different leg positions in patients with peripheral vascular disease. Eur J Vasc Surg 1990; 4: 185-
189.
174. Lassen NA, Tvedegaard E, Jeppesen FI, Nielsen PE, Bell G, Gundersen J. Distal blood pressure
measurement in occlusive arterial disease, strain gauge compared to Xenon-133. Angiology 1972:
23(4): 211-217.
175. Lassen NA, Tønnesen KH, Holstein P. Distal blood pressure. Scand J Clin Lab Invest 1976; 36:
705. (*)
176. Lassila R. The thrombogenic and vasoactive effects of cigarette smoking with special reference to
peripheral arterial disase. Academic dissertation 1989, University of Helsinki, Finland.
177. Lassila R, Lepäntalo M. Cigarette smoking and the lower limb outcome after arterial surgery. Acta
Chir Scand 1988; 154: 635-640.
178. Lassila R, Lepäntalo M, Lindfors O. Peripheral arterial disease – natural outcome. Acta Med
Scand 1986; 220: 295-301.
93
179. Laws PE, Spark JI, Cowled PA, Fitridge RA. The role of statins in vascular disease. Eur J Vasc
Endovasc Surg 2004; 27: 6-16.
180. Leinonen M, Saikku P. Evidence for infectious agents in cardiovascular disease and
atherosclerosis. The Lancet 2002; 2: 11-17.
181. Leng GC, Fowkes FGR, Lee JA, Dunbar J, Housley E, Ruckley CV. Use of ankle brachial
pressure index to predict cardiovascular events and death: a cohort study. Br Med J 1996; 313:
1440-1444. – b –
182. Leng GC, Lee JA, Fowkes FGF, Whiteman M, Dunbar J, Housley E, Ruckley CV. Incidence,
natural history and cardiovascular events in symptomatic and asymptomatic peripheral arterial
disease in the general population. Int J Epidemiol 1996; 25: 1172-1181. – a – 
183. Leppo K, Puska P. Tobacco control in Finland. Suomen Lääkäril 2003; 58: 2953-2957.
184. Lepäntalo M. The role of the vascular laboratory in the management of major lower limb
amputations. Ann Chir Gyn 1988; 77: 74-77.
185. Lepäntalo M. Should vascular surgery be centralised or decentralised? A nordic point of view. Eur
J Vasc Surg 1994; 8: 116-118.
186. Lepäntalo M,  Biancari F, Tukiainen E. Never amputate without consultation of a vascular
surgeon. Diab Met Res Rev 2000; 16 (suppl 1): S27-S32.
187. Lepäntalo M, Isoniemi H, Kyllönen L. Can the failure of a below knee amputation be predicted?
Ann Chir Gyn 1987; 76: 119-123.
188. Lepäntalo M, Kallio M. Diabetic foot. In: Geroulakos G, van Urk H, Hobson II RW, Calligaro
KD. Eds. Vascular Surgery. Cases, questions and commentaries. Springer London. 2003: 191-
1999.
189. Lepäntalo M, Kallio M. Diabetic foot. In: Geroulakos G, Van Urk H, Hobson RW II, Caligaro KD
(Eds). Vascular Surgery. Cases, questions and commentaries. Springer Verlag, London, Berlin,
Heidelberg, 2003. pp: 191-199.
190. Lepäntalo M, Lassila R. Smoking and occlusive peripheral arterial disease. Eur J Surg 1991; 157:
83-87.
191. Lepäntalo M, Lindfors O, Pekkola P. The ankle/arm systolic blood pressure ratio as a screening
test for arterial insufficiency in the lower limb. Ann Chir Gyn 1983; 72: 57-62.
192. Lepäntalo M, Tukianen E. Advanced leg salvage. Perspectives in Vascular Surgery and
Endovascular Therapy 2002; 15 (1): 27-41.
193. Lepäntalo M, von Bell M, Määttälä P, Malmberg P. Vascular laboratory for the surgeon. Int J
Angiol 1997; 6: 104-109.
194. Lepäntalo MJA, Haajanen J, Lindfors O, Paavolainen P, Scheinin TM. Predictive value of
preoperative segmental blood pressure. Acta Chir Scand 1982; 148:581-584. 
94
195. Leskinen Y, Salenius JP, Lehtimäki T, Huhtala H, Saha H. The prevalence of peripheral arterial
disease and medial arterial calcification in patients with chronic renal failure: Requirements for
diagnostics. Am J Kidney Dis 2002; 40 (3): 472-479.
196. Lezack JD, Carter SA. Systolic pressures in the extremities of man with special reference to the
toes. Can J Physiol Pharmacol 1970; 48´: 469-474.
197. Liedberg E, Persson BM. Age, diabetes and smoking in lower limb amputation for arterial
occlusive disease. Acta Orthop Scand 1983; 54: 383-388.
198. Linde B. Mätning av blodflöde med pletysmografisk teknik. In: Jogestrand T, Rosfors S. eds.
Klinisk fysiologisk kärldiagnostik. Studentlitteratur, Lund, 2002, p. 327-336.
199. Lindholt JS, BøvlingS, Fasting H, Henneberg EW. Vascular surgery reduces the frequency of
lower limb major amputations. Eur J Vasc Surg 1994; 8: 31-35.
200. Lindholt JS, Fasting H, Henneberg EW, Østergaard L. A review of chlamydia pneumoniae and
atherosclerosis. Eur J Vasc Endovasc Surg 1999; 17: 283-289. – b –
201. Lindholt JS, Vammen S, Lind I, Fasting H, Henneberg EW. The progression of lower limb
atherosclerosis is associated with IgA-antibodies against chlamydia pneumoniae. Eur J Vasc
Endovasc Surg 1999; 18: 527-529. – a –
202. Lipid Research Clinics Program. The Lipid Research Clinics coronary primary prevention trial
results. I. Reduction in incidence of coronary heart disease. JAMA 1984; 251 (3): 351-364.
203. LoGerfo FW, Coffman JD. Vascular and microvascular disease in the foot in diabetes. N Engl J
Med 1984; 311 (25): 1615-1619.
204. LoGerfo FW, Marcaccio EJ. Etiology and assessment of ischaemia in the diabetic. Ann Chir Gyn
1992; 81: 122-124.
205. Ludbrook J, Clarke AM, McKenzie JK. Significance of absent ankle pulse. Brit Med J 1962; 1:
1724-1726.
206. Luján S, Criado E, Puras E, Izquierdo LM. Duplex scanning or arteriography for preoperative
planning of lower limb revascularisation. Eur J Vasc Endovasc Surg 2002, 24: 31-36. 
207. Lukkari-Rautiainen E, Lepäntalo M, Pietilä J. Reproducibility of skin blood flow, perfusion
pressure and oxygen tension measurements in advanced lower limb ischaemia. Eur J Vasc Surg
1989; 3: 345-350.
208. Lundell A, Lindblad B, Bergqvist D, Hansen F. Femoropopliteal-crural graft patency is improved
by an intensive surveillance program: A prospective randomised study. J Vasc Surg 1995; 21: 26-
34.
209. Lusis JA. Atherosclerosis. Nature 2000; 407: 233-235.
210. Luther M. The influence of arterial reconstructive surgery on the outcome of critical leg ischaemia.
Eur J Vasc Surg 1994; 8: 682-689.
95
211. Luther M. Surgical treatment for chronic critical leg ischaemia: A 5 year follow-up of
socioeconomic outcome. Eur J Vasc Endovasc Surg 1997; 13: 452-459. – c – 
212. Luther M. Klaudikation, kritisk iskemi och livskvalitet. Finska Läkaresällskapets Handlingar
2002; 162 (2): 14-19. 
213. Luther M, Albäck A. Acute leg ischaemia – a case for the junior surgeon? Ann Chir Gyn 1995; 84:
373-378.
214. Luther M, Kantonen I, Lepäntalo M, Salenius J-P, Ylönen K for the Finnvasc Study group.
Arterial interventions and reduction of amputations for chronic critical leg ischaemia. Br J Surg
2000; 87(4): 454-458.
215. Luther M, Lepäntalo M. Femoropopliteal reconstructions – influence of risk factors on outcome.
Ann Chir Gynaecol 1996; 85: 238-246. – b – 
216. Luther M, Lepäntalo M. Arterial reconstructions to the foot arteries – a viable option? Eur J Surg
1997; 163: 659-665. – a – 
217. Luther M, Lepäntalo M. Femorotibial reconstructions for chronic critical leg ischaemia – influence
on outcome by diabetes, gender and age. Eur J Vasc Endovasc Surg 1997; 13: 569-577. – b –
218. Luther M, Lepäntalo M, Albäck A, Mätzke S. Amputation rates as a measure of vascular surgical
results. Br J Surg 1996; 83: 241-244 – a –
219. Lääperi T, Pohjolainen T, Alaranta H, Kärkkäinen M. Lower-limb amputations. Ann Chir Gyn
1993; 82: 183-187. 
220. MacMahon S, Cutler JA, Stamler J. Antihypertensive drug treatment. Potential, Expected and
observed effects on stroke and on coronary heart disease. Hypertension 1989; 13 (suppl I): I-45 –
I-50.
221. Magee TR, Stanley PRW, Al Mufti R, Simpson L, Campbell WB. Should we palpate foot pulses?
Annals of the royal college of surgeons of England 1992; 74: 166-168.
222. Mattes E, Norman PE, Jamrozik K. Falling incidence of amputations for peripheral occlusive
arterial disease in Western Australia between 1980 and 1992. Eur J Vasc Endovasc Surg 1997; 13:
14-22.
223. McCabe, CJ, Reidy NC, Abbott WM, Fulchino DM, Brewster DC. The value of
electrocardiogrphic monitoring during treadmill testing for peripheral vascular disease. Surgery
1981; 89: 183-186.
224. McDermott MM, Feinglass J, Slavensky R, Pearce WH. The ankle-brachial index as a predictor of
survival in patients with peripheral vascular disease. J Gen Intern Med 1994; 9: 445-449.
225. McDermott MM, Greenland P, Liu K, Guralnik JM, Celic L, Criqui MH, Chan C, Martin GJ,
Schneider J, Pearce WH, Taylor LM, Clark E. The ankle brachial index is associated with leg
function and physical activity; the walking and leg circulation study. Ann Int Med 2002; 136 (12):
873-883.
96
226. McGregor AS, Price JF, Hau CM, Lee JA, Carson MN, Fowkes FGR. Role of systolic blood
pressure and plasma trigycerides in diabetic peripheral arterial disease: The Edinburgh artery
study.  Diabetes Care 1999; 22 (3): 453-458.
227. McMillan DE. Development of vascular complications in diabetes. Vasc Med 1997; 2: 132-142.
228. Meade TW, Gardner MJ, Cannon P, Richardson PC. Observer variability in recording the
peripheral pulses. Brit Heart J 1968; 30: 661-665.
229. Mehta T, Venkata Subramaniam A, Chetter I, McCollum P. Disease-specific quality of life
assessment in intermittent claudication: review. Eur J Vasc Endovasc Surg 2003; 25 (3): 202-208.
230. Meijer WT, Hoes AW, Rutgers D, Bots ML, Hofman A, Grobbee DE. Periperal arterial disease in
the elderly. The Rotterdam study. Arterioscler Thromb Vasc Biol 1998; 18: 185-192.
231. Meillère D, Berrahal D, Desgranges P, Allaire E, Becquemin JP, Perlemuter L, Simon D.
Influence of diabetes on revascularisation procedures of the aorta and lower limb arteries: Early
results. Eur J Vasc Endovasc Surg 1999; 17: 438-441.
232. Michaels JA, Rutter P, Collin J, Legg FM, Galland RB. Relation between rates of leg amputation
and distal arterial reconstructive surgery. BMJ 1994; 309: 1479-1480.
233. Mohan IV, Berwanger CS, Mikhailidis D, Stansby G. Thromboembolic phenomenon in
hyperhomocysteinaemia is mediated by increased platelet activation. Br J Surg 1999; 86 (suppl 1):
82. – b –
234. Mohan IV, Berwanger CS, Ratnayaka I, Richmond W, Stansby G. Hyperhomocysteinaemia: a
common and treatable risk factor for all types of vascular disease. Br J Surg 1999; 86 (suppl 1):
82. – a –
235. Moore WS, Malone JM. Amputation level determination using isotope clearance techniques. In:
Bernstein EF Ed. Noninvasive diagnostic techniques in vascular disease. C.V.Mosby. St. Louis,
Toronto, Princeton. 1985 pp. 602-613.
236. Morgan MBF, Crayford T, Murrin B, Fraser SCA. Developing the vascular quality of life
questionnaire: A new disease-specific quality of life measure for use in lower limb ischemia. J
Vasc Surg 2001; 33: 679-687.
237. Morrison C, Woodward M, Leslie W, Tunstall-Pedoe H. Effect of socioeconomic group on
incidence of, management of, and survival after myocardial infarction and coronary death: analysis
of community coronary event register. Brit Med J 1997; 314: 541-546.
238. Murabito JM, Agostino RB, Silbershatz H, Wilson PWF. Intermittent claudication. A risk profile
from the Framingham heart study. Circulation 1997; 96 (1): 44-49.
239. Myers RR, Murakami H, Powell HC. Reduced nerve blood flow in edematous neuropathies: a
biomechanical mechanism. Microvasc Res 1986; 32:145-51. 
240. Myhre HO. Reactive hyperaemia of the human lower limb. Measurement of postischaemic blood
flow velocity in controls and in patients with lower limb atherosclerosis. Vasa 1975; 4 (2): 145-
149.  – a – 
97
241. Myhre HO. Reactive hyperaemia of the human lower limb. Vasa 1975; 4 (3): 227-234. – b –
242. Myhre HO. European vascular surgery 1988. Increasing needs in an era of constrained economical
resources. Eur J Vasc Surg 1989; 3: 1-4.
243. Mäkisalo H, Lepäntalo M, Halme L, Lund T, Peltonen S, Salmela K, Ahonen J. Peripheral arterial
disease as a predictor of outcome after renal transplantation. Transpl Int 1998; 11(suppl): S140-
S143.
244. Mätzke S, Biancari F, Ihlberg L, Albäck A, Kantonen I, Railo M, Lepäntalo M. Increased
preoperative C-reactive protein level as a prognostic factor for postoperative amputation after
femoropopliteal bypass surgery for CLI. Annales Chirurgiae et Gynaecologiae 2001; 90: 19-22.
245. Mätzke S, Tukianen E, Lepäntalo M. Survival of a microvascular flap despite the late occlusion of
the inflow artery in a neuroischaemic diabetic foot. Scand J Plast Reconstr Hand Surg 1997; 31:
71-75.
246. Naumann M. Der Blutdruck in der Arterie dorsalis pedis in der Norm und bei Kreislaufstörungen.
Z Kreislaufforschg 1933; 31: 513 (*)
247. Nehler MR, Moneta GL, Edwards JM, Yeager RA, Taylor LM, Porter JM. Surgery for chronic
lower extremity ischemia in patients eighty or more years of age: Operative results and assessment
of postoperative independence. J Vasc Surg 1993; 18: 618-626.
248. Newman AB, Siscovick DS, Manolio TA, Polak J, Fried LP, Borhani NO, Wolfson SK. Ankle-
arm index as a marker of atherosclerosis in the cardiovascular health study. Circulation 1993; 88:
837-845. – b –
249. Newman AB, Sutton-Tyrell K, Vogt MT, Kuller LH. Morbidity and mortality in hypertensive
adults with a low ankle/arm blood pressure index. JAMA 1993; 270 (4) 487-489 – a –
250. Newrick PG, Wilson JA, Jakubowski J, Boulton AJM, Ward JD. Sural nerve oxygen tension in
diabetes. 
251. Nicholas GG, Myers JL, De Muth WE Jr. The role of vascular laboratory criteria in the selection
of patients for lower extremity ampution. Annals of Surgery 1982; 195 (4): 469-473. (*)
252. Nicolaides AN, Angelides NS. Applications of isotope technology to the clinical study of arterial
disease. In: Bernstein EF Ed. Noninvasive diagnostic techniques in vascular disease. C.V.Mosby.
St. Louis, Toronto, Princeton. 1985 pp. 592-601.
253. Nielsen PE, Bell G, Lassen NA. The measurement of digital systolic blood pressure by strain
gauge technique. Scand J Clin Lab Invest 1972; 129 (4): 371-379.
254. Norgren L, Alwmark A, Ängqvist KA, Hedberg B, Bergqvist D, Takolander R, Claes G, Lundell
A, Holm J, Jivegård L, Risberg B, Örtengren T, Örtenwall P, Salenius J-P, Kaukinen S, Siitonen
O, Huttunen M, Ylitalo P, Nizankowski R, Szczelik A, Krolikowski W, Oberender H. A stable
prostacyclin analogue (Iloprost) in the treatment of ischaemic ulcers of the lower limb. A
Scandinavian-Polish placebo controlled , randomised multicenter study. Eur J Vasc Surg 1990; 4:
463-467.
98
255. Nypaver TJ, Whyte BR, Endean ED, Schwarcz TH, Hyde GL. Nontraumatic lower extremity acute
arterial ischemia. Am J Surg 1998; 176(2): 147-152.
256. O’Brien TS, Lamont PM, Crow A, Gray DR, Collin J, Morris PJ. Lower limb ischaemia in the
octogenarian: is limb salvage surgery worthwhile? Ann Roy Coll Surg 1993; 75: 445-447.
257. Oishi CS, Fronek A, Golbranson FL. The role of noninvasive vascular studies in determining
levels of amputation. J Bone Joint Surg – Am vol 1988; 70(10): 1520-1530. (*)
258. Olin JW, Thromboangiitis obliterans (Buerger’s disease). In: Rutherford RB. Vascular Surgery.
Fifth Edition. WB Saunders, Philadelphia, London, Sydney, Toronto 2000 pp 350-364.
259. Olsson AG, Ruhn G, Erikson U. The effect of serum lipid regulation on the development of
femoral atherosclerosis in hyperlipidaemia: a non-randomised controlled study. J Intern Med 1990;
227: 381-390.
260. Opper C, Clement C, Schwarz H, Krappe J, Steinmetz A, Schneider J et al. Increased number of
high  sensitive platelets in hypercholesterolaemia, cardiovascular diseases and after incubation
with cholesterol. Atherosclerosis 1995; 113: 211-217. (*)
261. Ouriel K, Green RM, DeWeese JA, Cimino C. Activated protein C-resistance: Prevalence and
implications in peripheral vascular disase. J Vasc Surg 1996; 23: 46-52.
262. Paaske WP, Lepäntalo M, Troëng T. Outcomes of emergency vascular procedures in Scandinavia.
In: Barros D’Sa AAB, Andros G, Chant ADB. Eds. Emergency vascular and endovascular surgical
practice. Second edition. Arnold, London, Sydney, Auckland. in press. 
263. Panayiotopoulos YP, Reidy JF, Taylor PR. The concept of knee salvage: Why does a failed
femorocrural/pedal arterial bypass not affect the amputation level? Eur J Vasc Endovasc Surg
1997; 13: 477-485.
264. Parfitt AM. Soft-tissue calcification in uremia. Arch Intern Med 1969; 124: 544-556.
265. Pasterkamp G, Algra A, Grobbee DE, de Jaegere PPT, Banga JD, van der Graaf Y. Homocysteine
and the stage of atherosclerotic disease: a study in patients suffering from clinically silent and
clinically manifest atherosclerotic disease. Eur J Clin Invest 2002; 32 (5): 309-315. 
266. Pearlman RA, Uhlmann RF. Quality of life in chronic diseases: Perceptions of elderly patients.
Journal of Gerontology 1988; 43(2): M25—M30. 
267. Pecoraro RE, Reiber GE, Burgess  EM. Pathways to diabetic limb amputation: basis for
prevention. Diabetes care 1990; 113: 513-521. 
268. Pedersen TR, Kjekshus J, Pyörälä K, Olsson AG, Cook TJ, Musliner TA, Tobert JA, Haghfelt T.
Effect of Simvastatin on ischemic signs and symptoms in the Scandinavian Simvastatin Survival
Study (4S). Am J Cardiol 1998; 81: 333-335.
269. Pell JP. Impact of intermittent claudication on quality of life. Eur J Vasc Endovasc Surg 1995; 9:
469-472.
99
270. Pell JP, Fowkes FGR, Ruckley CV, Clarke J, Kendrick S, Boyd JH. Declining incidence of
amputation for arterial disease in Scotland. Eur J Vasc Surg 1994; 8: 602-606.
271. Pell S, D’Alonzo A. Factors associated with long-term survival of diabetics. JAMA 1970; 214:
1833-1840.   
272. Peltonen S, Biancari F, Lindgren L, Häkisalo H, Honkanen E, Lepäntalo M. Outcome of
infrainguinal bypass surgery for critical leg ischaemia in patients with chronic renal failure. Eur J
Vasc Endovasc Surg 1998; 15: 122-127.
273. Peräkylä T, Lepäntalo M. Accuracy of patients’ own estimate of intermittent claudication. Int J
Angiol 1998; 7: 62-64.  – a –
274. Peräkylä T, Lindholm H, Lepäntalo M. Can reactive hyperaemia be used instead of exercise test in
assessment of mild intermittent claudication. Ann Chir Gyn 1999; 88 (4): 276-279.
275. Peräkylä T, Tikkanen H, von Knorring J, Lepäntalo M. Poor reproducibility of exercise test in
assessment of claudication. Clinical Physiology 1998; 18 (3): 187-193. – b –
276. Pillsbury HC, Hung W, Kyle MC, Freis ED. Arterial pulse waves and velocity and systolic time
intervals in diabetic children. Am Heart J 1974; 87 (6): 783-790.
277. Pohjolainen T, Alaranta H. Lower limb amputation in southern Finland 1984-1985. Prosthetics
and Orthotics International 1988; 12: 9-18.
278. Quick CRG, Cotton LT. The measured effect of stopping smoking on intermittent claudication. Br
J surg 1982; 69 (suppl): S24-S26. 
279. Raines JK, Darling RC, Buth J, Brewster DC, Austen WG. Vascular laboratory criteria for the
management of peripheral vascular disease of the lower extremities. Surgery 1976; 79 (1): 21-29.
280. Ray SA, Srodon PD, Taylor RS, Dormandy JA. Reliability of ankle:brachial pressure index
measurement by junior doctors. Br J Surg 1994; 81: 188-190.
281. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988; 37: 1696-1607.
282. Reichard P, Nilsson RY, Rosenqvist U. The effect of long-term intensified insulin treatment on the
development of microvascular complications of diabetes mellitus. N Engl J Med 1993; 329: 304-
309. 
283. Remington JW, Wood EH. Formation of the peripheral pulse contour in man. J Appl Physiol
1956; 9: 433-442.
284. Reunanen A, Takkunen H, Aromaa A. Prevalence of intermittent claudication and its effect on
mortality. Acta Med Scand 1982; 211: 249-256.
285. Ridker PM, Hennekens CH, Roitman-Johnson B, Stampfer MJ, Allen J. Plasma concentration of
soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently
healthy men. Lancet 1998; 351: 88-92.
100
286. Roberts JC, Moses C, Wilkins RH. Autopsy studies in atherosclerosis. I Distribution and severity
of atherosclerosis in patients dying without morphologic evidence of atherosclertotic catastrophe.
Circulation 1959; 20: 511-519.
287. Rutherford Dow D. The incidence of arteriosclerosis in the arteries of the body. Br Med J 1925;
vol II : 162-163.
288. Rutherford RB, Baker JD, Ernst C, Johnston KW, Porter JM, Ahn S, Jones DN. Recommended
standards for reports dealing with lower extremity ischemia: Revised version. J Vasc Surg 1997;
26: 517-538. 
289. Salomaa V, Miettinen H, Niemelä M, Ketonen M, Mähönen M, Immonen-Räihä P, Lehto S,
Vuorenmaa T, Koskinen S, Palomäki P, Mustaniemi H, Kaarsalo E, Arstila M, Torppa J,
Kuulasmaa K, Puska P, Pyörälä K, Tuomilehto J. Relation of socioeconomic position to the case
fatality, prognosis and treatment of myocardial infarction events; the FINMONICA MI register
study. J Epidem Community Health 2001; 55: 475-482. 
290. Salonen R, Nyyssönen K, Porkkala E, Rummukainen J, Belder R, Park J-S, Salonen JT. Kuopio
Atherosclerosis Prevention Study (KAPS). A population-based primary preventive trial of the
effect of LDL lowering on atherosclerotic progression in carotid and femoral arteries. Circulation
1995; 92: 1758-1764. 
291. Sambraus HW. Die hydrostatische Zehendruckmessung. Dtsch Med Wschr 1996; 121: 364-368.
292. Sandemann DD, Shore AC, Tooke JE. Relation of skin capillary pressure in patients with insulin-
dependent diabetes mellitus to complications and metabolic control. N Engl Med 1992; 327: 760-
764.
293. Satomura S. Study of flow patterns in peripheral arteries by ultrasonics. J Acoust Science Jpn
1959; 15: 151 (*)
294. Sawka AM, Carter SA. Effect of temperature on digital systolic pressures in lower limb in arterial
disease. Circulation 1992; 85: 1097-1101.
295. Sayers RD, Thompson MM, Varty K, Jagger C, Bell PRF. Changing trends in the management of
lower limb ischaemia: a 17-year review. Br J Surg 1993; 80: 1269-1273.
296. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444
patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). The
Lancet 1994; 344: 1383-1389.
297. Schilling FJ, Christakis G, Hempel HH, Orbach A. The natural history of abdominal aortic and
iliac atherosclerosis as detected by lateral abdominal roentgenograms in 2663 males. J Chron Dis
1974; 27: 37-45.
298. Schroll M, Munck O. Estimation of peripheral arterisclerotic disease by ankle blood pressure
measurements in a population study of 60-year old men and women. J Chron.Dis 1981; 34: 261-
269.
299. Second European Consensus Document on Chronic Critical Leg Ischaemia. Eur J Vasc Surg 1992;
6: suppl A.
101
300. Shearman CP, Chulakadabba A. The pathophysiology of critical leg ischaemia. In: Branchereau A,
Jacobs M (eds.) Critical limb ischemia. Futura publishing. New York 1999, p 11-18.
301. Shinton R, Beevers G. Meta-analysis of relation between cigarette smoking and stroke. BMJ 1989;
298: 789-791. 
302. Shore AC, Sandeman DD, Tooke JE. Effect of an increase in systemic blood pressure on nailfold
capillary pressure in humans. Am J Physiol 1993; 265 (3): H820-823.
303. Slevin ML, Plant H, Lynch D, Drinkwater J, Gregory WM. Who should measure quality of life,
the doctor or the patient? Br J Cancer 1988; 57: 109-112.
304. Smith FCT, Shearman CP, Simms MH, Gwynn BR. Falsely elevated ankle pressures in severe leg
ischaemia: The pole test, an alternative approach. Eur J Vasc Endovasc Surg 1994; 8(4): 408-412.
305. Smith I, Franks PJ, Greenhalgh RM, Poulter NR, Powell JT. The influence of smoking cessation
and hypertriglyceridaemia on the progression of peripheral arterial disease and the onset of critical
ischaemia. Eur J Vasc Endovasc Surg 1996; 11: 402-408.
306. Sprung J, Abdelmalak B, Gottlieb A, Mayhew C, Hammel J, Levy PJ, O’Hara P, Hertzer NR.
Analysis of risk factors for myocardial infarction and cardiac mortality after major vascular
surgery. Anesthesiology 2000; 93 (1): 129-140.
307. Statistics Finland.  Statistical yearbook of Finland 2000. Otava. Keuruu. 2000; 95: 462-463 + 650-
651.
308. Stirnemann P, Walpoth B, Würsten HU, Graber P, Parli R, Althaus U. Influence of failed arterial
reconstruction on the outcome of major limb amputation. Surgery 1992; 111: 363-368). 
309. Stoffers HEJH, Rinkens PELM, Kester ADM, Kaiser V, Knotterus JA. The prevalence of
asymptomatic and unrecognised peripheral arterial occlusive disease. Int J Epidemiol 1996; 25:
282-290. 
310. Stoffers J, Kaiser V, Kester A, Schouten H, Knotterus A. Peripheral arterial occlusive disease in
general practice: the reproducibility of the ankle-arm-systolic pressure ratio. Scand J Prim Health
Care 1991; 9: 109-114. 
311. Stokes J, Kannel WB, Wolf PA, D’Agostino RB, Cupples LA. Blood pressure as a risk factor for
cardiovascular disease. The Framingham study – 30 years of follow-up. Hypertension 1989; 13
(suppl I): I-13 - I-18.
312. Strandness DE jun, Bell JW. An evaluation of the hemodynamic response of the claudicating
extremity to exercise. Surg Gyn.Obst 1964; 119, 1237-1242.
313. Strandness EE Jr, McCutcheon EP, Rushmer RR. Application of a transcutaneous Doppler
flowmeter in evaluation of occlusive arterial disease. Surg Gynecol Obstet 1966; 122: 1039-1045.
314. Straus SE, Majumdar SR, McAlister FA. New evidence for stroke prevention. JAMA 2002; 288
(11): 1388-1395. 
102
315. Sumner DS, Mattos MA. Influence of surveillance programs on femoral-distal bypass graft
patency. In: Yao JST, Pearce WH (Eds). The ischemic extremity: Advances in treatment. Norwalk
Connecticut: Appleton and Lange. 1995: pp 455-474.
316. Suzuki E, Kashiwagi A, Nishio Y, Egawa K, Shimizu S, Maegawa H, Haneda M, Yasuda H,
Morikawa S, Inubushi T, Kikkawa R. Increased arterial wall stiffness limits flow volume in the
lower extremities in type 2 diabetic patients. Diabetes 2001; 24 (12): 2107-2114.
317. Takahashi T, Nishizawa Y, Emoto M, Kawagishi T, Matsumoto N, Ishimura E, Inaba M, Okuno
Y, Shimada H, Morii H. Sympathetic function test of vasoconstrictor changes in foot arteries in
diabetic patients. Diabetes Care 1998; 21 (9): 1495-1501.
318. Takeuchi N, Kawamura T, Kanai A, Nakamura N, Uno T, Hara T, Sano T, Sakamoto N, Hamada
Y, Nakamura J, Hotta N. The effect of cigarette smoking on soluble adhesion molecules in middle
aged patients with type 2 diabetes mellitus. Diabet Med 2002; 19: 57-64.
319. Takolander R. Differentiation between acute and acute on chronic limb ischaemia. Ann Chir Gyn
1992; 2: 143-145.
320. Takolander R, Rauwerda JA. The use of noninvasive vascular assessment in diabetic patients with
foot lesions. Diabet Med 1995; 13 (suppl 1): S39-S42. (*)
321. Tan KH, Cotterell D, Sykes K, Sissons GRJ, de Cossart L, Edwards PR. Exercise training for
claudicants: changes in blood flow, cardiorespiratory status, metabolic functions, blood rheology
and lipid profile. Eur J Vasc Endovasc Surg 2000; 20: 72-78.
322. Taniwaki H, Shoji T, Emoto M, Kawagishi T, Ishimura E, Inaba M, Okuno Y, Nishizawa Y.
Femoral artery wall thickness and stiffness in evaluation of peripheral vascular disease in type 2
diabetes mellitus. Atherosclerosis 2001; 158: 207-214.
323. Taylor LM, Hamre D, Dalman RL, Porter JM. Limb salvage vs amputation for critical ischemia.
Arch Surg 1991; 126:1251-1258.
324. Tesfaye S, Malik R, Ward JD. Vascular factors in diabetic neuropathy. Diabetologia 1994; 37:
847-854.
325. The Criteria Committee of the New York Heart Association, Inc.: Diseases of the heart and blood
vessels; nomenclature and criteria for diagnosis, 6th ed Boston, Little, Brown, 1964. (*)
326. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment
of diabetes on the development and progression of long-term complications in insulin-dependent
diabetes mellitus. N Engl J Med 1993; 329: 977-986. 
327. The I.C.A.I. goup. Long-term mortality and its predictors in patients with critical leg ischaemia.
Eur J Vasc Endovasc Surg 1997; 14: 91-95.
328. The Vascular Surgical Society of  Great Britain and Ireland. Eur J Vasc Endovasc Surg 1995; 10:
108-113.
329. Thompson MM, Sayers RD, Varty K, Reid A, London NJM, Bell PRF. Chronic critical leg
ischaemia must be redefined. Eur J Vasc Surg 1993; 7: 420-426.
103
330. Thorsen H, McKenna S, Tennant A, Holstein P. Nottingham health profile scores predict the
outcome and support aggressive revascularisation for critical leg ischaemia. Eur J Vasc Endovasc
Surg 2002; 23: 495-499.
331. Tooke JE. Microvascular function in human diabetes: A physiological perspective. Diabetes 1995;
44 (7): 721-726.
332. Trans Atlantic Inter-Society Consensus Working Group (TASC). Management of peripheral
arterial disease. J Vasc Surg 2000; 31(1Pt2): S1-S296.
333. Trautner C, Haastert B, Giani G, Berger M. Incidence of lower limb amputations and diabetes.
Diabetes Care 1996; 19 (9): 1006-1009.
334. Treiman GS, Oderich GSC, Ashrafi A, Schneider PA. Management of ischemic heel ulceration
and gangrene: an evaluation of factors associated with successful healing. J Vasc Surg 2000; 31:
1110-1118.
335. Tsang GMK, Crowson MC, Hickey NC, Simms MH. Failed femorocrural reconstruction does not
prejudice amputation level. Br J Surg 1991; 78: 1479-1481.
336. Ubbink DT, Kitslaar PJEHM, Tordoir JHM, Reneman RS, Jacobs MJHM. Skin microcirculation
in diabetic and non-diabetic patients at different stages of lower limb ischaemia. Eur J Vasc Surg
1993; 7: 659-666.
337. Ubbink DT, Spincemaille GHJJ, Reneman RS, Jacobs MJHM. Prediction of imminent amputation
in patients with non-reconstructible leg ischemia by means of microcirculatory investigations. J
Vasc Surg 1999; 30 (1): 114-121
338. Ubbink DT, Tulevski II, de Graaff JC, Legemate DA, Jacobs MJHM. Optimisation of the non-
invasive assessment of critical limb ischaemia requiring invasive treatment. Eur J Vasc Endovasc
Surg 2000; 19 (2): 131-137.
339. UK Severe Limb Ischaemia Study Group. Treatment of limb threatening ischaemia with
intravenous iloprost: A randomised double blind placebo controlled study. Eur J Vasc Endovasc
Surg 1991; 5: 511-516.
340. Upchurch GR Jr, Keagy BA, Johnson G Jr. An acute phase reaction in diabetic patients with foot
ulcers. Cardiovasc Surg 1997; 5: 32-38.
341. Wahlberg E, Olofsson P, Swedenborg J, Fagrell B. Level of arterial obstruction in patients with
peripheral arterial occlusive disease (PAOD) determined by laser doppler fluxmetry. Eur J Vasc
Surg 1993; 7: 684-689.
342. Walker A. Ultraljudsteknik/Doppler. In: Jogestrand T, Rosfors S. eds. Klinisk fysiologisk
kärldiagnostik. Studentlitteratur, Lund, 2002, p. 47-59.
343. Van Damme H, Zhang L, Baguet E, Creemers E, Albert A, Limet R. Crural artery bypass with the
autogenous greater saphenous vein. Eur J Vasc Endovasc Surg 2003; 26 (6): 635-642.
344. Vankka E. Study on arteriosclerotics undergoing amputations. Acta Orthopaedica Scandinavica
1967; suppl 104.
104
345. van Soest MG, Breslau PJ, Jorning PJ, Greep JM. The clinical value of preoperative indirect
systolic ankle pressure measurements in wound healing after amputation of the lower extremity.
Netherlands Journal of  Surgery 1985; 37(3): 75-78. (*)
346. Watson CJE, Collin J. Estimates of distance by claudicants and vascular surgeons are inherently
unreliable. Eur J Vasc Endovasc Surg 1998; 16: 429-430.
347. Watson HR, Schroeder TV, Simms MH, Buth J, Horrocks M, Norgren L, Bergqvist for the
Iloprost bypass international study group. Relationship of femorodistal patency to clinical
outcome. Eur J Vasc Endovasc Surg 1999; 17: 77-83.  
348. Vayssariat M, Gouny P, Cheynel C, Gaitz J-P, Baudot N, Nussaume O. Haemodynamics of
patients with severe lower limb arterial disease: The critical aspects of critical leg ischaemia. Eur J
Vasc Endovasc Surg 1997; 14: 284-289.
349. Vehkavaara S, Mäkimattila S, Schlenzka A, Vakkilainen J, Westerbacka J, Yki-Järvinen H.
Insulin therapy improves endothelial function in type 2 diabetes. Arterioscler Thromb Vasc Biol
2000; 20 (2): 545.
350. Veith FJ, Gupta SK, Samson RH, Scher LA, Fell SC, Weiss P, Janko G, Flores SW, Rifkin H,
Bernstein G, Haimovici H, Gliedman ML, Sprayregen S. Progress in limb salvage by
reconstructive arterial surgery combined with new or improved adjunctive procedures. Ann Surg
1981; 194: 386-401.
351. Whelton PK, Klag MJ. Hypertension as a risk factor for renal disease. Hypertension 1989; 13
(suppl I): I-19 - I-27.
352. Widmer LK, Greensher A, Kannel WB. Occlusion of peripheral arteries. A study of 6400 working
subjects. Circulation 1964; 30: 836-842.
353. Winsor T. Influence of arterial disease on the systolic blood pressure gradients of the extremity.
Am J Med Sci 1950; 220: 117 (*)
354. Winsor T. The segmental plethysmograph. Angiology 1957; 8: 87-101.
355. Winsor T, Hyman C, Payne H. Exercise and limb circulation in health and disease. Arch Surg
1959; 78: 184-192.
356. Vogt MT, Cauley JA, Newman AB, Kuller LH, Hulley SB. Decreased ankle/arm blood pressure
index and mortality in elderly women. JAMA 1993; 270 (4): 465-469.
357. Vogt MT, Wolfson SK, Kuller L. Lower extremity arterial disease and the aging process: a review.
J Clin Epidemiol 1992; 45 (5): 529-542. 
358. Wolf PA, D’Agostino RB, Kannel WB, Bonita R, Belanger JA. Cigarette smoking as a risk factor
for stroke. JAMA 1988; 259: 1025-1029.
359. Wolfe JHN. Defining the outcome of critical leg ischaemia: a one year prospective study. Br J
Surg 1986 73: 321.
105
360. Wolfe JHN, Wyatt MG. Critical and subcritical ischaemia. Eur J Vasc Endovasc Surg 1997; 13:
578-582. 
361. von Knorring J, Lepäntalo M. Prediction of perioperative cardiac complications by
electrocardiographic monitoring during treadmill exercise testing before peripheral vascular
surgery. Surgery 1986; 99: 610-613. 
362. von Knorring J, Lepäntalo M. Effect of risk factors on outcome in patients with peripheral arterial
disease. Ann  Chir Gyn 1992; 81: 103-106.
363. von Knorring J, Lepäntalo M, Hietanen H, Peder M. Predicting of postoperative cardiac events
using ambulatory ECG monitoring prior to abdominal aortic surgery. Eur J Vasc Endovasc Surg
1995; 9: 610-613. 
364. Woodcock JP. Doppler ultasound in clinical diagnosis. British medical bulletin 1980; 36 (3): 243-
248. 
365. Yao ST, Hobbs JT, Irvine WT. Ankle systolic pressure measurements in arterial disease affecting
the lower extremities. Brit J Surg 1969; 56: 676-679.
366. Yki-Järvinen H. Management of type 2 diabetes mellitus and cardiovascular risk: lessons from
intervention trials. Drugs 2000; 60(5): 975-983.
367. Young MJ, Adams JE, Anderson GF, Boulton AJM, Cavanagh PR. Medial arterial calcification in
the feet of diabetic patients and matched non-diabetic control subjects. Diabetologia 1993; 36:
615-621.
368. Youssef F, Seifalien AM, Jagroop IA, Myint F, Baker D, Mikahilidis DP, Hamilton G. The early
effect of lipid lowering treatment on carotid and femoral intima media thickness. Eur J Vasc
Endovasc Surg 2002; 23: 358-364.
369. Zdanovski Z, Troeng T, Norgren L on behalf of the Swedish Vascular Registry. Outcome and
influence of age after infrainguinal revascularisation in critical limb ischaemia. Eur J Vasc
Endovasc Surg 1998; 16: 137-141.
370. Ögren  M, Hedblad B, Engström G, Janzon L. Leg blood flow and long-term cardiovascular
prognosis in men with typical and atypical intermittent claudication. Eur J Vasc Endovasc Surg
2003; 26: 272-279.
 
106
14.  ORIGINAL PUBLICATIONS
107
15.  APPENDIX
Questionnaire for patients attending to the vascular outpatient clinic or the ward: 
NAME_____________________ID_____________________
Date__________________________
Questions to be asked: 
History and risk factors
Smoking  yes duration __________ amount___________
 no has quit __________ ago
Does the patient have at present /Did the patient use to have?:   Y=yes, N=no
Diabetes      Y  N     duration___________    insulin dependent diabetes    Y  N
Hypertension    Y  N    duration___________    Hyperlipidaemia  Y  N 
Chest pain/dyspnea during exercise  Y  N Myocardial infarction Y  N         CABG      Y  N
 
Renal disease   Y  N   Serum-Kreatinine____________ Pulmonary disease    Y  N
    Renal transplantation             Dialysis        
Previous vascular surgery  Y  N          Brain infarction/TIA   Y  N
What procedure _________________________________
When did the patient first turn to a doctor due the present complaint in the legs?
_________________________ Where /To whom?__________________________________________
Symptoms Does the patient have....?
claudication        Yes         No
if yes: for how long?
  Location? right left
foot foot
calf calf
thigh thigh
buttock buttock
other, specify other, specify
Nature of the symptoms?     pain          numbness etc.
When do the symptoms occur?
       at home         outsideof the thouse        walking uphill         other , specify________
Do the symptoms disappear after rest?           Yes, how soon________             No   
Does the pain ever disappear while walking?  Yes         No
Does the patient have to stop walking because of some other complaint?  
      Yes, which complaint_____________________________             No
Did the patient previously experience claudication pain, that has subsequently subsided?
       Yes, Location            No 
108
Rest pain  Yes        No
if yes: Duration
  Location right left
toe toe
foot foot
ankle ankle
calf calf
other, specify other, specify
Does the patient need regular pain killers for the rest pain?       Yes                 No 
Ulcers Yes         No 
if yes: Duration
  Location right left
toe toe
foot foot
ankle ankle
calf calf
other, specify other, specify
Did the patient have previous ulcers that have healed after therapy?        Yes      No
Location?
Gangrene Yes          No 
if yes: Duration
 Location right left
toe toe
foot foot
ankle ankle
calf calf
other, specify other, specify
Vascular lab: date:__ __ __ __ __ __
Pressures          DX         SIN other notes:
ankle TP   ______________  ______________
ankle DP   ______________  ______________
toe   ______________  ______________  
A.brachialis ______________  ______________  
ABI (ATP)   ______________  ______________
ABI (ADP)  ______________  ______________
